The calcinogenic principles of Trisetum flavescens by Levack, Valerie M.
  
 
 
This PDF was created from the British Library’s microfilm copy 
of the original thesis. As such the images are greyscale and no 
colour was captured. 
 
Due to the scanning process, an area greater than the page 
area is recorded and extraneous details can be captured. 
 
This is the best available copy 
IMAGING SERVICES NORTH                                          
Boston Spa, Wetherby 
West Yorkshire, LS23 7BQ 
www.bl.uk 
 

>
.nt
^  *r •
i t ì c e i l t i o n  i s r - ^ r a :
copyiight ot tills thesis rests witJi its author. "
• •  ^  ^ _
This copy of the thesis has been supplied 
on condition that anyone who consults it is • 
K upderstood to recognise that its copyright rests 
^ th  its autlwr and that no quotation from  
toe thesis and no information derived from it 
^ y  be published X without the author’s prior 
[tten consent. - ■ ^Jli
P  ; ? , 9 3 4 / ? 7
LtVACK V^-
CíÁa^ f^ oJ^
\)c~Pr^
Z ( o S
Of Loffíy»^
' ( C  N f \ ^  '

CONTENTS
PAGE NO.
1. Abstract....................................................... 1
2. Acknowledgements.............................................  (xiv)
3. Chapter 1
LITERATURE REVIEW .........................................  2
1:1 The Significance of Plant-induced Calcinosis..........  5
1:2 Endocrine Control of Calcium Metabolism.............  15
1:3 The Relationships Between the Vitamin D Endocrine
3
System and the Known Calcinogenic Plants •••••« . .....  AO
Sumnary................................................ 55
A, Chapter 2
GENERAL METHODS .............................................  57
2:1 Preparation of Extracts of Trisetum flavescens
Using Aqueous and Organic Solvents .................. 58
2:2 Techniques for the Analysis of Plasoia Minerals
and Alkaline Phosphatase.............................  55
2:3 Liquid Scintillation Counting........................ 71
2:A Bone Culture Technique.......... .....................  yy
5. Chapter 3
The Biological Activity of Organic Soluble Extracts
of Trisetum flavescens...........  ................. . 8A
Experiment 1 Demonstration of the Ability of Organic
Solvent Soluble Extracts of Trisetum flavescens to Promote
Radiophosphate Uptake from the I l e u m ....................  86
^ e r i m e n t  2 An Investigation into the Effects
of a Purified Organic Extract of Trisetum flavescens
on Radiocalcium Transport Across the Duodenum............  98
PAGE NO.
5. Chapter 3 Contd/...
Experiment 3 The Effects of a Purified, Organic
Soluble, Extract of Trisetum flavesoena on Bone
Cultured ^  v i t r o .........................................  iq4
6. Chapter A
The Biological Activity of Aqueous Soluble
Extracts of Trisetum flavescens ....................... 113
Experiment 1 A Comparison of the Effects of a Crude 
Aqueous Extract and a Partially Purified Aqueous Extract of
Trisetum flavescens on Vitamin D^-Deficient Chicks......  115
Experiment 2 Evidence for the Potentiation of
Biologically Active Substances by the G u t ...............  120
Experiment 3 Ultra-violet Spectroscopy of Aqueous 
Extracts of Trisetum flavescens Following
Sephadex Chromatography................................... j25
Experiment A(i) The "Strontium Chick” Model ............. 129
Experiment A(ii) Experiment to Determine the 
Effects of a Crude Aqueous Extract of Trisetum
flavescens in the "Strontium Chick"...................... 133
p é r i m e n t  5 A  Comparison of the Effects of "Peak 3" and 
"Peak A" on Radio-calcium Uptake from the Gut,
in the "Strontium Chick" .................................. 137
Experiment 6(i) The Effects of "Peak A" on Plasma 
Calcium and Phosphate in Vitamin D^-Deficient Chicks....  lAA
^eperiment 6(ii) Examination of the Effect of 
A" on Plasma Calciiim and Phosphate in 
Vitamin IKreplete Chicks .................................. 151
(ii)
PAGE NO.
6. Chapter 4 Contd/...
Experiment 7 An Investigation into the 
Relative Effects of "Peak 4" and Vitamin
on Ileal Radio-Phosphate Uptake .........................  157
Experiment 8 The Effect of Partially Purified 
Aqueous Extracts of Trisetum flavescens on 
Bone Cultured ^  v i t r o ....................................
7. Chapter 5
Partial Purification and Characterisation of
Experiment 1 Evidence that the Biologically 
Active Eluate from the Liquid Chromatography
1:1 Examination of the Ultra-*violet
1:4 Polarimetry ...............................
Experiment 2 Evidence that the Phosphataemic 
Fraction Contains no Substances Structurally 
Similar to Vitamin .........................
2:3 Comparison Between Vitamin D and the
3
Phosphataemic Fraction Using X-ray
(iii)
PAGE NO.
198
TJST OF TABLES
PAGE NO.
Table 1
The Distribution of Pastoral Calcinosis ................  13
Table 2
Composition of Standard Calcium Solutions ..............  66
Table 3
Relationship Between Level of Formic Acid and Quench ... 73 
Table A
Table Showing Optimum Level of Solubilised Tissue
for Counting.............................................. 74
Table 5
The Optimum Level of Lumen Contents per Vial ........... 75
Table 6
Dosing Regimen ............................................ 87
Table 7
Effects Upon Blood Parameters of Chicks Treated with
Various Organic Extracts of Trisetum flavescens ........ 90
Table 8
To Show the Results for the Neasurenents of the Transport 
32of Phosphate Across the Gut Wall as the Result of 
Administration of Organic Solvent-Soluble Extracts of
Trisetum flavescens ......................................  93
Table 9
Dosing Regimen ...........................................  99
Table 10
Plasma Calcium and Phosphate levels in Vitamin D^-Deficient 
Chicks Treated with an Active, Organic Solvent Soluble 
Extract of Trisetum flavescens and untreated controls. ..100
PAGE NO.
Table 11
45Duodenal Calcium Transport in Vitamin 
D-deficient Chicks Treated with Either 
Vitamin or an Organic Soluble Extract
of Trisetum flavescens ...........................  jqj
Table 12
Treatment Regimen for Cultured Bones ............. ....... 105
Table 13 
45Calcium Released from Pre-labelled Calvariae
for each Treatment.......................................  107
Table 14
• 40Medium Total Calcium, Inorganic Phosphate
and Glucose Levels of Bones Cultured in vitro ........... 109
Table 15
Dosing Regimen ............................................. ^^ 5
Table 16
The Effects of Two Aqueous Extracts of 
Trisetum flavescens on Plasma Levels of 
Calcium, Inorganic Phosphate and Alkaline
Phosphatase in Vitamin IHdeficient Chicks...............  117
Table 17
Dosing Regimen............................................  121
Table 18
Effects of Dosing Site on Plasma Calcium and 
Phosphate Levels 122
Table 19
Effects of Vitamin D^ and Calcitriol on 
Several Plasma Constituents in Strontium
Treated Chicks 131
(Vi)
PAGE NO.
Table 20
The Effect of a Crude Aqueous Extract on Plasma 
Calcium, Inorganic Phosphate and Radiocalcium
Transport ............................................  ^^ 4
Table 21
Dosing Regimen .................................
Table 22
The Effects of "Peak 3" and "Peak A" on Plasma
Calcium, Phosphate and Strontium Levels . ................ 139
Table 23
Table to Show the Effects of "Peak 3" and "Peak A" on
Duodenal Calcium Transport in the Chick ................  lAO
Table 2A
Treatment of Experimental Groups ..........   144
Table 25
Plasma Calcium and Phosphate Changes in
Chicks Dosed with "Peak A".............................  4^5
Table 26
Changes in Plasma Calcium and Phosphate in
Response to Oral Administration of "Peak A"..............  152
Table 27
Dosing Regimen.............................................  X58
Table 28
The Effects of Vitamin D^ and "Peak A" upon Plasma 
Calcium, Plasma Phosphate and Radio-Phosphate Absorption . 159
(vii)
PAGE NO.
Table 29
Dosing Regimen ............................................
Table 30
Sampling Times of Tissue Culture Medium .................  165
Table 31
Table to Show the Effects on Medium Calcium 
and Phosphate Levels of "Peak 3" and "Peak 4"
and Glucose Utilisation.................. ........ ...... 165
Table 32
The Effects of "Peak 4" l^on Radiocalcium
Release from Pre-labelled Bones .........................  167
Table 33
Ratios of Absorption Maxima Intensity of 
Fractions Obtained from a Sephadex G15 
Column and a Sançle of Partially Purified 
Trisetum flavescens Extract Containing the
Phosphataemic Principle................... .............. 174
Table 34
Table to Show Relative Peak Heights of
Fractions Obtained from a Preparative
Sephadex G25 Column, in the Region of the
Phosphataemic Principle ..................................  175
(viii)
PAGE NO.
Table 35
Choice of a Suitable Mobile and Stationary Phase ....... 180
Table 36
Reagents Used in the Characterisation of
"Peak A" Fractions......................................  i82
Table 37
Sample Positions ..........................................  191
Table 38
Comparison of the Physiological Effects of the Three
Calcinogenic Factors of Trisetum flavescens with
Whole Lyophilised Plant L e a f .............................  215
(ix)
PAGE NO.
LIST OF FIGURES 
Figure I
The Pathway of Biosynthesis of Vitamin D
Metabolites............     16
Figure 2
The Calcium Homeostatic Cycle ............................  20
Figure 3
The Elution Profile at 280nm of a Crude
Aqueous Extract of Trisetum flavescens
Following Sephadex Chromatography........................ 61
Figure 4
Steps in the Preparation of an Organic
Soluble Extract ..........................................  63
Figure 5
p-Nitrophenol Standard Curve............................... 70
Figure 6
Histogram Showing Levels of Radiophosphate
Absorbed by the Ileum of Vitamin D^deficient
3
Chicks Dosed with Organic Soluble Plant Extracts ......... 95
Figure 7
The Effects of Organic Extracts of Trisetum
flavescens on ^^Calcium Release from Bone
y ^ t r o ....................................................  108
Figure 8
Typical Elution Profile of the Separation of
a Crude Aqueous Extract of Trisetum flavescens.
Showing Peaks Containing the Biologically
Active Material ..........................................  126
(X)
PAGE NO.
Figure 9
Absorption Spectra of Fractions from under
"Peak 3" and "Peak 4 " ................................. . \21
Figure 10
Plasma Phosphate Response to either "Peak 4"
or Vitamin in Vitamin D-de£icient Chicks.............  147j 3
Figure 11
Plasma Calcium Response to either "Peak 4"
or Vitamin D3 in Vitamin IKdeficient Chicks.............  148
Figure 12
Variations in [Ca x P^] with Time in
"Peak 4" or Vitamin D3-dosed Chicks...................... 149
Figure 13
Plasma Calcium and Phosphate Responses in
Vitamin D^replete Chicks Dosed with3
"Peak 4 " ................................................... I53
Figure 14
Variations in [Ca x P^] with Time in 
Vitamin D^replete Chicks Dosed with
"Peak 4".................................................... 154
Figure 15 
45Calcium Release from Bones Cultured
and Treated with Aqueous Soluble
Extracts of Trisetum flavescens ..........    168
Figure 16
Absorption Spectrum of Fluorescent Component
of "Peak 4" ......................      177
(xi)

LIST OF PLATES PAGE NO.
Dimethylaminocinnemaldehyde Reagent....................... 18A
lodine/Potasaium Iodide Reagent...........................  185
Ehrlich's Reagent.........................................  186
Ehrlich's Reagent ..........................................  187
Fluorescein/Amnonia Reagent ................................  188
Alkaline Silver Nitrate Reagent...........................  189
Ferric Chloride/Potassium Ferricyanide Reagent...........  190
Powder X -*ray Diffraction Photography of
Vitamin D2 ................................................. 196
Powder X -ray Diffraction Photography of
Vitamin D^ ................................................. 196
Powder X -ray Diffraction Photogr^h of
"Peak 4 " .....................    195
(xiii)
ACKNOWLEDGEMENTS
I would like to acknowledge the valuable help and advice I have 
received from Dr. K.M.L. Morris and Dr. C. Brownson during the course 
of this project. I also thank the Agricultural Research Council for 
their financial support.
I am grateful to Mr. R. Ranasinghe for technical assistance. Miss 
Trudie Brogan and Mrs. J. Newman for typing the text and Miss K.V. Forster 
for proof reading.
Finally, I thank my parents for their help and encouragement over 
the years.
(xiv)
ABSTRACT
The Calcinogenic Principles of Trisetum flavescens.
Valerie M. Levack BSc.
Studies have been conducted on the calcinogenic plant Trisetum 
flavescens in order to determine the physiological actions and 
chemical nature of the toxic substance or substances.
An organic soluble substance was extracted and purified and shown 
to promote intestinal phosphate transport and increase plasma 
phosphate levels. This factor was shown to influence the movement 
of phosphate from the serosa to the bloodstream but not direct 
uptake from the intestinal lumen. This substance was found to be 
unlike vitamin D» or its hydroxy - metabolites in that it did not 
promote intestinSl calcium transport, or bone resorption when 
studied in vitro. This substance did decrease plasma alkaline 
phosphatase levels in vitamin D^->deficient chicks however.
An aqueous soluble extract was partially purified on a Sephadex 
column and found to promote an increase in plasma phosphate in both 
vitamin D^-replete and vlteunln D^-deficlent chicks. The extract was 
also able'^to Influence intestinal phosphate transport in a similar 
manner to the organic solvent soluble phosphataemlc factor. As both 
the aqueous soluble and organic solvent soluble factors were active 
in vitamin D^-deflclent chicks they were presumed to act upon the 
paracellular'^route for intestinal phosphate uptake. The aqueous 
soluble factor differed from the organic solvent soluble one in that 
its administration produced a dramatic decline in the plasma 
calcium levels of vitamin Do-deflcient chicks. The aqueous soluble 
factor MBS without effect upon bone cultured in vitro.
A second aqueous soluble extract was shown to increase intestinal 
transport of calcium in chicks with a metabolic deficiency of 
vitamin caused by the inclusion of strontium in the diet. This 
substance appears to be able to mimic the actions of 1,25(0H)2chole- 
calciferol.
The potent aqueous soluble phosphataemic factor is not related 
chemically to vitamin but has the characteristics of an aromatic 
indole or amine.
It is concluded that the actions of these three substances in 
raising plasma [Ca x results in calcinosis.

CHAPTER 1
INTRODUCTION
Calcinosis is a disease caused by the deposition of calcium and 
magnesium salts in the soft tissues of vertebrates as the result of 
the breakdown of the calcium regulatory system. Several plants 
have been implicated as causative agents having been found to promote 
an unregulated rise in the plasma levels of either calcium and/or 
phosphate» resulting in salt deposition in soft tissues. The extent 
of the debility experienced by an affected animal increases with 
time and seriously affects the economic value to the farmer» in terms 
of both milk yield and slaughter value.
Research into plant induced calcinosis began seriously in 1967 when 
the cause of enzootic calcinosis of cattle in the Argentinian province 
of Buenos Aires was ascribed to a toxic plant (Worker and Carrillo»
1967). This plant» Solanum malacoxylon, was later discovered to
contain an active form of vitamin D which caused serious malfunctions
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of the calcium regulatory system of ruminants. Subsequently» rapid 
advances were made involving the determination of the mechanism of 
action of the plant toxin and its identity as l»25(OH)2cholecalciferol. 
This progress was greatly facilitated because at the same time research
into the vitamin D endocrine system was also making rapid strides.
3
In 1971 l,25(OH)2cholecalciferol was discovered» and its role in calcium 
regulation in normal animals ascertained (Lawson» Fraser» Kodicek» Morris 
and Williams» 1971. Following the imderstanding of the relationship
between vitamin D metabolism and actions and Solanum malacoxylon
3
induced calcinosis» other plants were proposed as being responsible
for the disease in other parts of the world where Solanum malacoacylon 
was not present. Cestrum diumma (also a mend>er of the Solanaceae), 
and Solanum torvam have both been fotmd to cause similar signs to 
Solanum malacoacylon.
In 1973 it was discovered that calcinosis of cattle grazing in the 
foothills of the Austrian and Bavarian alps was caused by a member of 
the Graminae family (Dirksen, Flank, Hänichen and Spiess, 1973). This 
plant, Trisetum flavescens, was found to promote a high plasma phosphate 
level, with normal or slightly elevated calcium unlike the aforementioned 
Solanaceae which promoted elevated plasma calcium levels with little 
effect on phosphate. Thus, it appeared the calcinosis induced by 
Trisetum flavescens differed from that caused by other plants.
The early research on the calcinogenic activity of this plant was 
carried out using organic soluble extracts, but no substance was 
found which could be toxic to the extent noted in affected animals. 
The present research project was designed to elucidate whether or not 
organic soluble and/or water soluble calcinogens exist in the plant, 
and the nature of their physiological actions and chemical structure.
LITERATURE REVIEW
1:1 The Significance of Plant Induced Calcinosis.
Calcinosis in grazing animals is a problem in several parts of the 
world. The plants responsible for the disease have been found to belong 
to different families and to originate from both tropical and temperate 
regions. The existence of calcinosis was first established at the 
turn of the century (Lignieres, 1898). Lignieres reported on cattle 
suffering from calcinosis in Argentina. Later, Collier (1926), indicated 
that the disease was caused by the plant Solanum malacoxylon (syn.Solanum 
glaucophyllum). Unfortunately the work was overlooked for many years, 
and it was not until the 1960s that Solanum malacoxylon was "rediscovered" 
as the causative agent.
Prior to the 1960s Arnold (Arnold and Finchman,1950, Arnold, 1954) 
described the calcinosis problem found in Jamaica, where the disease 
is called 'Manchester Wasting Disease*. (The Manchester Uplands, Jamaica, 
is an area where the disease is commonly found). He did not realise 
that a plant was responsible but did associate the disease with certain 
types of grazing and reported the typical macroscopic signs of 
calcinosis in detail (Arnold, 1954). Affected animals had a stiff 
gait and found it difficult to lie down and stand up; they became 
anorexic, emaciated and listless and their milk yield eventually 
ceased. Young and in-calf heifers seemed to exhibit the most severe 
problems although no definite age or sex correlation was apparent. 
Internally, widespread calcifications were noted at the sites of all 
elastic and collagenous fibres. Of particular note was the deposition
of calcium salts In the alveolar walls of advanced cases. The extent 
of calcification in the lungs could be so severe that the lungs did not 
collapse when the thoracic wall was opened. In addition calcifications 
were visible in the aorta and other major and minor arteries and in the 
kidneys where crystals containing calcium phosphate and calcium carbonate 
were found.
In Argentina, the disease (known as "Enteque Seco") was responsible 
for the loss of about five to ten per cent of an affected herd each 
year. The incidence of the disease was known to vary with the season 
and to be associated with certain soil types (Worker and Carillo, 1967)• 
Animals would recover if moved from the area in which the disease was 
contracted,to one with different ('better') pasture (Tilley, 1967 ; 
Worker and Carillo, 1967).
In the early 1960s the low productivity of Argentine cattle was noticed 
by the United Nations Technical Assistance Board, and a five year 
project was initiated by the United Nations and the Argentine government 
to investigate the problem. "Enteque Seco" was quickly singled out 
for the study by the research group set up. The group identified a 
plant that was responsible for causing the calcifications and high 
levels of plasma calcium and phosphate; this was Solanum malacoxylon. 
This plant is a member of the Solanaceae and was a shrub found in 
abundance in the grazing areas harbouring the disease (Tilley, 1967).
The high toxicity of the plant was of particular note, and it was 
found that as little as fifty grams per week of dried leaves of Solanum 
malacoxylon could cause all the signs of "Enteque Seco" in cattle.
It was thought that cattle became ill by accidentally grazing the fallen 
leaves of the plant; they did not graze on the live plant preferentially.
Eradication of the plant from the pasture was the obvious means of 
dealing with the problem, but this proved inq>ractical, mainly because 
the plant has an extensive root system which sends up stems at a 
distance from the parent plant, and so the problem remained unsolved. 
However, research work into the mode of action of the plant toxin 
proceeded in various locations, leading rapidly to a clear understanding 
of the underlying pathophysiology.
Another plant was found to be responsible for the .calcinosis found 
in horses in Florida; this is Oestrum diumum ("Day-Blooming Jessamine"). 
The condition was first reported in 1970 by Krook and Vasserman (1975).
It was found that horses were severely affected three to four months 
after showing the first signs . The lesions were the same as those 
found in the Argentine cattle suffering from Solanum malacoxylon 
intoxication. Oestrum diumum was suspected as the cause as it was also 
a member of the Solanaceae and was found in the areas grazed by affected 
animals. Oestrum d i u m u m  is a sub-tropical to tropical erect shrub 
growing up to five metres in height; it was introduced in Florida 
and Oalifomia from the West Indies. The affected animals were found 
to have locomotory problems similar to those found in cattle with 
"Snteque Seco": they had high plasma calcium and phosphate levels 
and internally there was calcification of areas such as the aorta, left 
atrium, ligaments and cartilage.
Signs of calcinosis in cattle have also been reported from Papua,
New Guinea by Oopland (1975)• The affected animals were grazed in 
pine plantations. These tended to be young, introduced cattle. Again 
they showed typical calcinosis signs , such as stiff gait, pronounced 
wasting and increased levels of plasma calcium and phosphate. Several
plants, suspected of being causative agents, were tested (Morris,
Simonite, Pullen and Siiq>son, 1979) but only Solanum torvum (var.
Swartz) was found to be calcinotic, causing elevations in serum calcium 
and phosphate in rats.
The presence of enzootic calcinosis in Austria was first described 
by Libiseller and Gunhold (1969). In 1970,Dirksen's group described 
a new form of 'spontaneous* calcinosis in cattle reared on grassland 
farms in Germany, (Dirksen, Flank, Dammrich and Hänichen, 1970).
He described the pathological and anatomical features of the disease 
and found that they were very similar to those found by Arnold in Jamaica. 
However,no preponderance of Solanaceous species were found in the pasture.
Research workers presumed that a plant was responsible for the disease 
because of the earlier discovery of Solanum malacoxylon and also because 
the other diseases that might be responsible for the synqptoms (eg. 
osteomalacia, manganese deficiency,hyperparathyroidism) could be
discounted for one reason or another. The problems, however, 
resemble hypervitaminosis D^and so the coiq>arison could be made with 
"Enteque Seco" (Dirksen, 1975). Dirksen*s group therefore looked to 
the fodder composition for the answer.
Trisetum flavescens was soon identified as the calcinogenic plant by 
Dirksen, Plank, Hänichen and Spiess(1972, 1973) who fed rabbits with 
pure Trisetum flavescens and coiq>ared the development of arterial 
calcifications with groups fed on only Dactylis glomerate and mixed 
Graminae. Further experiments in sheep (Dirksen, 1975) confirmed 
Trisetum flavescens as the calcinogenic plant. It was found that in
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a severely affected animal, calcifications of the abdominal aorta could 
be felt in the live animal by palpation via the rectum. In Germany, 
up to half a herd could be affected, as opposed to the S-IOZ of 
animals affected in Argentina, although the onset of the disease 
appeared to be slower than in animals grazing the Solanaceous species. 
There was a time lag of twelve to thirty-six months before cattle 
grazing on the German pastures became seriously affected. Sheep fed 
only Trisetum flavescens developed macroscopic calcifications within 
fifty three days (Simon, Daniel, Hänichen and Dirksen, 1978) ^ Signs 
were often first noticed at the end of the summer, with the animals 
initially showing a humped back, (a synq>tom typical of the disease), 
difficulties with locomotion, particularly when rising, as well as 
reduced milk yield and general lethargy.
Signs of macroscopic calcifications in major arteries could be 
seen in experimental sheep grazed on lOOZ or 25Z Trisetum flavescens 
pasture, but not Trisetum flavescens - free pasture. The first signs 
of the development of calcinosis was calcification of the major 
arteries (Dirksen, Flank, Simon, Hänichen, Daniel and Spiess, 1974).
In affected cattle, serum calcium levels were generally in the upper 
physiological range, but serum phosphate was very much elevated (up 
to 12 mg/100 mis). Elevations in urinary phosl>hate were also noted.
The increase in serum phosphate was particularly evident towards the 
end of the summer, suggesting seasonality in the calcinosis inducing 
agent. Moving animals to a new environment caused a reduction in senim 
phosphate levels and they recovered within a few months. Necropsy 
findings showed calcinosis to be similar to that of animals 
suffering Solanum malacoxylon or Oestrum diumum intoxication.
Typically, calcifications occurred in the left atrium (the first site 
of calcium salt deposition), the arteries and lungs. There was also 
hardening of the digital flexor tendons where calcium foci were 
visible. In the arteries it appeared that destruction of elastic and 
collagenous fibres preceded calcification of these areas; the intima 
and elastic lamina increased in size, the arterial elastic fibres 
became swollen and fragmented and occasionally they were finely 
calcified. Dirksen concluded that metaplasia of the connective tissue 
was caused by fibroblasts which, when fibres become damaged, regenerate 
excessive connective tissue (Dirksen,Plank,Hänichen,Daniel and SpiessA974)
Microscopic examination of the bone tissue showed some major ab~ 
normalities. These could be termed as systematised osteo ~ myelosclerosis, 
which meant that new layers of bone had been laid down which were 
more highly mineralised than normal bone. This generalised excess of 
bone formation was explained as an Increase in bone tissue formation 
rather than to a cessation of bone resorption.
It would appear that the management of pastures in German alpine 
regions prone to calcinosis is detrimental, in that it encouraged the 
prevalence of Trisetum flavescens at the most potent stage of its 
growth (Lichtenegger, Kutsclera, Kohler and Libiseller, 1970).
Management involved the mowing of the pasture once or twice a year 
which prevented maturation of the plant,resulting in the persistence 
of young leafy plants which are the most calcinogenic. Manuring of 
the pastures resulted in a reduction of the nunA>er of plant species in 
the pasture, which increased the population of Trisetum flavescens 
since it competes well under these conditions.
10
This information suggests that a certain measure of control over the 
disease could be obtained by altering the pasture management regime 
to one which diversified the number of species and allowed maturation 
of the plants. Other studies (Swieboda and Dabrowska, 1976) showed 
that Trisetum flavescens would not grow in soil containing less than 
0.15Z nitrogen and that other grasses coiq>eted well with it under 
these conditions (eg Arrhenatherum elatius and Agropyron repens).
The method of encouraging differences in soil and plant composition 
in pastures where Trisetiim flavescens induced calcinosis could occur, 
may be the most sensible May of preventing the disease in these 
regions.
Various groups of workers agreed that the leaves of the plant held 
the calcinogenic activity (Libiseller, Kohler, Glawischnig, Sarafidis 
and Schmid, 1978j Rambeck, Wetzel and Stark, 1979; Wolf and Dirksen,
1976; Kohler, Libiseller, Schmid and Swoboda, 1978; Rainbeck, Kreutzberg, 
Bmns-Droste and Zucker, 1981) rather than the flowers, roots or 
stems. Young leaves were more potent than old leaves. Feeding the 
grass as silage did not destroy its calcinogenic activity (Heinritzi, 
Kragenings and Hänichen, 1977; Kohler, Libiseller, Schmid and Swoboda, 
1978), neither did 'artificial green drying*, (Dirksen, Kragenings, 
Hänichen and Elmer-Engelhard, 1981). It was also established that 
all the various comnercial cultivare of Trisetum flavescens that are 
calcinogenic, and to roughly the same extent (Rambeck, 
Kreutzberg, Bruns-Droste and Zucker, 1981). In addition, it was found 
Trisetum elatior, a close relative of Trisetum flavescens was 
inactive. Other experiments showed that the growing of Trisetum flavescens
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under different levels of fertiliser had little influence on the 
subsequent development of calcinosis in test animals (Simon, Daniel, 
Hanichen and Dxrlcsen, 1978) • All these experimental approaches were 
designed to detect a simple way of either destroying the calcinogen 
or discouraging the plant, but none were successful.
Trisetum flavescens is a member of the Graminae (grasses) and there­
fore became the only known plant, not belonging to the Solanaceae, 
to be calcinogenic.
The following table shows the known distribution of the disease and 
identifies the plants responsible.
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TABLE 1
THE DISTRIBUTION OF PASTORAL CALCINOSIS.
COUNTRY LOCAL NAME GIVEN TO 
CALCINOSIS SYMPTOMS
CALCINOGENIC PLANT
Argentina "Enteque Seco" Solanum malacoxylon
Brazil "Espichamento" Solanum malacoxylon
Hawaii "Naalehu Disease" S. Malacoxylon/S. Torvum or
Cestrum diumum
Jamaica "Manchester Wasting 
Disease"
Solanum malacoxylon
Florida Calcinosis Cestrum diumum
Papua "Enzootic Calcinosis" Solanum torvum
Aus tria/6ermany "Weidekrankheit" Trisetum flavescens
Australia "Humpy Back" Solanum sodomaeum 
(suspected)
South Africa 
(Affects sheep)
Calcinosis unknown
possibly
S. Malacoxylon
Israel
(Affects goats)
Calcinosis unknown
Clearly, the scale of the problem appears to warrant further efforts 
by fanners and research workers in identifying and eradicating
13

1:2 Endocrine Control of Calcium Metabolism.
The Vitamin Metabolites.
Vitamin ^  was first characterised in 1932 (Askew, Bourdillon and 
Bruce, 1932) following the classic experiments of Sir Edward Mellanby 
(Mellanby, 1919) which showed that a specific diet could induce 
rickets in puppies. Askew characterised the 'vitamin* as a seco*- 
steroid, that is a steroid that has undergone fission by the severing 
of a carbon-carbon bond, resulting in the breaking of one of the six 
member carbon rings thus forming an open-chain structure. In the 
case of vitamin I^^tbe steroid 'B* ring is broken. (See figure 1).
Vitamin is the only vitamin to be generated by photobiogenesis in 
the skin, the precursor being 7-dehydrocholesterol. Experiments have 
shown that light in the 253 nm to 400 nm range transforms 7-dehydro- 
cholesterol to previtamin This involves the severing of a C-C 
bond and a subsequent isomerisation step (a thermally regulated 
reaction) to produce Vitamin D^. (Holick, Richtand, McNeill, Holick, 
Frommer, Henley and Potts, 1979). The function of vitamin D^(see 
figure 2) is to maintain serum calcium and phosphate at levels required 
for bone mineralisation and the prevention of tetany (muscular spasms
that occur if serum calcium becomes too low). Vitamin D cannot do
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this directly, but functions as a precursor for a number of metabolites 
that help to achieve the homeostasis of calcium and phosphate in the 
body.
The vertebrate system for maintaining constant blood levels of the 
mineral ions Ca ^  and PO^* is very elaborate. These levels are
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FIGURE 1
PATHWAY OF BIOSYNTHESIS OF THREE MAJOR 
METABOLITES OF THE CALCIUM HOMEOSTATIC
SYSTEM.
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maintained within narrow limits by a metabolic system that functions 
in a manner akin to the other major endocrine systems of vertebrates. 
This means that a coiq>lete array of glands, hormones and feedback 
inhibition mechanisms are in evidence. The calcium homeostatic system 
requires the presence in the diet of calcium, phosphate and vitamin 
(where the animals'skin does not have regular exposure to sunlight) 
in order to function correctly. Otherwise all the necessary metabolites 
are synthesised at various sites around the body. The ability of 
ultra-violet light to convert 7-dehydrocholesterol to pee-vitamin 
is one aspect of the metabolism of this so-called vitamin that has led 
to its more accurate description as a pro-hormone.
The levels of calcium and phosphate in the plasma are maintained at 
a supersaturated level. The serum calcium is either in free ionic 
form, or is combined with proteins. Fifty per cent of serum calcium 
is diffusible; this portion is either or is combined with anions 
such as phosphate or bicarbonate. The other fifty per cent is non- 
diffusible (5Z is combined with an ultrafiltrable anion). Hence it 
is only partly diffusible through a semi-permeable membrane. When serum 
calcium is measured using Atomic Absorption Spectroscopy, as in this 
project, the total level of calcium is measured; i.e. diffusible and 
non-diffusible. The relationship between diffusible and non-diffusible 
calcium can be expressed in the following way, where P “ protein 
concentration and Ca d++ ■ diffusible calcium (presuming all diffusible 
calcium is ionised).
P/CaP - 0.403 ♦ 5.80/Ca d++
which gives a pKa Ca-Prot of 2.44. In contrast, all serum phosphate
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(as PO^ » or ) is ultrafiltrable when calcium and phosphate
levels are both normal.Howeverwhen levels of either one increase suffi­
ciently» a complex of colloidal calcium phosphate is formed (Greenberg» 
Larsen and Tufts» 1934: McLean and Hinrichs» 1938). The latter found 
that the intravenous injection of phosphate caused an increase in 
the levels of 'colloidal calcium phosphate conq>lex' until the product 
Cca X PO^^of the plasma approached 3 nM/litre» at which point precipi­
tation of calcium phosphate salt begins to occur. It then became clear 
that calcium and phosphate in serum obey the solubility product law.
The solubility product relation applies to a sparingly soluble salt 
in the solid state and its ions in solution. The law can be represented 
in the following way - where a saturated solution of binary elect­
rolyte in contact with an excess of undissolved solid at constant 
temperature.
C M+] Ca-] ■ constant 
C MA solid ]
therefore C M + ] [.A-3 ■ constant ■ the solubility product ofCMA3at that
temperature. This quantitative relation occurs between serum calcium
and phosphate and it was found that in normal plasma the Total
Calcium X Total Phosphate ■ 40 mgZ (this is equivalent to 40 mg per
hundred mis of plasma) or more. But in rachitic animals it is 33 mgZ
or less (Howland and Kramer» 1922). This is expressed more accurately
as ; [Ca** 33 x ChPO 32.
4
Comparisons made between theCCa x P0^3 products of pure solution and 
blood plasma showed that plasma is super-saturated with respect to 
these ions. The calcium x phosphate product of an aqueous solution
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—26of these ions in the laboratory ■ 10 whereas that of plasma
-23" 10 The reason for this super-saturation was shown to be
the further equilibration of carbonate ions with calcium and phosphate 
leading to the more accurate representation of the equilibrium as 
follows:
C Ca*^ 3 7 X C POy 14 X C CO* 34 3
It can be seen from this that calcium and phosphate concentrations 
in the blood are interdependent, and if the concentration of either 
one increases so as to exceed the solubility product, there will be 
precipitation of solid salt. This is the ultimate cause of calcinosis 
and when precipitates have formed extensively throughout the body, 
then the condition is exceedingly difficult to reverse. Precipitation 
of calcium phosphate is often acconq>anied by other salts. Animals 
with calcinosis are found to have precipitates of other salts in 
their tissues. These include magnesium carbonate and calcium carbonate. 
Magnesium can be substituted for calcium in the formation of salts.
The presence of carbonates is not surprising, since, as shown above, 
the carbonate ion is involved in a three way equilibrium with calcium 
and phosphate.
The regulatory mechanisms that form the basis of the control of 
calcium metabolism are shown in figure 2. It can be seen that the 
processes are regulated by negative feedback based on the level of 
calcium in the blood. A low level of calcium initiates the production 
and secretion of parathyroid hormone, which acts on bone to increase 
resorption, and on the kidney (discussed further in the section on 
parathyroid hormone) to stimulate production of the crucial enzyme 
25(0H)cholecalciferol - I o -hydroxylase. This ioq>ortant enzyme
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converts 25(OH) cholecalcifcrol to 1,25(OH) cholecalciferol in the
2
kidney mitochondria, the only site of calcitriol production. Calcitriol 
(or 1,25(0H]^ cholecalciferol) is the metabolically active form of 
vitamin D^ . It was discovered in 1971 by Lawson, Fraser, Kodicek,
Morris and Williams (1971), using mass and ultra violet spectroscopy 
to confirm the chemical structure. Holick, Schnoes and DeLuca (1971) 
demonstrated that a previously unknown metabolite of vitamin D^was 
produced when tritium labelled vitamin D^was given to chicks, and 
intestinal extracts from these birds subjected to detailed chromat­
ography. Subsequent mass spectroscopy showed evidence of a vitamin 
I^metabolite previously unknown. The enzyme 25((HI) cholecalciferol- 
Ic-hydroxylase is responsible for the insertion of an hydroxyl group 
at carbon 1. It is a mixed fimction monoxygenase, which requires 
molecular oxygen, magnesium ions and internally generated NADFH. 
25(OH)cholecalcifer.ol -L^~hydroxylase contains cytochrome PASO. 
25(OH)cholecalciferol -l*c~hydroxylase has been found to be present 
in the kidney of every class of vertebrate.
The detailed transformation of the precursor, vitamin into the 
active form 1,23 (OH^ cholecalciferol is shown in figure 1. The 
presence of the hydroxyl group at carbon 1 is the major determinant 
of biological activity, althou^ the hydroxyl group at carbon 25 
does assist with the binding of the molecule to its receptor sites 
in the intestine. Steroid competition assays inq>lied that the hydroxyl 
group at carbon 25 binds with the receptor to allow the correct 
positioning of the hydroxyl groups at positions 1 and 3 on the 
receptor (Norman and Henry, 1979). Molecules such as 25(OH)chole­
calciferol and 2A,25(0H)2 cholecalciferol have very low activity in
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comparison. The production of 25(OH)cholecalciferol-la-hydroxylase 
is controlled by parathyroid hormone and the secretion of the latter 
is initiated by lov blood calcium. Following the discovery that 
calcitriol (l,25(OH) cholecalciferol) is synthesised from vitamin 
and is released into the body under the control of parathyroid 
hormone, calcitriol could legitimately be classified as a hormone; 
thus vitamin D« becmne a pro-hormone. Calcitriol (l,25(OH) chole-J 2
calciferol) obeys the prerequisites of a hormone, in that it is 
synthesised and released in response to the calcium and phosphate 
status of animals, and its interaction with its target organs 
resembles the situation encountered with classic steroid hormones. 
Further it is liberated directly into the blood stream by its gland 
(the kidney) from where it is carried to its target organs : the 
intestine, bone and possibly kidney^ and is regulated by negative 
feedback.
The calcium regulatory cycle is geared to respond to either an increase 
or a decrease in serum calcium. 25((Hl)cholecalciferol is the major 
circulating form of vitamin It has virtually no biological 
activity, but acts as a pool of substrate ready for conversion to the 
active form. However, 25(OH)cholecalciferol is largely converted to 
24,25(OH)2Cholecalciferol, a circulating metabolite, the concen­
tration of which is inversely related to that of l,25(OH)2 chole- 
calciferol. The synthesis of 25(OH)cholecalciferol is increased in 
normo-calcaemic or hyperphosphataemic conditions (Kumar 1984). This 
metabolite has a limited ability to activate the intestinal steroid 
receptor complex but has been shown to inhibit parathyroid secretion 
and increase bone mineralisation (Miravet et al.1976). The results of 
Miravet et al (1976) and Stern, DeLuca and Ikekawa (1975)
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contradict the work of Dziak (1978) who has shown that both 
25(OH)cholecalciferol and 2A,25(OH)2cholecalciferol decrease calcium 
uptake in isolated bone cells.
Conversion of 24,25(OH)2 cholecalciferol to 1, 24, 25 (OH)^ chole- 
calciferol occurs when the serum calcium level drops and secretion of 
parathyroid hormone causes the specific repression of the 24(OH)-hydro- 
xylase and induces the lot-hydroxylase (Tanaka, Lorenc and DeLuca,
1975) in order to increase levels of l,25(0H)2cholecalci£erol.
24, 25(OH)2 cholecalciferol is produced in the kidney mitochondria by 
25(OH) cholecalciferol-24”hydroxylase, and also in the intestine 
(Castillo, Tanaka, DeLuca and Ikekawa, 1978). However, several possible 
roles for 24, 25(OH)2 cholecalciferol have been suggested. One such 
suggestion is that it may function as a step in the excretion pathway 
of vitamin D^(6arabedian, Lieberherr, N'Guyoi, Corvol, Bailly Du Bois 
and Balsan S , 1978). According to another group of researchers 
(Bates, Care, Peacock,Mawer and Taylor, 1975) the low levels of 
24, 25(OH)2 cholecalciferol in the plasma of normocalcemic humans 
inhibits parathyroid secretion by the parathyroid gland, thereby 
implicating this metabolite in calcium homeostasis. Evidence has 
also been presented to suggest that 24, 25(OH)2 cholecalciferol has 
a specific action on bone mineralisation (Omoy, Goodwin, Noff and 
Edelstein, 1978). Recent reviews on vitamin D^metabolites (eg Eumar,, 
1984) however, refer to the continuing lack of understanding of the 
true role of this metabolite.
The most convenient method of studying the effects of various vitamin
metabolites, the substances related to vitamin D metabolism and cal-
3
cinogens from plant sources on bone, was found to be an in vitro
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bone culture technique first described by Reynolds and Dingle (1970). 
This involves dissecting the calvariae from five to seven day 
old mice and maintaining them in an appropriate tissue culture 
medium. Reynolds found that calcitriol was one hundred times 
more potent than 25(OH)cholecalciferol at promoting bone resorp** 
tion and that vitamin D^vas ineffective. Stained sections of the 
treated calvariae shoved that 1 ng/ml of calcitriol caused almost 
C0iq>lete resorption of the immature bone already laid down.
However, this would not happen in vivo without the presence of 
parathyroid hormone. This dees not affect the validity of the 
technique but allows isolated study of a chosen metabolite.
THE INTESTINAL STEROID-RECEPTOR C(»1PLEX
By 1979 the appearance of calcitriol in intestinal mucosal cells 
was shown conclusively using frozen section autoradiography 
(Stumpf, Sar, Reid, Tanaka and DeLuca, 1979). There is clear evidence 
in the autoradiographs of the subcellular localisation of tritiated 
calcitriol in the intestinal mucosa of rats. Similar work showed 
that calcitriol could be detected autoradiographically in the chick 
duodenum four hours after the administration of labelled calcitriol. 
(Zile, Bunge, Bareness, Yamada, Schnoes and DeLuca, 1978). The 
radioactivity was concentrated around the nuclei of absorptive 
cells in the villi. Calcitriol was also detected in the liver 
after four hours exposure. The intestinal steroid-receptor conqplex 
for calcitriol is a protein of sedimentation value 3.75 situated 
within target intestinal mucosal cells. When calcitriol enters the 
cell, it attaches to a binding site on the receptor. There is then 
a process of activation before the steroid-receptor complex
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migrates to the nuclear chromatin fraction where it joins to an 
acceptor site on the DNÂ itself. The DNA then codes for a messenger 
RNA specific for calcium binding protein. The affinity of the 
complex for DNA is characteristic of the steroid hormones.
Saturation analysis demonstrates saturable binding of calcitriol 
to its receptor. The binding of the receptor conq;>lex to chromatin 
is temperature dependent (Frocsal, Okamura and Norman, 1975) and 
saturation of the chromatin binding sites has also been demonstrated. 
The stereochemistry of vitamin D^is very iiq>ortant in determining 
its interaction with its receptors. The main features are the 
conformation of the *A* ring which carries the vital hydroxyl 
group; this is in the *chair* conformation and oscillates continually 
between the axial and equatorial planes. (In calcitriol the equa­
torial to axial ratio is 55:45). This means that all vitamin 
group receptors must be capable of accepting this conformational 
mobility.
Experiments conducted by Norman and Henry (1978) have shown that 
for calcitriol to be recognised by the intestinal receptor system 
it must be a 9, 10 seco-steroid. They also showed that the hydroxyl 
groups at positions 1 and 25 must be present if the molecule is to 
be active. In tests on animals 1 (OH)cholecalciferol or 25(DH) 
cholecalciferol were shown to possess 1/1000 the activity of 
calcitriol. The intestinal receptor cooq>lex was found to be very 
intolerant of changes in the length of the side chain. On interaction 
with the receptor protein, it was thought that the *A* ring was 
frozen out*, that is stabilised to prevent oscillation within the 
/receptor conçlex.
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An ctiLclc xnCcsCin&l receptor system demonstr&ted the
relative ability of various calcitriol analogues to compete for 
the binding sites on chromatin (Procsal, Henry, Hendricksen and 
Norman, 1976)• These workers incubated increasing concentrations 
of cholecalciferol analogues with a reconstituted cytosol-chromatin 
receptor system in the presence of tritiated 1,25(OH)2 cholecal­
ciferol. Hence, the amount of radioactivity bound to the chromatin 
could be assessed for each analogue. This technique allowed the 
structural requirements for binding of calcitriol to chromatin to 
be elucidated. The 360H group is less inq>ortant for binding
than the laOH or 250H groups. The 5, 6 trans form of vitamin D has
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very little ability to attach to the binding sites. laOH vitamin 
is 900 times less effective at competing for the binding site 
than calcitriol indicating the great importance of the 25(OH)group.
VITAMIN D AMD CALCIUM TRANSPORT IN THE GUT 
3 ---------------------------------
The process of calcium transport across the gut is necessarily 
achieved by a process of active transport because there is a positive 
electrical potential difference between the serosal and mucosal 
surfaces. The calcium transport mechanism that exists appears to 
have two rate limiting steps: one which allows entry of calcium 
ions into the mucosal cells by a process of diffusion, and a
second which allows exit from them. This latter process involves 
2n active cation punq>.
Tbe early evidence for the existence of a specific calcium binding 
protein came from experiments which showed that there were higher
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levels of radiocalcium in the supernatant of centrifuged homogenates
of intestinal mucosa from vitamin Djreplete animals than in that of
rachitic animals (Wasserman and Taylor, 1963). These results
corresponded with others that showed the presence of a prominent
protein band of high electrophoretic mobility in a polyacrylamide
gel electrophoresis experiment, which separated proteins in the
supernatant fluid of vitamin l>-replete chicks allowing comparison with
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vitamin D^-deficient chicks. It was clear that this protein band was 
absent in the vitamin D^-deficient chicks (Taylor and Wasserman,
1967). Hence it was established that vitamin D^'was involved in the 
production of this protein.
The protein could be highly purified by a three-step process
developed by Wasserman and co-*workers (Wasserman, Corradino and
Taylor, 1968) involving: i) precipitation with (NH, )„S0. , ii) gel
4 2 4
filtration column chromatography and finally, iii) preparative 
discontinuous gel electrophoresis. The amino acid conçosition and 
molecular weight of calcium binding protein varies between species, 
but in the chick the protein was found to have a molecular weight 
of about 28000 (generally only 10000 to 13000 in mammals). The 
chick calcium binding protein contains four high affinity binding 
sites for calcium plus a larger number of low affinity sites.
Calcium binding protein will also bind other alkaline earth metal 
ions such as strontium, barium and magnesium (in that order of 
preference). Calcium binding protein is not produced prior to an 
increase in intestinal calcium transport as might be expécted, (Spencer
— ^ i976). Vitamin D-deficient animals, dosed with vitamin D,
3 3
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show an increase in calcium transport several hours before calcium 
binding protein is detected.
Other workers were also able to show that the rate of calcium 
binding protein formation and calcium absorption following vitamin D 
administration, are not directly comparable (Harmeyer and DeLuca, 
1969). The reason for this effect is not known.
In the hen high levels of calcium binding protein occur in the 
intestine and the uterus and these proteins are identical (Fullmer, 
Brindak, Bar and Wasserman, 1976). The protein appears in the uterus 
when ovulation and egg laying commence and there is a need for a 
large amount of calcium to form eggshells. Calcium binding protein 
is also found in the kidney. In the chick,which has calcium binding 
protein comprising 2.8% of total body weight,kidney calcium binding 
protein is identical to intestinal calcium binding protein and is 
also formed in response to calcitriol, Intestinal calcium binding 
protein is located at the microvillar border of duodenal enterocyte and 
goblet cells. Hence it is possible that the goblet cell is the
site of synthesis of calcium binding protein (Taylor and Wasserman, 
1970).
The synthesis of calcium binding protein occurs de novo (there is no 
precursor protein molecule) in response to calcitriol by the 
transcription of a specific messenger RNA. The necessity for the 
vitamin is illustrated by an experiment in which intestinal polysomes 
from rachitic chicks were found to be unable to direct the in vitro
28
synthesis of calcium binding protein whereas Chose from vitamin D-
3
replete chicks could (Emtage, Lawson and Kodicek, 1973) do so.
Following the injection with calcitriol of vitamin D-deficient
3
birds it was found that nascent polypeptide chains could be found 
on intestinal polysomes as early as two hours after dosing » rising 
to a maximum level of production thirteen hours after dosing (that 
is, two hours is sufficient time for the transcription of the 
messenger RNÂ (Mif 700,000))i Corresponding studies showed that two 
hours was enough time for injected, labelled calcitriol to be 
detected in the intestinal nuclei of rachitic chicks. These studies 
lend further weight to the probability that calcitriol regulates a 
subset of expressed genes which initiate production of calcium 
binding protein.
Other vitamin 1^  metabolites thought to stimulate calcitmi transport 
were 24, 25(OH)2 cholecalciferol and 25, 26(OH)2 cholecalciferol. This 
only occurred in animals on a low calcium diet (Miravet, Bedel,
Carre, Queille and Bordier, 1976). 24, 25(0H) 2 cholecalciferol is
the most abundant vitamin D metabolite to be found in normal or3
hypercalcémie plasma (Bates et al, 1970). 24, 25(OH)2 cholecalciferol 
and 25, 26(OH)2 cholecalciferol were also proposed as being able 
to stimulate osteoblastic activity in rachitic animals.
PARATHYROID HOBMONE AND THE PARATHYROID GLANDS 
Parathyroid hormone is a peptide hormone secreted by the para- 
thyoid glands in response to a decrease in circulating calcium ions 
(Potts 1966). The parathyroid gland itself is able to detect
small changes in the levels of serum calcium (ie it is the calcium 
’sensing* organ).
29
Parathyroid hormone acts upon the kidney and the bone and indirectly 
upon the intestinal calcium absorptive mechanism via its control of 
calcitriol production. It is responsible for stimulating the production 
of 25(OH) cholecalciferol lahydroxylase and this makes it a vital 
link in the calcium regulatory mechanism. Parathyroid hormone is also 
responsible for renal reabsorption of calcium as an indirect effect 
of its action in stimulating calcitriol production, leading to 
calcium binding protein production in the kidney. Finally (as 
described below) parathyroid hormone acts on bone in conjunction
with calcitriol, to promote resorption and so increase serum calcium 
levels.
Parathyroid hormone has been shown to induce the release of calcium
from bone expiants in culture, two hours after application (Reynolds
and Dingle, 1970). At the bone site, the movement of calcium from
the bone fluid compartment to the extra-cellular fluid compartment
is dependent upon the combined action of both parathyroid hormone
and calcitriol. A later response is that parathyroid hormone will
stimulate the formation of multinucleate osteoclasts which will
release more calcium. This multi-purpose hormone is, therefore, very
effective in reversing any tendency towards hypocalcaemia. Because 
• - 01 IS responsible for controlling the production of another hormone, ie 
calcitriol, parathyroid hormone can be classified as a ’tropic* 
hormone.
Many workers have shown that parathyroid hormone is cooq>letely 
ineffective on the intestine, its action in stimulating intestinal 
calcium absorption being mediated by calcitriol (Corradino, 1976).
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There is a mechanism by which parathyroid hormone and calcitriol 
act together to cause resorption of the bone * either one on its 
own is not very effective in this respect, (Garabedian, Tanaka, 
Holick and DeLuca, 1974). The precise mechanism of this process 
is not known. The levels of cyclic AMP of isolated bone cells 
were found to be raised in the presence of calcitriol (or 25(OH) 
cholecalciferol) plus parathyroid hormone, but not when in the 
presence of calcitriol (or 25(OH)cholecalciferol) alone (Mahgoub 
and Sheppard, 1975) thereby implicating (according to the authors) 
vitamin analogues as modulating the action of parathyroid hormone 
on cultured bone cells.
A vitamin deficient animal has high levels of circulating para*- 
thyroid hormone which is released in an attenpt to stimulate 
calcitnn resorption and lahydroxylase in the kidney but remains 
hypocalcaemic. It cannot maintain the levels of calcium without 
the acconpanying presence of calcitriol. The animal will eventually 
die from hypocalcaemic tetany. When administered to bones cultured 
in vitro both parathyroid hormone and calcitriol will resorb bone 
calcium, but in vivo they must both be present for resorption to 
occur.
It has been observed that in thyroparathyroidectomised (TPTX) rats 
pulsed with ^^calcium twenty days previously, there were significant 
increases in circulating radiocalcium levels, when either calcitriol, 
parathyroid hormone or 1(OH)cholecalciferol were injected (Boris, 
Hurley and Trmal, 1980). The results were in conflict with those of
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Garabedian et al (197A), who demonstrated the lack of response to 
calcitriol of thyroparathyroidectomised (TPTX) rats fed a low 
calcium diet. It appears most likely that this is the result of the 
large, unphysiological doses of calcitriol used by Boris et al 
(1980) to obtain the response (up to AOOO ng of calcitriol were used 
to inject each rat in this experiment) and may account for the 
discrepancy.
Further evidence indicating the synergistic effect of parathyroid 
hormone and calcitriol was obtained in an experiment using TPTX rats, 
dosed either with calcitriol alone or in concert with parathyroid 
hormone (Garabedian, Tanaka, Holick and DeLuca, 1974). The results 
showed that the rats, fed a low calcium diet, and dosed with calcitriol 
alone could not maintain their serum calcium levels which fell by 
AOZ in 142 hours. This contrasted with TPTX rats which were dosed 
with both parathyroid hormone and calcitriol who maintained their 
normal levels (around 6.0 mg/100 mis) of serum calcium after 56 hours. 
This experiment also showed that the TPTX rats were unable to 
synthesise the 25(OH) cholecalciferol - lot^-hydroxylase enzyme as found 
by Fraser and Kodicek(l973).
Parathyroid hormone, therefore, plays a leading role in the calcium 
regulatory system, firstly in initiating kidney 25(OH) cholecalciferol-l~ 
•«-'•hydroxylase and then by acting with calcitriol (in an undetermined 
process) to mobilise calciinn from bone. A rise in serum calcium is 
detected by the parathyroid gland which will cease to produce 
parathyroid hormone thereby 'switching off* the major processes by 
which serum calcium is increased. (Boris, Hurley and Trmal, 1980).
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An injection of parathyroid hormone in a vitamin D^deficient animal 
caused a temporary increase in plasma phosphate because of the 
release of calcium phosphate from bone. Later phosphate levels dropped 
because of the increased kidney excretion of phosphate brought about 
by parathyroid hormone (Henze, 1962). Further work showed that an 
injection of calcitonin could lower serum calcium within thirty 
minutes. Calcitonin is secreted by the *C* cells of the thyroid in 
response to high levels of serum calcium. The function of calcitonin 
is to cause an inoediate block of cell mediated calcium release by 
suppressing the bone resorptive effects of parathyroid hormone and 
calcitriol and promoting bone formation. An injection of calcitonin 
will cause an immediate fall in plasma calcium levels (Reynolds, 1972). 
This suppression can be demonstrated with mouse calvariae, cultured
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in vitro, that have been pre-labelled with calcium when, one and 
a half hours following treatment with calcitonin, the calvariae show a 
fifty per cent reduction in resorption as measured by the release 
of radiocalcium into the medium.
Reynolds,(1972), considered that calcitonin may act as a brake on the 
action of calcitriol by inducing the formation of new osteoblasts and 
reducing the effectiveness of existing osteoclasts. It was thought that 
bone resorption may only occur when calcitonin secretion is cut off 
entirely.
The mode of action of calcitonin has been clarified a great deal by 
workers who studied the ability of calcitonin to suppress bone resorption 
over a period of time and in the presence of parathyroid hormone.
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Calcitonin was found to have an unusual characteristic (Raisz, Wener 
Trumell, Feinblatt and Wyw, 1972) in that it was able to induce a 
prolonged inhibitory effect on resorption (confirmed by Reynolds, 1972) 
following the administration of a single dose of calcitonin even 
in the presence of parathyroid hormone* (This was termed 'induction'by Raisz 
et al (1972). However, with time there appears to be a change in 
the sensitivity of bone cells to calcitonin which occurs after 
about four to six days of in vitro culture of bone tissue. Re­
sorption begins again in the presence of parathyroid hormone even 
when calcitonin is administered at levels that were initially 
effective. This phenomenon was termed 'escape* by Raisz et al (1972).
Other substances foond to inhibit bone resorption are:(i) mith- 
ranycin and (ii) dichloromethylene diphosphonic acid (Reynolds,
1972). Mithramycin is thought to interfere with the differentiation 
of new osteoclasts, thereby preventing parathyroid hormone from 
stimulating the production of new bone resorptive cells. Dich­
loromethylene diphosphonic acid is thought to act by inhibiting the 
dissolution of hydroxyapatite, ie it acts as a crystal poison.
Whether calcitonin's mode of action is related to the action of 
either (i) or (ii) is not known, but (ii) would be more likely 
because the time course of the action of mithrao^cin is not conparable 
with that of calcitonin.
PHOSPHATE TRANSPORT
An early idea on the mechanism of transfer of phosphate across the 
gut was that it was transported with calcium as an accompanying anion 
and in equimolar proportions with it (Harrison and Harrison, 1961).
3A
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Thflt chis vfls noC Ch6 c&scy bsgsn Co bcconiB &ppdirenc in chs 6sirly 
1960*s when Wasserman (1962) showed that the simultaneous presence 
of calcium and phosphate in the gut mutually inhibited the absorption 
of both ions. Furthermore, the absorption profiles did not follow an 
identical pattern not explainable by the formation of insoluble 
calcium phosphate. The use of a calcium chelator (Sodium EGTA) in 
the gut had no effect on phosphate transport (Wasserman and Taylor, 
1973). Although some stimulation of phosphate absorption by vitamin 
was noted in the early stages, the general picture presented by 
Wasserman was that phosphate absorption was independent of vitamin 
3^ research was to disprove this.
Harrison and Harrison (1961) and Kowarski and Schacter (1969), 
fo\ind that vitamin could stimulate the uptake of phosphate in 
chick or rat duodenum maintained in organ culture. The response 
however was not detected before twelve hours, uptake continuing 
for 2A to 48 hours after administration of the vitamin and 
resulting in a much higher concentration of phosphate in the tissue 
than in the culture medium. Phosphate was transported at a linear 
rate. The transport of phosphate was found to be reduced by the
administration of uncouplers of oxidative phosphorylation to the 
gut sacs.
The active transport of phosphate was presumed to be reliant upon 
protein synthesis (Peterlik and Wasserman, 1976) as confounds such 
as cycloheximide and actinomycin D reduce it and eliminate the 
effect of vitamin D^in promoting its absorption by the gut
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(Peterlik and Wasserman, 1980). Vitamin Demist therefore have the 
ability to control gene expression in the intestine in order to 
induce phosphate transport^ as it does in the better known mechanisms 
by which it influences calcium transport.
It has been suggested that vitamin acts directly on the intestine 
to promote phosphate transport (Kowarski and Schacter, 1969;
Peterlik and Wasserman 1978). It is now unequivocally 
established that calcitriol also has a significant effect upon 
phosphate transport by the gut (Peterlik and Wasserman, 1980), 
including the jejunum (Peterlik and Wasserman, 1976) although 
inhibition of lt25(OH)2Cholecalciferol synthesis by strontium did 
not affect inorganic phosphate uptake by the jejunum. Thus another 
vitamin 1^metabolite appears to be implicated. It was clear also, 
that a step involving protein synthesis was necessary before phos** 
phate uptake occurred in response to calcitriol. Peterlik and 
Wasserman (1980), also demonstrated that phosphate influx into 
chick jejunum was influenced by diet, and a diet low in either 
calcium or phosphate would result in increased phosphate uptake.
The mechanism by which calcitriol influences phosphate transport 
is unclear.
Vitamin will stimulate phosphate uptake in rachitic animals 
(Peterlik and Wasserman, 1976; D'Doherty and DeLuca, 1976) and this 
action is therefore accepted as being independent of its effect 
on either calcium transport, calcium binding protein or alkaline 
phosphatase (Peterlik and Wasserman, 1976).
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The potency of calcitriol in stimulating phosphate uptake by the 
kidney is very high as demonstrated by one report (Liang, Barnes, 
Balakir, Cheng and Sacktor, 1981) where only a few molecules of 
calcitriol were effective in stimulating the uptake of phosphate 
in isolated renal cells.
Vitamin has been found to be less effective at promoting 
phosphate transport than almost any of its hydroKy**derivatives in 
the renal environment. Phosphate transport is not affected by 
strontium inhibition of the renal 25(0H)cholecalciferol lahydro- 
xylase because of the ability of metabolites such as 24,25(OH)2 
cholecalciferol to stimulate phosphate transport. Calcitriol, however,
is by far the most potent,known vitamin D metabolite as far as3
promotion of phosphate transport is concerned.
The transport of phosphate is not solely dependent on the presence 
of vitamin I^or its derivatives, as shown by sane experiments on 
genetically hypophosphataemic mice. These mice have abnormally 
high rates of renal excretion of phosphate and low rates of intestinal 
uptake of phosphate. Their intestinal calcium transport is 
unaffected (0*Doherty and DeLuca, 1976). When dosed with calcitriol, 
such mice showed an increase in calcium transport but no increase 
in intestinal phosphate transport. They appeared therefore to have
a defect unrelated to vitamin D metabolism and related solely to
3
phosphate transport in kidney and intestine. It has been repeatedly 
shown that phosphate uptake by the gut is a saturable process 
(Wasserman and Taylor, 1973; Peterlik and Wasserman, 1976;
Peterlik, 1978), the rate limiting step being the rate of diffusion from
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the mucosal to the serosal levels of the gut (Peterlik and Wasser- 
man, 1976,1978).
Entry at the lumenal side is an active process, akin to a phosphate 
*pump’. In vitro Vmax varies between 0.15 and 0.37 moles Pi/min/g 
tissue in vitamin ¡^deficient and vitamin Derapiate gut segments 
respectively (Peterlxk and Wasserman, 1976). Despite this variation
in Vmax, the Km of the reaction is not affected by vitamin D
3
metabolites (Peterlik, 1978). This vitamin Uninfluenced phosphate 
transport is dependent upon the presence of sodium ions i^Tu^ requires 
metabolic energy; vitamin D^metabolites merely increase the velocity. 
It has been hypothesised that vitamin D^metabolites increase the 
number of carrier proteins for phosphate. Another, completely 
separate pathway for phosphate transport has been identified which 
is thought to be para-cellular, and diffusional transport here occurs 
at a lower rate than the active sodium-dependent process, is the 
only route for phosphate entry in vitamin D^eficient animals (Fuchs 
and Peterlik, 1979; Birge and Avioli ,1981). The microtubular cyto- 
skeleton has been implicated in the transfer of phosphate from the 
nxicosa to the serosa since cytochalasin B and other microtubule 
inhibiting drugs will reduce the mucosal to serosal transfer in 
vitamin replete animals (Fuchs and Peterlik, 1979A).
The two pathways of phosphate entry into the gut were investigated by 
Birge and Avioli (1981) and they found that the first is energised 
By a soditim gradient in a high affinity process operating at a pH 
of less than 6.8. The second process is not sodium-dependent but
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acts optimally at a pH of 8.0 or above and is stimulated by calcium. 
It has become clear that alkaline phosphatase is somehow involved 
in phosphate transport (Birge and Avioli, 1981). The administration 
of calcitriol to vitamin I^eficient chicks causes an increase in 
phosphate uptake which is parallelled soon afterwards (3 hours) by 
a strcng increase in alkaline phosphatase in the brush border 
membrane vesicles. It is thought organic and inorganic phosphate 
transport changes with alkaline phosphatase activity (Moog and 
Glazier, 1972). Another intestinal constituent affected by vitamin 
metabolites is calcium dependent ATPase, although this enzyme has 
not yet been distinguished from intestinal alkaline phosphatase. 
Alkaline phosphatase and ATPase are not thought to participate in 
calcium transport as L-phenylalanine (a potent alkaline phosphatase 
inhibitor) does not affect either calcium transport or phosphate 
transport (Birge and Avioli ,1981). The role of alkaline phosphatase 
in phosphate transport, if any, remains unknown.
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1:3 The Relationships Between the Vitamin Endocrine 
System and the Known Calcinogenic Plants.
Solanum Malacoxylon.
Following the discovery of this calcinogenic plant, research began 
on the aetiology of the disease and the nature and mode of action of 
the toxic principle(s). It was already known (Tilley, 1967) that 
diseased animals had high serum calcium and phosphate levels. As 
little as five grams of dried leaf of the plant was shown to cause 
an increase in blood serum calcium and serum phosphate in cattle 
(Worker and Carillo, 1967). When first exposed to dietary Solanum 
m^lacoxylon there is a transient rise in serum phosphate (Cantos, 
Ladizesky and Mautalen, 1973) . Continued administration of the 
plant results in above-normal levels of serum calcium in two days. 
Serum calcium remains above-normal and serum phosphate declines to 
normal levels where it stabilises.
By 1972 it was known that Solaniim malacoxylon affected the intestinal 
absorption of calcium and phosphate (Mautalen 1972). Mautalen showed 
that rabbits treated with Solantm malacoxylon and fed a diet low in 
calcium and phosphate could transport 80Z more radiocalcium across 
the gut wall than a control group. Similarly, oral doses of radio­
phosphate were absorbed fifty per cent more effectively by animals 
treated with Solanum malacoxylon.
The effects of Solanum malacoxylon upon skeletal resorption were also 
revealed by the indirect method of measuring the urinary levels of
AO
radiocalcium in rabbits dosed five weeks previously with ^^calcium.
While the plant was administered, urinary levels of radiocalcium 
rose four to five times above basal. Labelled calcium in the bone 
was presumed to have been released by the active factor in Solanum 
malacoxylon. As a result of this work, Mautalen(1977)was able to deduce 
that the active factor of Solanum malacoxylon had similar physio­
logical actions to l,25(0H)2cholecalciferol. It was also shown 
that Solanum malacoxylon could promote resorption of cultured chick 
frontal bones (Puche and Locatto, 1974) and aqueous extracts of 
Solanum malacoxylon also promoted resorption of explanted mouse 
calvariae (Simonite, Morris and Collins, 1976),
Further evidence that a substance very similar to the active form of 
vitamin I^was involved in "Enteque Seco” was supplied by Wasserman 
(1974), Wasserman used the so-called "Strontium chick" technique.
In 1922 Shippey et al found that the inclusion of strcmtium in the 
diet produced rickets in pigs. Subsequently Omdahl and DeLuca (1971) 
showed that this was due to strontium inhibition of the 1-hydro- 
xylase, and thus the production of l,25(0H)2Cholecalciferol and 
dietary calcium absorption were inpaired, Hence the metabolic basis 
for strontium rickets was established.
This suggested that the strontium affected animal would be useful for 
determining whether or not certain substances possessed 1,25(OH)2 
cholecalciferol-like activity. If they possessed such activity they 
should be able to bypass the "strontium block" and restore normo- 
calcaemia.
These results were strengthened by other studies which showed,for 
instance, that kidney mitochondria from strontium-fed chicks had a
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low rate of synthesis of calcitriol (Omdahl and DeLuca, 1972) 
despite normal levels of 25(OH)cholecalciferol being present. In 
addition, there was strong evidence thatanother substance (designated 
peak Va by the authors) was produced in place of calcitriol if 
excess calcium was present in the diet. The results show that the 
declining levels of calcitriol in vitamin I^replete chicks fed 
dietary strontium are mirrored by increasing levels of peak Va. It 
was also confirmed by these workers that strontium fed chicks 
supplemented with calcitriol showed a normal rate of calcium 
absorption.
It can be seen from the figure of the calcium regulatory system 
(figure 2) that the introduction of calcitriol in sufficient 
quantity in the diet would cause the breakdown of calcium homeostasis 
because of the control point being by-massed. The la - hydroxylase 
is normally strictly controlled by feedback inhibition and so intro­
duction of the end product in the diet prevents any control of the 
levels of calcitriol by the regulatory mechanisms. Thus uncontrolled 
intestinal uptake of calcium takes place. This is exactly what occurs 
in animals that consume Solanum malacoxylon. The clinical manifestations 
of the disease begin when the increasing levels of plasma calcium 
reach a point where precipitation of calcium salt occurs,the notmal 
calcium X phosphate product being exceeded as a result of the uptake 
of calcium induced by the plant factor. This uncontrolled deposition 
of calcium salts interferes with the functions of the affected 
tissues and eventually microscopic lesions are apparent.
Further work revealed that Solamun malacoxylon extract could initiate 
synthesis of calcium binding protein in end>ryonic chick duodenum
A2
(Corradino and Wasseman, 1974), the tissue not noraally synthesising 
this protein until the day of hatching. This finding also showed 
that the active factor of Solanum malacoxylon was more conq>arable 
with calcitriol than with vitamin D, as only calcitriol and not 
vitamin D^can induce the formation of calcium binding protein in 
embryonic chick duodenum. Calcitriol-like properties could also be 
seen in the Solanum malacoxylon factor at the bone site, where the 
extract promoted calcium resorption from chick frontal bones 
cultured In vitro (Puche and Locatto, 1974). Peterlik and Wasserman 
(1975) also determined that the active factor was functionally 
similar to calcitriol and did not require transformation by the kidney.
Further evidence of the ability of the plant factor to mimic the 
action of calcitriol was provided when it was demonstrated that 
competition existed between the plant factor and labelled calcitriol, 
for the binding sites in the intestinal chromatin (Procsal, Henry, 
Hendricksen and Norman, 1976). These binding sites are very specific 
for calcitriol. The same workers also showed that renal 25(OH) 
cholecalciferol - la-hydroxylase levels were normalised in vitamin 
I^deficient animals by the plant factor to levels which existed in 
vitamin IKreplete or calcitriol-replete animals. The rachitic 
controls had high levels of the enzyme. Like calcitriol Solanum 
malacoxylon was also found to be ajctinomycin D-sensitive which meant 
that the active factor worked via DNA transcription and subsequent 
protein synthesis.
The puzzling feature about the calcinogenic principle in Solanum 
malacoxylon was that,although it appeared to mimic the actions of
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1, 25(OH)2 cholecalclferol, it was water soluble and therefore 
probably fundamentally different from authentic 1, 25(OH)2 chole- 
calciferol. This incongruity was solved partly in 1975 by Peterlik 
and Wasserman. These workers knew that the active principle of 
Solanum malacoxylon had an apparent molecular weight in excess of 1000, 
since the distribution of the Solanum malacoxylon factor on a liquid 
chromatography column containing Sephadex G-25, indicated this 
(Humphreys, 1973). This led to further analysis of the active factor 
by Feterlik ,Bursac,Haussler and Wasserman (1976). who were 
able to cleave the glycoside from the sterol with a Ji-gly-
cosidase. This produced an organic soluble substance which showed 
chemical and biological properties identical to calcitriol. By 
using a biologically active extract of the plant, Peterlik and 
Wasserman (1975) showed by thin layer chronatography and various 
chemical spot analyses, that the biologically active factor of 
Solantim malacoxylon contained a 5, 6 trans triene steroid structure 
as well as sugar moieties. This substance was not, therefore, pure 
calcitriol and it was not until the Solanum malacoxylon factor was 
hydrolysed with mixed glycosidases derived from the liver of 
Charonia lampus (a sea worm) that complete hydrolysis was achieved 
and the resulting organic soluble moiety was shown to have a mass 
spectrum and an ultra-violet absorption spectrum identical to 
that of calcitriol (Haussler and Uasserman, 1976). This substance 
was previously thought to have a function in the mammalian and .avian 
kidney only, and it was rather surprising to find it in a plant.
The native plant calcinogen is extremely likely to be hydrolysed by 
the endogenous glycosidases within the animal prior to its being able
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to react with the receptors in the intestine and bone. Calcitriol 
itself is only active when all three hydroxyl groups are present, 
as well as an unaltered side chain. Since the carbohydrate 
sequences are most likely to be linked to hydroxyl groups, 
hydrolysis is almost certainly a prerequisite of biological activity 
(Wasserman, Henion, Haussler and McCain, 1976). This has been 
demonstrated by an experiment which showed that the active factor 
of Solanum malacoxylon was only effective when dosed orally . Other 
means of administration, such as direct subcutaneous or intravenous 
methods were not effective in producing elevations in plasma calcium 
or phosphate (Ruksan and Carillo, 1976). There was, however, some 
activity of the factor on bone in vitro (Puche and Locatto, 1974; 
Simonite, Morris and Collins, 1976). Further evidence of the acti­
vating effect of the gut environment was provided by an experiment
Solanum malacoxylon extract was incubated in rumen liquor, and 
then injected into sheep subcutaneously or intravenously. This 
produced elevations in plasma calcium and phosphate (Ruksan and 
Carrillo, 1976).
The discovery that calcitriol was present in Solanum malacoxylon 
stirred considerable interest among medical researchers as it was 
seen as having potential therapeutic value for patients suffering 
from various diseases where there is a disturbance of the calcium 
regulatory system. Pure calcitriol is time cemsumirng to synthesise 
and so the possibility of obtaining relatively large amounts from 
a plant was very attractive. The diseases that would respond success­
fully to calcitriol are as follows:
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RENAL OSTEODYSTROPHY 
h yp op a ra t hy ro i di sm
VITAMIN D DEPENDENT RICKETS3
FIBROMA
OSTEOMALACIA
OSTEOPOROSIS
OSTEOPETROSIS
All these conditions are characterised by a low serum calcitriol 
level. Of these, hypoparathyroidism, hypophosphataemic rickets and 
osteopetrosis are conditions where an infusion of parathyroid hormone 
leads to an increase in calcitriol levels in blood (Aarskog and Aksnes, 
1980).
CESTRUM DIURNUM
Studies on the calcinogenic activity of Cestrum diumum (Hasserman, 
Corradino, Krook, Hughes and Haussler, 1976) using chicks as the 
experimental animal indicated that the dried leaf powder could 
reverse the effects of dietary strontium in a dose related fashion 
in exactly the same way as Solanum malacoxylon and restore synthesis 
of intestinal calcium binding protein and calcium transport in
vitamin D-deficient birds. The active factor of Cestrum diumum
3
could also interact with the high affinity saturable cytosol receptor 
of calcitriol in vitro. Chemically, the active factor was found to be 
extractable with organic solvents and showed very low water 
solubility. It was estimated to possess the equivalent of 30,000 
to 35,000 lu of cholecalciferol per kilogram of dried leaf powder.
There was thus strong evidence that the active factor was again identical 
to calcitriol, Hughes and co-workers (1977) showed that it is a
A6
l,2 5(OH)2cholecalcifcrol - glycoside, but coataining shorter 
carbohydrate side chains than that in Solanum malacoxylon (Hughes,
McCain, Chang, Haussier, Villareale and Wasserman, 1977). This explains 
the lower water solubility of the Cestrum diumum factor when compared 
with that of Solanum malacoxylon.
It was noted in the work done by Krook,Wasserman, McEntee, Brokken and
Teigland (1975) on horses in Florida, that at autopsy the 
thyroid gland had a very low level of calcitonin ( no..
detectable hypocalcémie activity; 0.05 MRC u/g tissue)which suggested
that there was a high level of secretion although, surprisingly, no
calcitonin was detected in the blood by these workers. Work done on
histologic changes in the bone tissue of animals suffering from Cestrum
diumum poisoning showed that bone tissue was abnormal, and osteopetrosis
occurred (ie death of cells and disintegration of the bony matrix).
With time, the general atrophy of bone cells caused by Cestrum diumum,
resulted in severe osteopenia between petrotic bands, and thinning of
the cortex (Kasali, Krook, Pond and Wasserman, 1977). The presence
of cementing lines in the bone tissue gave further evidence of
arrested osteocytic osteolysis.
Cestmm diumum caused detectable calcinosis of soft tissues within 
four weeks of feeding 3Z dried leaf to both normal and hyperparathyroid 
aniioals (Kasali, Krook, Pond and Wasserman, 1977). Similar experiments 
showed that the bone abnormalities were partly the result of hypercalcit- 
oninism resulting in the blocking of bone resorption and in the advanced 
cases this led to a reduction in hypercalcaemia resulting in normal cal 
cium levels (Krook, Wasserman, McEntee, Brokken and Teigland, 1975). The 
potency of dried leaf Cestrum diumum bears a close similarity to
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that of Solanum malacoxyloa*
Furthermore, it has been reported that feeding as little as 1.5Z 
¿^¿ed Cestrum diumum leaf powder to chicks with strontitim-induced
vitamin D deficiency resulted in the synthesis of calcium binding
3
protein, and increased rcdiocalcium absorption (Wasserman, Corradino 
and Krook, 1975). Ncphrectomised rats, treated with Cestrum diurnim 
were also able to synthesise calcium binding protein and transport 
calcium across the gut whereas nephrectomised, untreated rats were not. 
(Walling, Kimberg, Wasserman and Feinberg,1976).Mass spectroscopy has 
confirmed that the hydrolysed Cestrum diurnum factor is calcitriol(Hughes
et al, 1977).
SOLANUM TORVUM
This plant was suspected of causing calcinosis in Papua, New Guinea. 
Feeding trials showed that Solanum torvum could induce hypercalcaemia 
and hyperphosphataemia and mild tissue calcification in laboratory 
rats (Morris, Simonite and Pullen, 197,9).
Further work has shown that calcium release from bone with the 
in vitro culture technique (See "General Methods", Chapter 2) 
using calvariae from five to seven day old mice, showed that 250 
yg/ml of Solanum torvum promoted resorption of the bone, as shown by 
increases in medium calcium and phosphate (Morris and Levack un­
published observations.) The presence of calcitriol in the plant, 
attached to a carbohydrate moiety is probable but has not yet been 
confirmed. The data already obtained does suggest strongly that there 
is a strong similarity to the calcinogenic action of Solanum malacoxylon«
A 8
trisetum flavescens.
The discovery that calcinosis induced by Trisetum flavescens is 
characterised by high levels of serum phosphate rather than serum 
calcium, as in calcinosis caused by the Solaneceous species, suggests 
that a different mechanism is present. Wolf and Dirksen (1976) and 
Libiseller, Kohler, Glawischnig, Sarafidis and Schmid (1978) 
demonstrated that Trisetum flavescens induced high plasma phosphate 
in rabbits but had little effect on plasma calcium. Plasma phosphate 
returned to normal within a few days if Trisetum flavescens was 
withdrawn. The plant also reduced the high levels of plasma alkaline 
phosphatase, an effect reminiscent of the Solanaceous calcinogenic 
plants.
Feeding whole Trisetum flavescens to experimental animals (Vasserman, 
Krook and Dirksen, 1977) was found to be effective in reversing the 
rachitic state generally, as characterised by the induction of calcium 
binding protein and a rise in plasma calcium. However, these workers 
were not able to produce a reversal of strontium inhibition of calcium 
absorption or to demonstrate any reversal of the effects of dietary 
strontium on the bone. Typical effects of strontium-induced vitamin 
deficiency on bone structure is as follows: i) failure of resorption 
of the metaphyseal cartilage core ii) retarded osteocytic osteolysis 
and iii) the presence of osteoid seams in metaphyseal trabeculae and 
inner haversian lamellae of osteons. Later workers were able to show 
that feeding dried leaf Trisetum flavescens led to a reversal of the 
strontium inhibition of the kidney hydroxylase enzyme (Peterlik, Regal 
and Kohler, 1977). This was,however,in contradiction
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to the subsequent work of Zucker, Kreutzberg, Nitsche and Bittner 
(1979) who found that organic extracts of Trisetum flavescens were 
not able to overcome strontium inhibition of the renal 25(OH) 
cholecalciferol - la-hydroxylase.
Work on the organic soluble extracts of the plant was carried out by
Zucker,Kreutzberg and Rambeck (1977) who used a 'curative rat test' as a 
determinant of calcinogenic activity. This technique involved 
rearing rats for three weeks on a low calcium, vitamin IHdeficient 
diet. They were then changed to one with a very high calcium level 
(4Z) and low phosphorus. This causes a fall from about 10mg% to just 
3 in seriim phosphate. If vitamin D (or a plant extract with
vitamin D-like activity) is given at the time of the dietary change,
3
then a rise in serum phosphate after three days is found to be related
to the »ount of vit«d» D^do.«!, Zucker « a  were eble to
use this technique to show that both whole lyophilised Trisetum flayescens
anti purified organic extracts produced a significant increase in the
serum phosphate of rats treated in the above manner.
A nuniber of experiments, by various research groups, showed 
that Trisetum flavescens contained a high level of vitamin I^like 
activity (Waser, Meyer, Hänichen and Dirksen, 1983; Ranibeck, Wetzel 
and Stark, 1979; Regal, 1983A; Regal, 1983B) although there was a 
great variation in their estimates. Waser et al (1983) compared 
calcifications in sheep fed 100,000 iu vitamin and grass 
free of Trisetum flavescens per day, with sheep fed 1.5 kg Trisetum 
flavescens per day. Results revealed that sheep fed the Trisetiim flave­
scens developed moderate to severe calcifications within sixty two
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days, compared with the one hundred and twenty days required for minor
calcifications (small calcified plaques visible in the left atrium)
to become apparent in sheep fed 100,000 lu of vitamin I^per day. They
concluded that 1 kg of the plant was equivalent to 150,000 lu vitamin
D . Experiments by Raaobeck Wetzel and Stark (1979) and 
3
Rambeck and Zucker ( 1978) estimated that Trisetum flavescens only 
possessed the equivalent of 3000 to 4000 lu vitamin per kg dried 
plant material. This was carried out using the Japanese Quail egg­
shell test, in which the thickness of eggshell produced by the bird 
is proportional to the level of vitamin D administered (Zucker and 
Gropp, 1968) Zucker et al, (1977) obtained comparable results using 
the curative rat test which indicated a level of 4000 lu/kg of vitamin
D-like activitv in lyophilised Trisetum flavescens and 3000 luA^g in 
3
the purified organic extract.
Raod)eck, Oesterhelt, Vecchi and Zucker (1979) used GC/MS to ascertain 
that the active organic soluble extract contained vitamin but 
discovered that only lug cholecalciferol per lOg original plant 
material was present (equivalent to 0.1 ppm). This is not a sufficient 
level of the vitamin to cause hypervitaminosis This analysis was 
in agreement with kambecks' biological testing for vitamin 
activity in the plant (Rat bioassay and Quail egg-shell test).
Hence the cause of the severe calcifications found in affected cattle 
could be presumed not to be the result of an excess of vitamin D^. 
Calcitriol was also discounted as a possible calcinogen as the result 
of an HFLC analysis by Zucker, Kreutzberg and Rambeck, (1977) which 
showed that no calcitriol was present in the plant.
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The latter finding was not in accord with the results of Peterlik,
Regal and Kohler (1977) who presumed that calcitriol must be present 
because lyophilised Trisettm flavescens induced calcium binding protein 
synthesis in the "strontium chick". They also concluded that Trisetum 
flavescens was twenty five times less potent than Solanum malacoxylon 
in terms of calcitriol-like activity, as measured by the ability to 
promote the formation of calcium binding protein. These observations 
did not take into account the high plasma phosphate levels and little 
affected plasma calcium levels which are not seen in animals with an 
excess of calcitriol in the bloodstream.
The ratio of vitamin D activity of Solanum malacoxylon to Trisetum
3
flavescens has been estimated at 1 0 0 :1 and so it is reasonable to 
assume that Trisetum flavescens contains more than one calcinogen 
in order to account for its potency in causing calcinosis. This 
ratio of 100:1 was based on results obtained by Wasserman, Corradino, 
Krook, Hughes and Haussier, (1976), who used the induction of calcium 
binding protein in the duodena of vitamin I^deficient chicks as a 
reference point. The result showed Solanum malacoxylon to have the 
equivalent of AOO lu/g of vitamin I^like activity. Rambcck, Kreutz- 
berg, Bruns-Droste and Zucker (1981) estimated the activity of 
Trisetum flavescens at only 4 lu/g using both animal bioassays and 
HPLC/GC analyses. The potency of Trisetum flavcscens is such that 
sheep develop macroscopic calcifications of the aorta in only fifty 
three days (Simon, Daniel, Hänichen and Dirksen, 1978).
Further analytical studies on the organic soluble factor (Raiabcck, 
Oesterhelt,Vccchi and Zucker, 1979) failed to identify hydroxylatcd
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derivatives of vitamin I^in the plant. The abscence of calcitriol in 
organic extracts was demonstrated conveniently by co-chromatography 
with pure calcitriol. A hypothesis that the Trisetum flavescens active 
factor might be a 'bound' form of Vitamin was put forward (Rambeck 
et al 1979). There is no evidence to support this, however. Other sterols 
have been detected in the plant (Rambeck,Kreutzberg, Bruns-Droste and 
Zucker, 1981).
A study by Dirksen et al has shown that the daily administration of 
15g of aluminium hydroxide prevents the development of calcinosis 
when the animals are on a diet of Trisetum flavescens (Dirksen, Sachs, 
Held, Nowotzin, Hänichen, Meyer, Rainbeck and Zucker, 1983). Animals 
fed with Solanum malacoxylon were similarly affected by the admini­
stration of aluminium hydroxide (Wase, 1972);negatively charged 
phosphate ions are attracted to the aluminium hydroxide, bind to it, 
and thereby lower the calcium x phosphate product.
The synthesis of cholecalciferol in Trisetum flavescens appears to
be light dependent (Zucker, Stark and Rambeck, 1980). Yellow
plexiglass filters were used to prevent ultra-violet light reaching
the plants following germination. Wavelengths of light below 490 nm
were filtered out. It was then shown that the vitamin D-like3
activity was not synthesised. The workers do state however, that 
not all the activity is removed in this way. Brief exposure of a 
diethyl ether extract of these plants to ultra-violet light was 
enough to restore vitamin D^like activity as measured by the curative 
rat test. Trisetum flavescens grown in the absence of ultra-violet 
light was normal in appearance, but clearly a photosynthetic reaction 
was responsible for the production of a good proportion of the organic
53
soluble vitamin I^like activity. In 1981, Rambeck et al showed 
that 7-dehydrocholcsterol behaved similarly to ether extracts of 
Trisetum flavescens, when both were exposed to ultra-violet light for 
three minutes. These observations still do not explain the potent 
calcinogenic activity of the plant, since only 0 . 1  ppm cholccalciferol is 
found in plants grown under normal conditions. This implies that another 
calcinogen may be present in the plant in addition to this photo- 
synthesised cholecalcifcrol. Rambeck, Kreutzberg and Zucker (1982) 
found that incubation Of the residue of ether extraction of Trisetum 
flavescens with rumen fluid produced an increase in the serum phos­
phate of rats in the 'curative rat test*.
The apparent differences between the modes of action of Solanum 
malacoxylon and Trisetum flavescens were not found to result in 
marked differences in the soft tissue calcifications produced. Regal 
(1983A) showed that, as in Solanum malacoxylon, the calcifications 
produced by Trisetum flavescens were localised in connective tissues 
and elastic fibres within these organs. Notably, calcium depositions 
were found in the smooth muscle cells of the aortic media layer.
Regal (1983A) found that feeding Quail with either a high dose of vitamin
D (AOOO lu /day) or lyophilised Trisetum flavescens resulted in high
3
levels of proteoglycans and higih activity of the Ca -dependent ATP ase.
He also found that calcium deposits were formed in these animals within 
connective tissue cells of the lamina propria and in mitrochondria of 
glandular epithelium. These are presumably the first .sites of calcium 
deposition in animals with either hypervitaminosis or Trisetum flavescens
5A
- induced calcinosis. Regal (1983B) has also shown that either AOOOIu
vitamin D or lOZ lyophilised Trisetum flavescens induced the for-
3
mation of calcium binding protein in the Quail uterus. Further experi­
mentation (Regal 1983C) showed that calcium deposits induced by 
Trisetum flavescens or vitamin were formed at sites where proteo­
glycan deposits were found. This suggested that the proteoglycan 
deposits were the foci of formation of calcium deposits. In particular, 
calcifications were found in interstitial connective tissue of heart 
and kidney tissue, as well as the elastic fibres and basal membranes. 
Regal found that a large increase in proteoglycans and soluble calcium 
occurred simultaneously in animals treated with either Trisetum 
flavescens or high doses of vitamin .
SUMMARY
Different research groups have found several major discrepancies in 
their results during the course of the variety of experimental 
approaches eiq>loyed:
i) When the whole plant was used in feeding trials the vitamin D-like 
activity was estimated at 150,000 lu./Kg, whereas organic extracts 
only possessed 4000 lu/Kg.
ii) Controversy also existed concerning the ability of the plant to 
overcome strontium inhibition of the renal 25(OH)cholecalciferol 
la-hydroxylase. The literature revealed that the whole plant was 
able to overcome this inhibition whereas the organic soluble extracts 
were not.
The likelihood that calcinogenic activity resided in aqueous soluble, 
as well as organic soluble, extracts of Triseturo flavescens became
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CHAPTER 2
GENERAL METHODS
2;1 Preparation of Extracts of Trisetum flavescens Using 
Aqueous and Organic Solvents
A lOZ w/v suspension of lyophilised Trisetum flavescens was stirred 
at room temperature in ten times its own volume of distilled water 
for about twenty four hours. The solid material was then removed 
from suspension by filtration through muslin cloth. The application 
of mechanical pressure at this stage ensured that as much filtrate 
as possible was separated from the solid matter. The resultant 
brown liquid was clarified by centrifugation at 16,0CX)g for ten 
minutes. Finally the extract was reduced in volume to produce a 
highly viscous brown fluid. This was done either by freere-drying 
or by rotary evaporation (ten^>erature not exceeding 3^ C  if 
possible). The concentrate was diluted slightly to produce a 
known concentration of roughly 2g original dry plant material 
per ml. The crude aqueous extract was used for administration to 
animals and for further purification. Samples were stored at 20 C.
Gel Filtration
Sephadex (Pharmacia Fine Chemicals Ltd.)» is an extremely hydro­
philic and complex molecule, formed by cross linking dextran with 
epichlorohydrin. It is produced as dry beads varyiag in diameter
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and the degree of cross linkage. This allows molecules within 
well defined weight ranges to be fractionated on each grade of 
Sephadex, the principle being that smaller molecules are retained 
within the bead pores, allowing molecules to be eluted in order of 
decreasing molecular weight. The gel is very stable both physically 
and chemically.
The grade of Sephadex found to be most suitable for the partial 
purification of the crude aqueous extract of Trisetiim flavéSOéns 
was G-25 (fine grade, which is recommended for preparative work) 
which will fractionate molecules (theoretically presumed to be 
spherical) between the molecular weight range 1000 and 5000.
Larger molecules are eluted in the void volume.
A 70cm X 2.5cm glass chromatography column was used. This sire 
allowed a reasonable sample size to be used (about the equivalent 
of 1 . 5  g original dried leaf) while at the same time the flow rate 
of about 2 .0 mis per minute allowed a complete sample to pass 
through the column in about six to eight hours, with reliable 
resolution of the peaks. The column was fitted with a glass sinter 
at the base. A Sephadex *bed* of 60 cm in length was used (bed 
volume 319 cm*). The flow rate preferred was 1.5 cm* to 2.0 cm* 
per minute. The column was always eluted with fresh glass distilled 
water.
A typical preparative run was carried out by firstly, swelling 
the dry Sephadex beads in water at room temperature. The column 
was then packed with the Sephadex slurry in a slight excess of
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water, and allowed to settle overnight. The column was then 
equilibrated with the solvent by pumping water through the system 
for several hours. The water was pumped to the head of the column 
using a peristaltic pump (Gilson Minipuls 4). When the bed has 
equilibrated, the water level above the bed was reduced with cate 
(using a Pasteur pipette) to within 1 cm of the bed surface.
(It is important that the bed surfece remain completely undisturbed). 
The concentrated, crude aqueous extract produced by the method 
described above, was then applied to the head of the column; for 
this purpose the water level was reduced to 1 cm above the gel bed 
and the flow stopped. About 1 ml of concentrated extract was then 
carefully pipetted on to the surface of the bed (usually equivalent 
to about 1.5 g of the original plant material). After the extract 
had settled the pump was atarted and the water level very slowly 
increased at the head of the column, until the sample was washed 
into the gel bed. The top of the column was then sealed and 
the filtration allowed to proceed overnight. The next morning 
the flow of solvent was stopped and the elution profile compared 
with previous runs. Pea3ts cont«ning biological activity were 
then identified.
During the early stages of the work, it was necessary to test the 
peaks individually for biological activity, subsequently only 
fractions were retained.
The eluent was collected using an automatic fraction collector 
(LKB) in 15ml aliquots. Th« adjusted to
1.5 cm* to 2.0 cm* per minute. The eluate, on leaving the column.
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was passed through an ultra-violet detection cell (LKB) 
set at a constant wavelength of 280 x m . This was then linked up 
to a chart recorder which drew an elution profile of the run as 
it proceeded making subsequent identification of the fractions 
fairly simple. The coluan had a void volume of 112 cm’. Once 
set up the system was fully automatic, and could he left to run 
overnight as each run took 7 - 8 hours. The fractions found to have 
biological activity are illustrated in figure 3 which shows 
the elution profile from a typical run.
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Purification of an Organic Solvent Soluble Extract of Trisetum flavescens,
Four extracts were prepared as outlined in figure A below.
FIGURE 4-
Steps in the Preparation of Organic Solvent Soluble Extracts
Details of the purification procedures were as follows;
Extract 1 was derived from the following purification steps. 
lOOg of freeze-dried Trisetum flavescens was added to 500ml of 
diethyl ether. After ten hours standing the extract was filtered 
off and then washed with ether. Evaporation followed using a rotary 
evaporator. The ether-soluble material was then saponified with
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potassium hydroxide in ethanol. The non-saponifiable material 
was passed down a 20 x 2cm chromatography column packed with AI2O3 
using increasing amounts of diethyl ether in light petroleum. The 
fraction containing 9% diethyl ether in light petroleum was found 
to contain the active fraction . HPLC was carried out on this fraction 
using a Waters chromatograph. The stationary phase was u-porasil 
(silica) and the mobile phase was 2.5% isopropanol in hexane. A 
further separation was done on a reversed phase HPLC system utilising 
u-bondapak as the stationary phase and acetonitrile as the mobile 
phase. Monitoring of the effluent from these chromatographic procedures 
was recorded continuously at 25Anm so that individual peaks could 
be tested for biological activity (Rambeck, Oesterhelt. Vecchi and 
Zucker, 1979). Extract 1 was collected from the u-bondapak column, 
following biological testing for the active fraction by Rambeck 
et al (1979).
Extract 2 was a much cruder preparation than extract 1 and consisted 
of the ether soluble material prepared directly from the dried grass. 
Extract 3 consisted of the active eluate from the AI2O3 column 
step.
Extract A consisted of an extraction of the lyophilised plant with 
ethyl acetate.
The four extracts prepared in the above way were used for the 
experiments in chapter 3. For in vivo dosing purposes, the extracts, 
initially in hexane, were dried by passing a stream of nitrogen over 
them prior to re-dissolving them in propylene glycol. Propylene 
glycol is used as it is inert in biological systems.
6A
2:2 Techniques for the Analysis of Plasma Minerals 
and Alkaline Phosphatase
Atomic Absorption Spectroscopy
This technique allows the concentration of metallic elements 
in solution to be determined with great accuracy. The process 
consists of spraying the solution into an air/acetylene flame 
where it is irradiated with radiation from a laoq> which 
generates light at the same wavelength as the spectral emission 
of the element to be measured. In this way the sample is 
stimulated to absorb light and so be excited to higher electronic 
states. The amount of light absorbed is related to the concentration 
of the element in solution. There is excellent selectivity in 
terms of absences of spectral interference from other elements 
because the resonance spectra for elements are of very narrow line 
width (10 pm).
This technique was routinely used to measure serum levels of 
calcium, strontium and magaesium for all serum sanq>le8 and tissue 
culture media. The sensitivity of the analysis of these elements 
is 0.003, 0.002 and 0.9 ppm respectively.
Measurement of Plasma Calcium
A stock standard solution of calci\m (500V g/ml) was made up 
by adding exactly 1.249 g of spectroscopy grade calcium oxide to 50ml 
of glass distilled water. This was dissolved with a minimum volume 
of concentrated hydrochloric acid and made up to one litre with
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distilled water. A series o£ standards was set up in the follcwing 
way using glassware cleaned in ’Decon 90> (a surfactant solution) 
and well rinsed with glass distilled water.
TABI£ 2
Standard
(mgZ)
Stock Calcium 
Solution (mis)
Water i 
(mis)
— >Lanthanum
Solution
0 0 2 .0 98
2.5 0 . 1 1.9 98
5.0 0 .2 1 .8 98
7.5 0.3 1.7 98
1 0 .0 O.A 1 . 6 98
12.5 0.5 1.5 98
15.0 0 .6 l.A 98
Equipm ent c a l i b r a t i o n  i s  c a r r ie d  o u t u s in g  a  fu r t h e r  s ta n d a rd  o f  
A P g /m l w h ich  g iv e s  a t y p i c a l  r e a d in g  o f  0 .2 2  ab so rbance  u n i t s .
The absorbance levels of the above standards are measured and a 
graph of concentration versus absorbance drawn up to check for 
linearity. Both the standards and the samples are diluted fifty 
times, in order to enable direct comparability and also to be within 
the detection limits of the Atomic Absorption Spectrophotometer. 
Lanthantim chloride solution (O.IX) is used in both the standards 
and the samples to control interferences by other elements in the 
sample (eg. phosphate and sulphate).
The lanthanum  c h lo r id e  s o lu t io n  i s  made up by  a d d in g  5 8 .6A g  o f
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lanthanum oxide to 50 mis of water, slowly adding 250 ml of concentrated 
hydrochloric acid and making it up to a litre with distilled water.
The O.IZ diluent is prepared by diluting 20 mis of this stock solution
to one litre;.
For routine serum calcium measurements 0.1 ml of fresh plasma was 
pipetted (Gilson P200 Autopipette) into duplicate boiling tubes 
followed by the addition of 4.9 mis O.IZ lanthanum chloride solution.
The samples are then mixed thoroughly and the calcium levels measured 
by aspirating the air/acctylene flame with this solution. The samples 
were compared with the standard solutions while measurements were 
being taken, in order to compensate for any fluctuations in the responses 
of the machine. All measurements were made using the integrated 
measurement capability of the machine for greater accuracy.
Measurements of Plasma Strontium
This analysis was very similar to that for calcium, the standards 
being up from a stock standard solution containing lOCX)
Vg/ml of strontium nitrate. Standards ranging from 0 mg/100 mis 
to 15 mg/100 mis were set up for calibration of the instrument.
Both standards and solutions were made up in a IZ solution of 
lanthanum chloride in order to control the considerable ionisation 
of strontium in the air/acetylene flame.
Measurement of Plasma Phosphate
This was most conveniently done using a commercial colorimetric test 
kit (manufactured by Boehringer Mannheim Gmbh Diag^ostica). The 
colorimetric analysis involved reacting the phosphate with molybdate
and vanadate in nitric acid, to give a coloured complex.
Acid washed glassware was used and the routine analysis was carried 
out as follows: 0.2 ml of heparinised (Lithium heparin (Sigma)) 
plasma was pipetted into a 10 ml glass centrifuge tube and 2 .0  mis 
of trichloroacetic acid (1 .2H) was added. All samples were analysed 
in duplicate. After a ten minute interval the tubes were centrifuged 
at 1156g for 10 minutes and 1 .0  ml of the deproteinised supernatant 
was placed in a clean test tube then 1 . 0  ml of each of the test 
solutions was added to each tube. After ten minutes the reaction 
colour develops fully and the absorbance of the sample can be read 
against that of the blank in a Cecil spectrophotometer at a constant 
wavelength of 405 nm. The blank contained 1.0 ml of pure trichlor­
oacetic acid instead of deproteinised supernatant. Results were 
calculated using the following relation;
Concentration of
inorganic phosphorus ■ 5.5 x Absorbance of sample
Absorbance of standard
The test kit provided known standard concentrations of inorganic 
phosphorus.
Measurement of Serum Alkaline Phosphatase
This enzyme was assayed in alkaline solution, using p a r a —nitrophenol 
phosphate as the substrate. Enzymic cleavage of the phosphate 
group releases a yellow product (p-nitrophenol) which could be 
assayed colorimetrically.
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Reagents: i) Sodium bicarbonate/Sodium carbonate buffer 30 mM,
plus 2 mM magnesium chloride, the final pH of the buffer 
is adjusted to pH 9.8 by careful addition of sodium 
hydroxide solution.
ii) Phosphatase substrate 20 nM in water.
iii) Just prior to the assay, i) and ii) are mixed in 
equal proportions to give 10 nM substrate.
Assay:- 0.05 ml of plasma are added to test tubes, together with
2.5 ml of the buffered substrate. The tubes are then incubated at 
37°C for two minutes. The reaction is then stopped by the addition 
of 0.5M sodium hydroxide (3 mis) to each tube. The colour intensity 
is then measured at A05 nm against the blank.
Preparation of the blank: 2.5 ml of substrate is incubated for 2.0 
minutes at 37°C followed by the addition of 3.0 mis of sodium 
hydroxide and finally 0.05 ml of plasma is added. A standard curve 
was set up using standards containing 0 to 10 y g/ml of p—nitrophenol • 
The results were then represented as ymoles of PNPP hydrolysed/mxn/ 
litre plasma.
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FIGURE 5
p - N I T R O P H E N O L  S T A N D A R D  CURVE
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2:3 Liquid Scintillation Counting
This technique was used throughout for the measurement of the
AS 32concentration of two isotopes, namely ^calcium and phosphate 
The latter is a high energy beta emitter (Emax 1.71 mev) whereas
A5 calcium is a low energy beta emitter (Emax 0.254 mev). Because
32of this quenching of ^ phosphate emission is not really a problem 
and the best counting ' window^* for it was already set up on the 
Beckman LS 7500 counter. The scintillation fluid used for this work 
was Amersham Triton which is suitable for aqueous samples. The form­
ulation of Amersham Triton was as follows: i) O.OlZ (l,4DiC2- 
5-phenyloxazolyl)3d>cnzene). ii) 0.8Z Diphenyloxazole. The solvent 
is toluene. The above solution is mixed with Triton X 100 in the 
proportions of 2:1. Amersham Triton can accept up to 1.0 ml of 
aqueous saaq>le in 10 mis of the scintillant. The following information 
was gathered with respect to calcium, in order to determine the 
most favourable counting conditions. A number of experiments were 
performed prior to the use of ^^calcium in gut absorption studies, 
in order to determine the optimum conditions for measuring the radio- 
calcium levels of solubilised gut material. These were the determ­
ination of
i) The counting ’window* of ^^calcium.
ii) The 'counting efficiency* of the instrument with regard to 
calcium.
iii) The quenching effects of the tissue solubiliser.
Quenching can be caused by any substance in the vial that interferes 
'^ ith the interactions between the fluors and the solvent. Pure formic
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sacid was found to be suitable for this purpose. The optimum 
amount of tissue solubiliser was determined because this must be 
as small an amount as possible as the acid contributes to 'quench 
effects* and yet enough must be used for complete solubilisation 
of the tissue iv) The optimum amount of solubilised tissue to 
be used in each vial. (This must be enough to give a statistically 
reliable count and yet not enough to cause significant quenching). 
Separate determinations of the quenching effects of the solubilised 
gut tissue and the lumen contents were made.
Results
i) The counting window of calcium was determined as described
as in the Beckman manual and was discovered to be identical to the
. 14counting window of carbon.
45
ii) The counting efficiency of the instrument with regard to 
calcium was determined with greatest accuracy by counting a good 
number of scintillant-containing vials that have had identical 
smounts of the isotope added. Thus pipetting errors are minimised 
find a statistically acceptable result is obtained. In this case 
0.0146y Ci of calcium was added to each of 17 vials which were 
then hand shaken to mix the isotope with the 'Amersham Triton*.
The counts obtained were averaged out and the counting efficiency 
was obtained by using the following formula:
C ou n tin g  e f f i c i e n c y  *  co im ts p e r m inute
disintegrations 
per minute
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This resulted in a counting efficiency of 84.3Z for the instrument 
used in the early part of this study and an efficiency of 74.24Z 
for the Beckman (model LS 7500) machine used subsequently.
iii) The quenching effects of the tissue solubiliser and hence
the optimum amount of acid to use was determined by adding a known 
45amount of calcium to each of 12 vials (0.0148yCi). These vials 
were then counted before and after the addition of different amounts 
of formic acid. The results showed that more than 0.3 mis of formic 
acid per vial caused a detectable reduction in counts per minute. As 
a result of this it was decided to use 0 .2  mis of the solubilised 
gut tissue per counting vial and 0.5 mis of the diluted solubilised 
lumen contents (This was equivalent to 0.33 mis of acid).
EXPERIMENTAL RESULTS
3 Relationship Between Level of Formic Acid and Quench.
Formic Acid 
(mis/vial)
Z Reduction in counts
0 0
0 . 1 0
0 .2 0
0.3 0.26
0.4 3.63
0.5 19.97
(iv) The optimum amount of solubilised tissue to be used.
For the determination of the optimum amount of gut tissue to be 
used, a 6 .0 cm section of duodenum and another of ileum was taken 
from a four-week old chick. Each segment was chopped and then
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dissolved in 10 mis of lOOZ formic acid in a boiling tube.
Solubilisation was aided by agitation and after I k  hours the tissue
had almost completely dissolved. Vials containing 10.0 mis of
Amersham Triton were prepared and a radioactive 'spike* of 0.0148 
45yCi of calcium was added to each one. The following amounts of 
solubilised tissue were added to each of the vials prior to counting:
TABLE 4
Table Showing Optimum Level of Solubilised Tissue 
For Counting
Solubilised
Tissue
Sample
Saoqple
Volume
(mis)
CPM
Tissue
Z Reduction 
In Counts
Control 0 24663 0
Duodenum 0 .2 25466 0
Ileum 0 .2 24247 0
Duodenum 0.5 26726 0.4
Ileum 0.5 22420 0.4
Duodenum 1 .0 21443 17
Ileum I 1 .0 19492 17
A volume of 0.2 mis per vial was chosen as the most suitable for 
adding to scintillant, as quenching was minimal. There was no 
noticeable difference in the level of quench between duodenal or 
ileal tissue. A similar method was used to determine the optimum 
amount of solubilised lumen contents to be added to the scintillant.
Spikes* of 0.0148y Ci ^^calcium were added to the vials as before.
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TABLE 5
The Optimum Level of Lumen Contents per Vial,
Sample
Volume
(mis)
CPM Z Reduction in counts
0 .2 23150 6 .2
0.5 24292 1.5
1 .0 22020 10.7
A volume of 0.5 mis liimen contents was chosen as the most suitable 
for addition to the vials.
Technique For Determining Transport of Isotopes Across 
The Gut Wall
This method was used for measuring the transport of either radio­
phosphate or radiocalcium across the gut wall of the chick. The 
overall method was similar for either isotope differing only in the 
amount of each isotope used, the conq>osition of the salt solutions 
injected with the isotope and the region of gut used to measure 
isotope transport. For experiments where calcium was used, 
the 1 ml of isotope solution used contained 10 y Ci of radiocalcitm 
plus 1 mg of non-radioactive calcium acetate (Wasserman, 1962).
For experiments utilising radiophosphate, the conq>osition of the radio* 
active solution was as follows; 2niM dipotassium hydrogen
phosphate, 150mM sodium chloride and 5pCi of ^^phosphorus (as 
orthophosphate). The pH of the solution was adjusted to pH 7.2 by 
the careful addition of sodium hydroxide solution. Both 
radioisotopes were obtained from Amersham.
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iUimX
It was found to be most satisfactory for the transport of calcium 
to be measured across the duodenum. The duodenum is a major site 
of calcium transport. However, the transport of ^^hosphate 
cannot be measured across the duodenum because the rate of phosphate 
absorption is very fast here and would not allow any changes in 
phosphate absorption to be monitored by this technique (Wasserman, 
1962). Therefore the ileum was used (Canas et al. 1977: Wasserman 
and Taylor, 1973). The portion of ileum used in these experiments 
was about 8 cm long, and began 2 cm proximal to the prominent pair 
of caecae. Similarly for duodenum, segments eight to ten centimetres 
long were ligated for testing purposes. Experimental details of the 
^  techniques for measuring the transport of these isotopes are 
outlined in Chapter 3.
For increased accuracy, quench effects were nullified by the
addition of a known amount of isotope, in a 5 y 1 'spike' to each
vial. Vials were then recounted and the degree of reduction in
counts of the standard amount of isotope added was then applied
directly to the counts per minute of each test sample. This is a
popular technique for measuring quench effects and is called the
internal standard' technique. When corrected for counting efficiency
the total disintegrations per minute for each vial could be arrived 
at.
Example: (using ^\alcium)
The following sample vials were counted:**
i) 0.2 mis solubilised gut tissues ■ 14050 cpm
ii) 0.01095y Ci ^ ^calcium ■ 18047 cpm
Hi) 0.2 mis gut tissue plus 0.01095yCi^^Ca - 26192 cpm
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This means that the standard has been quenched by 32.73Z and only 
yields 12142 cpm as opposed to the initial level of 18047 cpm. The 
radioactivity in the sample can be presumed to have been quenched in 
a similar fashion. The true count rate for the sanqple is thus 20886 
cpm or 32.73Z above its original value.
In this way values for the total cpm present in each saoq>le of 
lumen contents or gut tissue could be calculated and when added 
together, the amount of radioactivity transported out of the gut to 
the body could be calculated using the following expression:
10 y Ci “ (dpm in luminal fluid + dpm in gut tissue)
~ M Ci transported to body.
>jCi transported to body were conveniently represented as a percentage 
of the initial radioactivity.
2:4 Bone Culture Technique
This tissue culture technique was first introduced by Reynolds and 
Dingle (1970) who used paired half-calvariae as an integral system, 
by using one half calvarium as a control to the other which was 
used as a test bone. It has proved to be a very useful and trouble 
free method for testing the effects of various agents on bone 
tissue. The method allows histological examination of the tissue 
as well as analyses of the bathing medium.
About eight pairs of albino mice were mated in order for litters to 
be b o m  at convenient times for experimentation. Bones were taken 
from a minimum number of litters, to aid uniformity of response.
Following decapitation of the mouse, the calvarium was dissected
out by removing the skin and cutting around the periphery of the bone
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Extraneous material attached to the bone was carefully removed 
with fine forceps. Bones weiB placed on stainless steel grids 
within an individual multidish »cell*. The grid size is such that 
when 2.0 ml of medium was added to the »cell* it just bathed the 
underside of the bone.
All necessary equipment for setting up the cultures in sterile 
conditions was wrapped in aluminium foil where necessary and auto­
claved. This included 0.22y m milliporc filters, fine dissecting 
instruments, glass medicine bottles, steel platforms (1.5 cm x
1.5 cm), gas jars, glass petri dishes and glass pipettes. The 
plastic multidishes (six 'cells' per tray) were packaged aseptically 
by the supplier (Linbro).
The culture medium used was medium BGJj^  (Fitton Jackson modification)
from Gibco-Biocult. This medium, the composition of which is shown
in Appendix 2, was developed for bone culture work. Medium BGJ was
b
prepared for use by adding Rabbit Serum (Burroughs Wellcome) to lOZ
of the final volume, as well as antimicrobial and antibacterial
agents: Benzyl Penicillin and Streptonycin Sulphate . The preparation
of medium additives and all subsequent operations (except incubation)
was carried out in a laminar flow cabinet. The complete medium was
then passed through a sterile millipore filter, the entire preparation
of the medium being done immediately prior to use. Because the pH of
medium BGJ^changes on exposure to air it was not until all the bones
had been dissected out and prepared for pre-incubation that BGJ.b
medium was added to the culture dishes. During dissections, prepared 
bones were placed in a special, pH stable, 'holding' medium. This 
was medium ' 199—HEPES * which was maintained at a low teoq>erature
78
during use by surrounding the dish with ice. (Appendix 2 shows 
the composition of medium * 199-HEPES*) . The final composition of
mediumBGJ^ was as follows:-
tissue c u l t u r e  MFniA
1. 100 mis BGJj^(Fitton-Jackson modification).
2. 1.0 mis Streptomycin sulphate (10 mg/ml).
3. 1.0 mis Benzyl penicillin (10^ units/ml).
4. 1.0 mis Fungizone (0.5 mg/ml).
5. 0.7 ml L-Glutamine (0.002 mg/ml).
6. 11.0 mis Rabbit serum.
The final composition of medium * 199-HEPES* was as follows:-
1* 82.5 ml sterile water.
2. 10.0 ml Medium 199 (10 x concentrate).
3. 2.0 ml HEPES buffer.
4. 0.342 L-glutamine (0.001 mg/ml).
5. 0.5 ml Sterile 4.4Z NaHCO^.
6. 1.0 mis (Streptomycin sulphate (10 mg/ml).
1.0 mis (benzyl penicillin (10^ units/ml).
7. 1.0 mis fungizone (0.5 mg/ml).
8. 11.0 mis Rabbit serum.
As with BGJ|j,this medium is passed through a millipore filter.
The concentrations of cocq>onents in the above media represent the 
final medium concentration.
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Following dissection the bones were trimmed to uniform size and 
rinsed in two changes of ice-cold medium BGJJ. Each bone was then 
placed on a grid in a multidish *cell*, containing 2.0 ml of medium, 
before being quickly placed in a gas jar inside a 37°C incubator.
The jars were gassed with 20Z oxygen and 5Z carbon dioxide to 
adjust the medium pH to 7.4.
Experimental Incubation
After about 18 hours pre-incubation the gas jar was placed in the 
laminar flow cabinet, the petri dishes removed and each bone 
carefully placed on a fresh grid in one of the six 'cells' of a 
'Linbro' tissue culture unit. Two millilitres of fresh medium 
BG^was quickly added, either containing test substances or control 
medium. The bones were returned to the incubator and were gassed as 
before. After a prescribed period (usually 48 or 72 hours) the 
bones were removed from the medium and the medium analysed.
Pre-Labelling Of The Calvariae With Calcium
Some experiments involved the In vivo labelling of the skeleton 
with radiocalcium. Its subsequent release In vitro under the 
influence of test substances was then monitored.
Pre-labelling was carried out on the mice at one day of age to 
allow time for the label to be incorporated into the bone tissue 
prior to experimentation five to seven days later. Each mouse in 
the litter was injected with 5p Ci of calcium in 50 p 1 of distilled 
water sub-cutaneously. This dosage level gave counts per minute of 
about 200,000 per calvarium and over 10,000 counts per 2.0mls
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of culture medium, thus giving statistically reliable counts.
When the mice were killed at five to seven days of age, the calvariae 
were treated as previously described. This method allows any re­
sorption of the bone to be detected accurately throughout the culture
period by taking small samples (20yl) of the medium from each 
45
culture for calcium measurements. These samples were taken 
from each culture dish using sterile pipette tips, before being 
added to 0.5 ml lOOZ formic acid for solubilisation. At the end of 
the experiment the calvariae themselves were dissolved in lOOZ 
formic acid (4 mis per bone) and a 0.1 sample was added to scintillant 
prior to counting in the Beckman LS7500 machine. The bones took 12 
to 24 hours, with frequent agitation, to solubilise completely. 
Radiocalcium release was expressed as a percentage of that initially 
available in the bone for release ■ total release x 100
total release + residual
Analyses Of Tissue Culture Medium
It was important to determine that all bones used for experimentation 
were still viable at the end of the experiment, because if not, 
then the results would be valueless. The viability of each bone 
was tested by analysing the amount of glucose utilised during the 
culture period, thereby ensuring that active respiration had occurred.
Glucose Analysig-
This technique involved reacting glucose oxidase with its substrate 
and measuring the absorbance of a coloured product in a fixed wave­
length spectrophotometer.
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Method
Glucose oxidase reagent was made up by adding 5 mg 'o* dianisidine 
(carcinogenic) to 1 ml acetone. When dissolved this solution was 
added to 100 ml 0.05 M  Tris buffer (pH 7.0) together with 2.0 mg 
peroxidase (BDH) and 1 ml glucose oxidase (Sigma). Aliquots of 
tissue culture medium (0.1 ml) from each bone culture were added to 
0.9 ml distilled water. This solution was further diluted by adding 
20 pi of this to 0.5 ml distilled water. 1 ml of the glucose oxidase 
reagent was then added to the latter tubes. At this stage the tubes 
were incubated in a water bath maintained at 37°C for thirty minutes. 
One millilitre of 7M HCl was then added to all tubes to stop the 
reaction. Colour developed after ten minutes and the absorbance 
could be measured in a Cecil fixed wavelength spectrophotometer at 
530 nm. Standards were obtained by adding 20 p 1 of a standard 
glucose solution to a reaction tube, instead of diluted tissue 
culture medium (Glucose absorbance is linear up to a concentration 
of 1.5 mg/ml, allowing a direct comparison with the standard).
Standard glucose solution contained 1 mg/ml in water, giving an
absorbance of 0.03. A  blank was made by adding 2 0 p 1 of water to a 
reaction tube.
Sterility Testing
All cultures were tested for contamination by microbes at the end 
of the culture period. This was done by plating loopfuls of tissue 
culture medium onto nutrient agar plates, prior to a three day 
incubation at 37 C. No contamination problems were encountered.
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CHAPTER 3
The Biological Activity of Organic Soluble 
Extracts of Trisetum flaveacens
INTRODDCTION
Following the demonstration by Dirksen and colleagues (1973) of 
the calcinogenic nature of Trisetum flavescens and its ability, 
when fed to rachitic chicks, to reverse the rachitic atate, 
(Wassecman et al 1977) chemical analyses were performed on organic
extracts to determine whether or not the plant contains vitamin D.
3
Rambeck and associates (1979A) showed that cholecalciferol 
(vitamin D^) was present in purified organic extracts of the plant, 
but they were unable to demonstrate the presence of hydroxylated 
metabolites« The biological activity of these extracts was 
estimated by their ability to raise plasma phosphate levels.
It was thought necessary to confirm these observations using more 
discriminating biological tests for vitamin l^like activity. As an 
initial step in studying the pathophysiology of Trisetum flavescens 
induced calcinosis, the ability of diethyl-ether extracts of the 
leaves, at various stages of purification, to raise plasma phosphate 
and to promote radio-phosphate transport was determined.
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Experiment 1
Demonstration of the Ability of Organic Solvent Soluble Extracts of 
Trisetum flavescens to Promote Radiophosphate Uptake from the Ileum.
Experimental 
Plant Extracts
Four organic extracts, prepared in the manner described in the 
general methods section,were used in this study (see p.63,64).The samples, 
supplied by Dr. W. Raabeck (Dhirersity of Munich) in hexane were 
reduced to dryness under a stream of nitrogen and then taken up 
in propylene glycol at a known concentration«
The extracts used were as follows:
Extract 1: Final purified, following HELD.
Extract 2: Crude.
Extract 3s Partially purified following aluminium oxide
chromatography«
Extract 4: Ester fraction (not saponified).
Administration of Extract«
Twenty fire cock chicks (Rhode Island Red x Light Sussex) were 
reared to four weeks of age on a vitamin D deficient diet (see appendix
l,page b for diet composition) fire more chicks were reared 
on the same diet supplemented with »itamin D^ (2000 luAg). At this
time five chicks were assigned to each experimental group in the 
following manner.
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TABLE 6
Dosing Regimen.
Each extract contained the eqnlTalent of 1.5g of original ^ a n t  
material diasolTed in 1,(Xal propylene glycol. Chicks in groups 
1 - 4  received 0.3ia of extract sub-cutaneously 48h and 2kh prior 
to estimations of radio-phosphate transport,plasma calcium, phosphate 
and alkaline phosphatase. Chicks in grcups 5 and 6 received 0.5ml 
vehicle at these times.
This procedure was essentiaUy the sane for both '^^cadun and
32
phosphate - the differences are outlined in the General Kethods 
section.
Procedure
Each bird was anaesthetised with 4mg/l00g body weight sodium 
pc abarbitone, which was injected intramuscularly. When unconscious.
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feathers were remoTed from the ventral side of the abdomen. An 
incision two to three centimetres long was then made diagonally, 
and slightly to the left of the raid-line. The intestine beneath 
was then gently pulled through the incision with thick forceps.
The desired piece of gut having been located, tied with suture at 
one end, (care being taken not to damage any of the mesenteric 
blood vessels) 1ml of ^phosphate solution was then injected into 
the gut sac while tightening the second suture around the syringe 
needle during the introdaction of the solution. The suture was 
pulled tight as the needle was %rithdrawn, so as to prevent any 
leakage. The exteriorised gut was then carefully replaced 
within the abdominal cavity, and the wound closed with artery clips.
The animal was then kept warn and unconscious,for a further fifteen 
minutes to allow absorption of the isotope.
At the end of this time, a ^.Oml blood sample was removed from the 
wing vein and added to a cooled glass centrifuge tube containing 
lOOIu of solid lithium heparin (sigma). The animal %ms killed 
with an overdose of anaesthetic and the gut sac removed from the 
abdominal cavity and held above a 50ml measuring cylinder. The sac 
was then slit lengthways with fine scissors and the contents 
thoroughly washed into the cylinder with a total volume of kOmLa of 
the appropriate washing solution (identical to the radioactive 
solution injected into the gut segment, but minus the isotope). The 
rinsed gut tissue was then finely chopped and dropped into a 
oiling tube containing 13id1s of 100% Formic acid. ^(Omls of the suspended
lumen contents (prepared as described above) were then allowed 
to solubaise for 2k hours (aided by mechanical agitation). The 
blood sample was then spun at 1156g in an 'MSE Minor' centrifuge, for 
ten minutes and the plasma used for the measurement of isotope, total 
phosphate, calcium and alkaline phosphatase.
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The resiilts of the plasaia and radio»phos|^iate transport neasurenenta 
are shown in Tables 7 and 8.

Significance of Differences (t-test)
All pairs of groups were tested and revealed the following notable 
results«
(i) Vitamin D-deficient v vitamin D>replete groups
3 3
For calcium: (p<0«087 i«e p^0«05)
For phosphate: ( p < 0.013)
For alkaline phosphatase: (p< 0.001)
For [Ca x P^] : (p<0«01)
(ii) Vitamin ^deficient v groups 1-4
For calcium: None of the values differed significantly 
For phosphate: Vitamin ¡^deficient v group 3 (p<0.067) 
otherwise no significant differences.
For alkaline phosphate: No significant differences.
For [Ca X : vitamin ¡^deficient v group 3 (p^O.Ol)
(iii) Vitamin O-replete v group 2: plasma phosphate did not3
differ significantly.
(iv) Vitamin I^replete v groups 1-4
For [Ca x P^] , groups 1,3 and 4 (p<0«04) group 2 v 
Vitamin i^replete, not significant.
The results sho%m in Table 7 indicate that the mean values for each 
group for plasma calcium are greater than the mean value for the
vitamin D-deficient controls, with the exception of group 2.
3
However, none of these values is significantly different from the 
^deficient controls.
The vitamin Oureplete group has the hipest mean plasma calciiim
3
level, but this difference is not significantly greater than the
▼itamin D-deficient controls.3
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Similarlyt mean alkaline phosphatase levels for all groups treated 
with a plant extract, though lower than that for the vitamin 
deficiont jroup, wer#* not significantly so. A similar situation, 
again, is found for plasma phosphate levels; while the mean value
for each group is higher than for the vitamin D-deficient group,
3
none is so significantly so (p<0.03)* The mean value of plasma 
phosphate for the vitamin replete group is the highest, but again 
the difference is not significantly greater than vitamin ¡^deficient 
levels. Plasma phosphate levels of the vitamin lUreplete controls and 
group 2 are not significantly different. However, all four groaps 
treated with plant extract, show greater mean plasma [Ca x P^] than 
vitamin D-deficient controls although they are significantly lower
(p<0.0^) than that for the vitamin D-replete group (with the
3
exception of group 2 ( p < 0.03))*
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s t a t i s t i c a l a n a l y s i s
a) for % in Iwnen (coluom k)
Vitamin ^  deficient ▼ group 2 (p^O.01)
b) for % ^ P transferred to body (column 5)
Vitamin D deficient ▼ group 2 (p<0*0l)
3
Vitamin ^  deficient t group ^ (p < 0.05)
32c) % ^  P transferred to body/cm gut tissue.
Vitamin D deficient t  group 2 (p<0.03)
Otherwise differences between groups are not si^iificant.
Column 8 represents the sum of walues in columns 3 nnd 5*
Lerels of *^phosphate in the gut tissue were similar for all groups. 
Howeyer, the mean yalue for % radio-i^osphate remaining in the Itimen
is highest in the yitamin D-deficient group. The yalue, for this
3
latter group, of 8 3 * ^  is 11.39^ hif^er than for the vitamin I>-reiOLete
3
group and all groups treated with id.ant extracts haye between 12.8%
Ttp
and 21.6% less residual ^ phosphate in the lumen than the yitamin 
¡^deficient gvoup.
The yitamin D-deficient group shows the lowest leyel of ^^phosphate
3
transference to body and is significantly lower than that for group 
2 (p<0.01) and group k (p<0.05). When the ^^phosphate results 
were adjusted to take the gut lengths into account there was no 
significant difference between groups with respect to ^ phosphate 
remaining in the gut tissue and the levels of ^phosphate transferred
•to body per cn gut tissue was again lowest in the vitaoiin D-deficient
3
group. The latter group showed significantly lower (p< 0.03)
32phosphate transference to body per cm gut tissue than group 2
32snimals. The ability of the extracts to stimulate phosphate 
absorption is seen by reference to column 8 (table 8).
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FIGURE 6
A Comparison of the Effects of Organic Solvent Soluble Extracts
of Trisetum flavescens with Vitamin in the Chick.
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Figure 6 shows the mean % **phosphate removed from the lumen of 
vitamin D^-deficient chicks that were dosed with organic solvent- 
soluble extracts of Trisetum flavescens. Control groups were either 
vitamin D^-deficient or fed a complete diet.
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DISCUSSION
These results indicate that the rise in plasma phosphate noted 
by previous workers (Zucker, Kreutzberg and Rambeck , 1977) was
the result of an increase in the intestinal absorption of 
phosphate. Renal retention cannot be ruled out however.
The extracts appear to promote little change in plasma calcium levels 
of plant extract-treated chicks.Three treated groups exceed control levels 
although the differences are not statistically significant.
Confirmation of the upward trend in plasma phosphate and
the stability of plasma calcium is seen in the Tslues of the calcium
X phosphate product for plant extract treated groups, which indicates
a reversal of the vitamin D-deficient state. The plant extracts3
also appear able to reduce the abnormally high alkaline j^osphatase
levels induced by the vitaunin D-deficient state, which also indicates3
a partial reversal of vitamin D deficiency. This effect was found3
by Canas, Ortiz, Asteggiano, Pereira (1977) Tor Solanjun malacoxylon 
treated chicks. All four extracts are active in promoting intestinal 
phosphate transport. Indeed, in three of the four groups receiving 
the plant extract ^phosphate transport is greater than in the
vitamin D-replete group.3
Rambeck, Kjneutzberg, Bruns-Droste and Zucker (1981) estimated, in 
biological assays, that organic extracts of Trisetum flavescens 
contained only k lu/g of cholecalciferol. The chicks in this 
experiment were given only 1.5g oT original dried leaf which 
represents, according to Rambeck's figures, only 6 lu of cholecalcifer­
ol per chick. It seems tmlikely that 6 lu of cholecalciferol could 
produce the extent of reversal of the symptoms of Vitamin ^  
deficiency apparent in forty-eight hours. It is therefore likely
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that either; a) another biologically active factor, in addition 
to the cholecalciferol is present or b) Hambeck's estination of
the vitamin D activity is too low.3
The uptake of radiophosphate into the gut does not appear to be
affected by vitamin D deficiency or the plant extract suggesting3
that the rate limiting step (and the one influenced by the plant 
extracts or vitamin D^) is the passage of j^osphate out of the gut 
and into the bloodstream. It appears that phosphate levels within 
gut tissue cells are maintained at a constant level regardless of 
the rate of passage of i^osphate through them.
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Experiment 2.
An Investigation into the Effects of a Purified Organic Extract 
of Trisetum flavescens on Radio-Calcium Transport Across the
Duodenum.
Introduction.
The previous experiment indicated that organic-soluble extracts 
of Trisetum flavescens can stimulate intestinal phosphate transport, 
an effect reminiscent of vitamin D^. An increase in the [Ca x P^] was 
apparent essentially because of increased plasma phosphate but both 
plasma calcium and phosphate levels showed some increase.
Because of the work of Zucker, Kreutzberg and Rambeck (1977) which 
suggested that neither vitamin nor any of its major hydroxylated 
derivatives were present in sufficient quantity to be responsible 
for the biological effects of the plant, it was decided to examine 
the effects of the purified extract on intestinal calcium transport.
The latter is known to be dependent upon the action of hydroxylated 
vitamin D^.
Experimental.
The experiment was carried out using the most highly purified organic 
solvent soluble active fraction of Trisetum flavescens. This was extract 1 
prepared as detailed on page 63, chapter 2. The extract was dissolved 
in propylene glycol prior to use.
Ten day-old cock chicks (Rhode Island Red x Light Sussex) were reared 
to four weeks of age on a vitamin D^-deficient diet. They were then 
divided into two groups of five, one group was then dosed with the 
plant extract and the other was untreated. The dosing regimen is 
shown in the following table.
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TABLE 9 DOSING REGIMEN.
GROUP VITAMIN D., NUMBER OF TREATMENT ADMINISTRATIONSTATUS CHICKS
1 -D 5 EXTRACT 1 2.7g dried 
leaf per 
chick.
Orally, by 
dosing tube.
2 -D 5
■
Each chick in group 1 received the equivalent of 2.7g of the 
original dried leaf in two equal doses, forty eight and twenty four 
hours before testing. Analyses of radio-calcium transport as well as 
plasma calcium , phosphate and alkaline phosphatase levels were 
performed.
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Statistical analysis.
Students t~tests.
Extract 1 v controls
For plasma calcium: No significant difference.
For plasma phosphate: The groups differ significantly
(p<0.05).
For [Ca x P^]: The groups differ significantly
(p<0.05)
A5For plasma calcium :No significant difference.
45For % calcium in lumen: No significant difference.
45For % calcium in gut tissue: No significant difference.
45For % calcium transferred to body: No significant 
difference.
Extract 1 produced no significant increase in plasma calcium levels,
although the mean plasma calcium level is slightly higher than for
the controls. Plasma phosphate, however did show a significant increase
above control levels. Measurements of the intestinal calcium transporting
ability of both groups revealed that , although the plant extract
treated groups have a higher mean level of calcium transport, this is
45not significantly different to the controls. Similarly, calcium 
levels within the gut tissue and lumen are not significantly different 
for groups 1 and 2. There is a significantly higher [Ca x P^] in 
chicks treated with the plant extract.
DISCUSSION.
The purified extract of Trisetum flavescens possesses phosphataemic 
activity which was also demonstrated in experiment 1 (chapter 3), 
and it was able to restore the [Ca x P^] to normal levels. Plasma 
calcium levels did not decrease and so this organic solvent soluble 
extract does not contain the same active factor as the aqeous soluble 
phosphataemic principle discussed in chapter 4. The latter was found
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to cause a dramatic decline in plasma calcium when administered to 
vitamin D^-deficient chicks. It may be that the O.lppm of vitamin 
known to be present in extract 1 is responsible for the apparent 
stability of the plasma calcium levels seen in this experiment.
In conclusion, the organic solvent soluble extract used has no 
significant effect on ^^calcium uptake by the gut . It is able to 
produce an increase in plasma phosphate and restores the [Ca x P^] 
to normal. It is unlikely that the extract contains calcitriol or 
a more than a very low level of vitamin D^.
103
Experiment 3
Introduction
An in vitro method for testing the action on bone of various agents 
was developed by Reynolds and Dingle (1970). This method >as since 
been utilised by workers studying the effects of vitamin Dj 
metabolites on bone tissue. (Raisz, Wener, Trummel« Feinblatt and 
Au 1972). The method has also been found useful by workers studying 
the calcinogenic plants such as Solanum malacoxylon (Simonite 
Morris and Collins, 1976; Puche and locatto, 197^)«
Since experiments 1 and 2 have revealed that organic extracts of 
Trisetum flavescens are able to increase the [Ca x P^] of vitamin 
deficient chicks, without significantly increasing calcium transport 
in the gut, it was decided that bone might possibly be t^e
site of action . At this time it. was decided to examine the effects
of the organic extracts on the release of '^calcium from pre-labelled 
mouse calvariae cultured in vitro.
^5,
Experimental
The time course of release of ~^^calcium from the calvariae of six- 
day old mice, prelabelled at one-day old, was ascertained over a 
period of sixty eight hours.
Following the pre-incubation period, test substances were added to 
groups of culture 'cells' as shown in table 12.
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TABLE 12
TREATMENT REGIMEN FOR CULTI•KJDÌ» BONES
Culture
Number Additive Doseage Level
Source of 
Additive
1 - 6 Control None -
7 - 1 1 1,25(0H)2Dj 2.5ng in Ethanol Roche Products
12 - 1,25(M),D 
KLu b  p i t  ^
2.5ng in BthanoV 
3iu PTH
PTH from M.R.C.
15-20 Extract 1 
(D^ Ester)
H  o.o6g
Dried Plant
V. Rambeck
2 1 - 2 7 Extract 2 
(D^ fraction)
•s0.0i*8g 
Dried Plant
W. Rambeck
28
(No Bone)
Medium only - -
29
(No Bone)
Medium plus 
Extract 1
«  0.06g
Dried Plant
-
30
(No Bone)
Medium plus 
Extract 2
s O . O W g  
Dried Plant
Following the addition of these substances to the cultures« they were 
returned to the 37^ ^ incubator and maintained in an atmosphere of ^  
carbon dioxide in air« and were removed at intervals so that 20pl 
samples of medium could be removed from the dishes for counting.
This was done after gently arirling the tissue culture fluid in order 
to tharonghiy mix the contents. Samples were removed at one« three 
five« twenty« forty and sixty eight hours after the addition of test 
substances and assayed for calcium« phosj^te« glucose and radio»
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FIGURE 7
The Effect of Organic Solvent-Soluble Extracts of Trisetum flavescens 
—  A5;on Release from Bone in vitro.
= CONTROL
TIME (HOURS)
Organic solvent-soluble extracts of Trisetum flavescens, calcitriol 
and parathyroid hormone were tested for their ability to promote 
the release of ^^calcium from prelabelled bone tissue in vitro. 
Figure 7 shows the increase in isotope levels in the culture medium, 
with time, for each group. The bone resorbing capabilities of 
bones treated with either calcitriol, calcitriol plus parathyroid 
hormone or either of two extracts of Trisetum flavescens are 
compared.
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STATISTICAL ANALYSIS (Students t-test)
a) for calcium: no significant differences between groups.
b) for phosphate: controls v l.,25(0H)2eholecalciferol 
plus PTH-dosed group (p<0.03) no other groups differed significantly,
if5
c) for % available "^calcium released during the 
experimental period.
(i) at one hour post-treatment:- 
control V extract 1 (p <,0.0 0 5) 
extract 1 ▼ calcitrici (p <0 .0 1) 
extract 1 v 1» 25 + PTH (p<^0.023)
(ii) at three hours post-treatment:- 
control ▼ calcitriol ( p < 0.0 1 3 )
(iii) at five hours post-treatment:- 
extract 1 v extract 2 (p<0.04) 
extract 1 ▼ calcitriol (p^ 0.00 5) 
extract 2 y calcitriol ( p < 0.002) 
extract 2 y 1,25 + PTH ( p < 0.027)
(iy) at twenty hours - no significant differences between the
(y) at forty hours and sixty hours no two groups differed
significantly.
The results Ibr total medium calcium leyels show that 1 ,2 5(i® )2 
cholecalciferol and 1 ,2 5(0H )2 cholecalciferol with parathyroid 
hormone result in elevated levels of total calcium at sixty-eight 
hours when compared with controls. The differences are not 
statistically significant, however. Both extracts 1 and 2 have meas 
total media calcium levels rather below control levels but not 
significantly so. Medium phosphate is slightly elevated above control
no
level in bones receiving extract 2 but again, not significantly so. 
Only the bones treated with 1 ,2 5(CW)2cholecalciferol and parathyroid 
hormone show a statistically significant elevation of phosphate 
in the culture medixim. All bones used in the experiment were found 
to be viable as indicated by their utilisation of medium glucose.
if5Results for the measurements of the release of ^calcium to the medium 
revealed that extract 1 treated bones had released isotope to the 
culture medium at a level significantly higher than control bones at 
one hour post addition of test substances (p<0 .0 0 5)»
No other group was significantly different to the control group at 
one hour. At three hours post-treatment only the calcitriol 
treated group was significantly higher than the control group with 
respect to isotope levels in the culture medium (p<0.013). At five 
hours no groups differed significantly from the controls although 
groups treated with calcitriol and/or parathyroid hormone had 
higher mean levels of medium isotope than all other groups. In 
contrast plant extract treated groups had the lowest levels of 
medium isotope at five hours. After twenty hours exposure to the 
test materials both plant extract treated groups showed higher 
mean levels of isotope in the medium than any other group although 
these differences were not statistically significant. After forty 
and sixty eight hours no significant difference between any pair 
of groups was found, although calcitriol and calcitriol/parathyroid 
hormone treated groups had slighty higher mean levels than other 
groups.
DISCUSSION
The relatively small numbers of bones used in this experiment tend 
to preclude clear statistical differences but although small 
differences in the time course of release of ^^ssleium in groups
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treated with the plant extract were apparent,these were not likely 
to he the result of the action of a resorbing agent. At twenty 
hours, post treatment, the plant extract treated bones show a small 
(statistically insignificant) elevation in isotope levels in the 
medium, although this is not sustained and by forty hours the 
extract treated bones are no different from control levels while 
calcitriol and calcitriol/parathyroid hormone treated bones - show 
an increase over control levels of release at this time. This 
suggests that the extracts are not causing active resorption of bone. 
Similarly, at one hour post-treatment both groups treated with plant 
extract show the highest levels of calcium resorption. The plant 
extracts are not producing responses similar to either calcitriol or 
calcitriol in concert with parathyroid hormone and are therefore 
unlikely to contain calcitriol or a calcitriol analogue. This is 
further supported by analytical work carried out by German workers 
on these extracts. Rambeck ^  al (1979A) could not detect 
hydroxylated vitamin derivatives in these plant extracts. No 
stimulation of medium phosphate levels or calcium levels overall 
were found in plant extract treated groups indicating that the 
increases in plasma phosphate noted in the first experiment are not 
the result of bone resorption of phosphate salts in conjunction 
with the observed stimulation of intestinal phosphate absorption.
In conclusion little effect of the plant extracts on calcium 
resorption from bone is found there being no significant variations 
from control levels beyond one hour of treatment. The small amount 
of vitamin known to be present in these extracts will not be 
able to induce bone resorption (Reynolds 1972A).
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CHAPTER k
Examination of the Calcinogenic Activity of Aqueous Soluble 
Extracts of Trisetum Flavescens Using a Variety of Biological 
Assay Techniques
INTRODPCTION
The investigations into the mode of action of the organic soluble 
phosphataemic principle as described in chapter 3 i revealed that the 
factor was unlike vitamin D_ or calcitriol in its mode of action* 
Oerman researchers had only looked at organic soluble extracts of 
Trisetum flavescens and the possibility that a vitamin retype 
compound might be present in aqueous soluble form (as found within 
Solanum malacoxylon) did exist* It was necessary therefore to 
determine whether or not any aqueous soluble calcinogenic activity 
existed in the plant*
l U
Experiment 1
A Comparison of the Effects of a Crude Aqueous Extract and a 
Partially Purified Aqueous Extract of Trisetum Flavescens on
Vitamin D-deficient Chicks*
3
Introduction
A partially purified extract of Trisetum flavescens, the final peak 
obtained by passing a crude aqueous extract through ‘a Sephadex 
column (’’Peak V'), was tested by dosing vitamin I^deficient chicks and 
comparing its effects with those of the crude extract* Isolation of 
fractions that constituted the partially purified extract used in 
this biological testing) was determined by the ultra-violet absorption 
spectra of these fractions* ''Peak fractions possessed absorption 
maxima of 269nm which is similar to that of 1 ,2 5(0H)2Cholecalciferol 
which has an absorption maximum of 265nm* The blood parameters of 
total calcium, inorganic phosphate and plasma alkaline phosphatase 
were assayed at the end of the experiment*
Experimental Procedure
Fifteen day old cock chicks (Rhode Island x Light Sussex) were
reared on a vitamin D-deficient diet to four weeks of age when signs
3
of vitamin ¡^deficiency were apparent. Five other chicks were 
reared simultaneously on a vitamin D-replete diet to form a control
group. The vitamin D-deficient birds were then divided randomly
3
into three groups of five. The experimental protocol is shown in 
Table 1 5 .
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TABL5 13 DOSING BEGIMSN
Group No. of Chicks
Vitamin D 
Status ^
T. flavescens
Sampling Time 
(hours post dosing)aqueousextracts
1 5 •i-D3
- k 8
2 5 -D3 -
k 8
3 5 P.Ps0.5^g k 8
k 5 C s O . k S g k 8
Key: P.P. = Partially purified extract of Trisetum flavescene 
("peak ^") following Sephadex chromatography.
C = Crude aqueous extract of T. flavescens.
Either 2 k or k S hours following oral dosing, blood samples (about 2mls) 
were taken from the wing vein of each bird and placed in clean pyrex 
centrifuge tubes, to which had been added 10DIu of lithium heparin.
The samples were then spun on a bench centrifuge at 1156g for 
ten minutes. The plasma was then used for calcium and phosphate 
analyses, as described in the general methods section. Plasma levels 
of alkaline phosphatase were also measured.
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STATISTICS - Students t-test
The following groups differed significantly.
(i) Vitamin re píete v vitamin I^deficient 
For calcium: ( p < 0.012) 
for phosphate: ( p < 0.0 0 1) 
for alkaline phosphatase: (p^O.OO^) 
for [Ca X P^] : (p<;0.002)
(ii) Vitamin D^deficient v partially purified extract
3
for phosphate: (p< 0 .008)
(iii) Vitamin D>deficient v crude extract3
for [Ca X Pil : (p<0.003)
for phosphate: ( p ^ 0.006)
There is, notably, no significant difference between the plasma calcium 
and phosphate levels between groups 1 and A.
Chicks fed the vitamin D-deficient diet (group 2) had significantly
3
lower plasma calcium and phosphate levels and significantly higher
levels of plasma alkaline phosphatase when compared with vitamin 0-
3
replete chicks. Vitamin D-deficient chicks treated with the
3
partially purified extract showed an average increase in plasma
phosphate of 875^  above the vitamin D-deficient controls (p<^0.008)
3
Pereas plasma calcium was 139^  below the mean vitamin D-deficient
3
control level (not significant). The levels of plasma calcium in 
the group treated with the partially purified extract are significantly
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lo w e r (p <  0 ,0 0 1 ) th an  th o se  o f  the v it a m in  E ^ re p le te  c o n t r o l  g ro u p .
C h ic k s  t r e a te d  w ith  the crude  e x t r a c t  a l s o  showed a s i g n i f i c a n t  
in c r e a s e  i n  p la sm a  phosphate  l e v e l s  when com pared w ith  th e  v it a m in
D - d e f ic ie n t  c o n t r o l s  ( p < 0 , 0 0 6 ) ,
3
D IS C U SS IO N
The d a ta  i n  T a b le  16 s u g g e s t  t h a t  the crude  aqueous e x t r a c t  prom oted  
an In c r e a s e  in  p lasm a phosphate  le v e l s  in  v ita m in  - d e f i c i e n t  c h ic k s  
r e s u l t i n g  in  a  r e s t o r a t io n  o f  the  [Ca x P^] to  l e v e l s  s im i l a r
to  th o se  found  in  v ita m in  D ^ -re p le te  c h ic k s .  F u r th e r ,  r e s u l t s  
o b ta in e d  w ith  "p e a k  4 "  in d ic a t e d  th a t  o n ly  j^ o sp h a ta e m ic  a c t i v i t y  w as 
p re se n t  i n  t h i s  p a r t i a l l y  p u r i f i e d  e x t r a c t .  N e ith e r  th e  cru d e  e x t r a c t  
n o r  "p e ak  4 "  had  any s i g n i f i c a n t  e f f e c t  upon a l k a l in e  p h o s j ^ t a s e
l e v e l s  a s  m i ^ t  be expected  i f  th ey  c o n ta in e d  a  v it a m in  D - l i k e
3
su b sta n c e .
In  c o n c lu s io n ,  th e re  i s  e v id e n ce  th a t  b o th  a crude  aq u eou s e x t r a c t  o f  
T r ise tu m  f la v e s c e n s  and a p a r t i a l l y  p u r i f ie d  aqueous e x t r a c t  a re  
ca p a b le  o f  s i g n i f i c a n t l y  in c r e a s in g  the  p lasm a ph osph ate  l e v e l s  o f  
v ita m in  D ^ -d e f ic ie n t  c h ic k s .  The e x t r a c t s  d i f f e r  in  t h e i r  e f f e c t s  
upon p lasm a c a lc iu m  (a lth o u g h  t h i s  i s  n o t s t a t i s t i c a l l y  s i g n i f i c a n t ) .  
The p a r t i a l l y  p u r i f ie d  e x t r a c t  produced a  low er p la sm a  c a lc iu m  le v e l  
than  v ita m in  D ^ -d e f ic ie n t  c o n t r o ls .  A h ig h e r  le v e l  o f  phosphataem ic  
a c t i v i t y  r e s id e s  in  th e  crude  aqueous e x t r a c t .
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Experiment 2
Evidence for the Potentiation of Biologically 
Active Substances by the Gut«
Introduction
The water soluble calcinogen of Solanum malacoxylon was shown by 
Ruksan and Carillo (1976) to be modified by the gut environment. 
Glycosidases cleaved the sugar moiety from the molecule to release 
calcitriol. Since the previous experiment showed that the crude 
aqueous extract of Trisetum flavescens restored the [Ca x P^] to 
levels found in vitamin D^replete animals, an experiment was 
designed to test whether or not effects of Trisetum flavescens 
administration varied %rith dose site. To this end, a crude aqueous 
extract of the plant was administered via three different routes 
and the effects on plasma calcium and phosphate levels compared.
EXPERIMENTAL
Twenty four cock chicks (Rhode Island Red x Light Sussex) were reared
to four weeks of age on a vitamin D>replete diet. They were then
3
divided into four groups of six and dosed with a crude aqueous 
extract of Trisetum flavescens each dose being equivalent to one gram 
of dried plant leaf.
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TABLE 17 DOSING REGIMEN
GRODP NO. OF CHICKS
SITE OF 
ADMINISTRATION
1 6 ORAL DOSING
2 6 INTRAMUSCULAR
3 6 SUBCUTANEOUS
k 6 CONTROLS (NO DOSE)
Forty eight hours follovdng the administration of plant extract, 
blood samples were taken from the wing veins for analysis of 
plasma calcium and phosphate.
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STATISTICAL ANALYSIS - Students t-test
Significance of Differences 
a) for calcium
experimental groups v control - no significant differences 
at O.OO^ level.
oral V subcutaneous (p<0.001) 
oral V intramuscular (p ^ 0.003)
b)
c)
for phosphate
oral V intramuscular (p ^ 0.001) 
oral V subcutaneous (p < 0.003) 
control V intramuscular (p <0.00?) 
control V subcutaneous (p<0.023)
for [Ca X P^]
oral V intramuscular (p <0.006) 
oral V subcutaneous ( p ^0.029) 
intramuscular v control (p <0.006) 
subcutaneous v control (p < 0.032) 
oral V control NS
Plasma calcium levels in chicks dosed subcutaneously or intra­
muscularly are elevated when compared with controls though not 
significantly so. The group dosed orally showed a decrease in plasma 
calcium, which, while not significantly lower than control levels, 
was significantly lower than the intramuscularly (p ^ 0.0 0 3) and the 
subcutaneously treated groups, ( p ^ 0.0 0 1). Plasma phosphate levels 
in the control group are lower than in the orally dosed group, 
although the difference is not statistically significant. In contrast
123
the subcutaneously and intramuscularly treated groups show plasma
phosphate levels that are significantly lower than the control group
(p^ 0.0 25) a n d (pCO.OO?)respectively). [Ca x P^] levels are
significantly below control values in birds treated intramuscularly
or subcutaneously, whereas those dosed orally show no significant
change from vitamin D-deficient control values.3
DISCUSSION
The results suggest that the phosphataemic factor in the crude 
aqueous extract is only active when the extract is introduced orally; 
indeed, plasma phosphate levels are depressed significantly when non­
oral routes are utilised. In these circumstances the 
depression of plasma phosphate levels reduces the [Ca x P^] 
to dangerously low levels. This may be due to either precipitation 
of calcium phosphate or an effect of the calcinogenic compounds 
themselves. When dosed orally, the extract brings about an increase 
in plasma phosphate and a decrease in plasma calcium 
without altering the [Ca x P . ]X •
In conclusion, a crude aqueous extract of Trisetum fláveseens appears 
capable of exerting a phosphataemic effect only when dosed orally; 
when dosed at other sites there is a significant depression of plasma 
phosphate. There is also evidence of slight calcaemic action in 
groups dosed subcutaneously or intramuscularly.
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Experiment 3
Ultra-Violet Spectroscopy of Aqueous Extracts of Trisetum 
flavescens Following Sephadex Chromatography.
Introduction
Following partial purification of the crude aqueous extract of 
Trisetum flavescens, the fractions obtained from the Sephadex column 
were routinely pooled after identification by ultra-violet 
spectroscopy. Use was made of the 280nm absorption profile of the 
eluate as a general guide to the separation efficiency of a particular 
run.(See figure 8).
Methodology
(i) Individual 13ml fractions eluted from the Sephadex G23 column 
with distilled water were routinely scanned between 400nm and 190nm 
using a micro-processor controlled double beam, ultra-violet/visible 
spectrophotometer (Perkin Elmer 332). Routinely, this procedure was 
confined to fractions %rithin peaks expected to contain biologically 
active material. Fractions were diluted as necessary to give a 
suitable absorbance reading (usually one to two absorbance units). 
Typical absorption spectra for the biologically active regions of the 
elution profile are shown in figure 9« Initially the four major peaks 
identified from the elution profile were pooled separately and 
reduced in volume by either freeze drying or by evaporation under 
reduced pressure. The latter process was carried out at the lowest 
possible temperature (not more than 35^C), so as to avoid possible 
deterioration of the extract. Concentrated fractions containing the 
biologically active material were stored at -20®C for further
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experimental work. Fractions with very similar spectra were pooled.
(ii) After concentration by rotary evaporation, fractions within 
"peak were subjected to further chromatography using finer grades 
of Sephadex (615 and 610). The method was the same as for the runs 
using Sephadex 625 except that a smaller column was used (48cm x 
1.5cm).
RESULTS.
(i) Fractions taken from under "peak 3” or "peak 4" had the 
characteristic ultra-violet absorption spectra shown in figure 9»
These two elution regions were subsequently shown to contain the 
biologically active principles. "Peak 3‘'i in some runs, was resolved 
into several smaller peaks, but their resolution was poor and they 
were re-pooled. Fractions from beneath "peak 3" have absorption 
maxima at 269nm and 320nm and absorption minima at 293nm and 227nm. 
Fractions constituting "peak 4" have absorption maxima at 269nm and 
340nm and absorption minima at 246nm and 297nm.
(ii) No further resolution of "peak 4" was obtained on chroma­
tography through Sephadex 610 or 6 1 5 . Concentrates of both "peak 3" 
and "peak 4" were tested on the 'strontium chick model* (as described 
in experiment 4(i) chapter 4). The results are given in experiment 5-
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Experiment U
The Strontium Chick Model
Introduction
Shippey et al (1922) first introduced the model of »'strontium 
rickets", They reported that dietary stable strontium, when 
introduced into the diet, produced the symptoms of rickets and
effectively rendered the animal vitamin EUdeficient* Subsequent
«1^
workers utilised this ability of strontium to cause rickets as a 
system upon which to base studies of vitamin metabolites (Omdahl 
and DeLuca, 1972) or calcinogenic plants (Wasserman, 197^; Zucker, 
Kreutzberg, Nitsche and Bittner, 1979)» Thus plant substances having 
1 ,2 5(0H)2Cholecalciferol activity should be able to by pass the 
strontiiun blockage of endogenous 1 ,2 5(0H)2cholecalciferol production 
and treated animals should not show inhibition of calcium binding 
protein synthesis or intestinal calcium transport.
The following experiment was carried out in chicks in order to test 
this exx>erimental model.
Experimental
Ten day-old cock chicks were raised to six weeks of age on a complete 
diet. They were then changed to a diet low in calcium (0.159^) and 
supplemented with 0.8^ strontium (as strontium carbonate) for a further 
thirteen days.After eleven days the chicks were divided into two groups 
of five and dosed sub-cutaneously with either vitamin (lOOIu/bird) or
calcitriol (0.2 5yg/bird) forty eight hours and again at twenty four 
hour prior to sacrifice. Measurements of duodenal transport of radio- 
calcium were then made. Immediately following the fifteen minute
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STATISTICS - Students t-tests
a) for calcium: (p<C0 .0 5)
b) for phosphate: (no significant difference)
c) for plasma ^^calcium: (p\0,CX)3)
There was little difference between plasma phosphate levels in chicks 
treated with either vitamin or calcitriol. There is a clear 
indication that calcium absorption is stimulated by calcitriol as 
plasma radio-calcium levels are significantly higher (p<0.CXD3) than 
in the vitamin treated group.
The mean level of ^calcium ’transported to body* in the calcitriol 
treated group is approximately 509  ^higher than the vitamin 
(control) group. Plasma strontium levels in the calcitriol treated 
group are significantly higher than in the vitamin D^-treated group 
(p< 0.00 5). There is no difference between the groups with respect 
to [Ca X P^] . If the relationship of [(Ca + Sr) x P^] is considered 
then it is found that birds treated with calcitriol have a value 
of 58 as opposed to only W  for vitamin treated birds.
DISCUSSION
The results for radio-calcium transport confirm the previously reported 
observation that vitamin is unable to overcome the situation of 
suppressed kidney 2 5(C»5cholecalciferol-la-hydroxylase brought about 
by dietary strontium. Calcitriol, however, is able to do so as seen 
by the increased uptake of ^^calcium. There is also evidence that 
calcitriol is stimulating absorption of strontiiwn in preference to 
calcium in the gut. (It is known that the chick, unlike other animals 
does not discriminate in favour of calcium at the level of intestinal
132
absorption (Vasserman, 1962). The fact that the [(Ca + Sr) x P^]
value for calcitriol treated birds is 38 is notable because this is
the value at which the [Ca x P^] causes precipitation in normal
animals. In other words, strontium appears to be transported in the
same way as calcium.
Experiment A (ii)
Experiment to Determine the Effects of a Crude Aqueous 
Extract of Trisetum flavescens in the "Strontium Chick”
Introduction
The crude aqueous extract is tested here for its ability to by-pass 
the strontium inhibition of the kidney l»thydroxylase, in order to 
determine whether calcitriol-like activity is present.
Experimental Procedure
Ten day-old cock chicks were reared to five weeks of age on a 
complete diet and then changed to one low in calcium (0.153^) and 
supplemented %dLth O.Sjlé strontium (as strontium carbonate) for a 
further thirteen days. After eleven days the chicks were divided into 
two groups to form a control (undosed) and an experimental group. The 
latter group was treated with a crude aqueous extract of Trisetum 
flavescens at a level of 0 » 2 k g  (original dried leaf) per bird, at 
forty eight hours and again at twenty four hours prior to 
experimentation. Forty eight hours after the administration of the 
first dose, calcixm transport was measured. The procedure was 
identical to that described in experiment k  (i), and used the radio- 
calcium transport technique described in the general methods 
section
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STATISTICAL ANALYSIS - Students t-tests:-
(i) Plasma calcium - no significant differences
(ii) Plasma phosphate - no significant differences
(iii) [Ca X P^] - no significant differences
(iv) for plasma ^^calcium - (p<[0,002)
(v) for % ^^calci\un remaining in lumen - (p<0.00^)
(vi) for % ^^calcium in gut tissue - (p <0,004)
The results show that while there is no significant difference between 
the total plasma calciiim levels of the two groups, the uptake of 
radio-calcium by the gut is significantly stimulated by the plant 
extract as shown by the plasma radio-calcium levels although the 
detectable level of radio-calcium transferred to body is Ojù for both 
groups. The mean level of radio-calcium remaining in the lumen of 
the control group is significantly higher than for the experimental 
group (p<0,004). The control group shows a correspondingly lower 
level of radio-calcium in the gut tissue itself (p<.0,CX)4),
DISCUSSION
The results show that the crude extract is active in promoting 
transport of radio-calcium across the gut as demonstrated by the much 
higher level of radio-calcium in the serum of experimental birds (the 
difference between the control and experimental groups are significant 
at p <  0,002), The gut tissue levels also support the latter 
observation. The ability of the plant extract to promote intestinal 
radio-calcium transport in the "strontium chick" suggests that it 
contains a substance or substances which are either water soluble 
forms of 1,2 5(OH)2Cholecalciferol or substances able to mimic the
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intestinal actions of 1,25(0H)2Cholecalciferol. The chicks dosed 
with 0,5ygcalcitriol (experiment ^(1)) show very similar levels of 
plasma ^^calcium to the chicks given the crude extract (that is, 
approximately double that of either control group). Provided that 
the dose-response of chicks given 0.5Mg calcitriol is within the 
linear dose-response range, then the crude aqueous extract contains 
approximately 1yg of calcitriol/g of dried leaf material. As shown 
previously, (experiment 1, chapter 4) total plasma calcium levels 
of chicks treated with the crude extract remain similar to control 
values; although it might be expected that they would rise to 
normal physiological levels with continued administration of the 
extract. It is unlikely that a significant increase in overall 
plasma calcium levels would occur %dthin the timespan of this 
experiment (where calcitriol or plant extract was dosed) particularly 
as the chicks were on a low calcium diet containing large amounts of 
strontium which would compete with calcium for transport.
Restoration of normocalcaemia might therefore not be possible unless 
there was a large calcium contribution from the skeleton.
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Experiment 5 «
A Comparison of the Effects of ”Peak 3” and ”Peak A” on 
Radio-Calcium Uptake from the Gut, in the "Strontium Chick” ,
Introduction.
This experiment was designed to test two partially purified aqueous 
extracts of Trisetum flavescens for calcitriol-like activity. 
Radio-calcium absorption by the duodena of chicks treated with 
either "peak 3" or "peak 4" were compared with untreated controls. 
Methodology.
Fifteen cock chicks (RIR x LS) were reared to four weeks of age on 
a complete diet and then changed to one low in calcium (0.15%) and 
supplemented with 2.4% strontium (as strontium carbonate) for five 
days. This level of strontium was chosen so as to supplement 
strontium for calcium on a molar basis, rather than as a percentage, 
By this time their plasma calcium levels had dropped to about 8mg/ 
lOOmls. The birds were then divided into three groups in the 
following manner.
TABLE 21. DOSING REGIMEN.
GROUP TREATMENT
1 NONE (CONTROL)
2 "PEAK 3" ( s  0.75g dried leaf, orally)
3 "PEAK 4" ( s  0.60g dried leaf, orally)
The above test substances were administered as two half doses, 
forty eight and twenty four hours prior to experimentation.
The usual procedure, as outlined in experiment 4(i) in this chapter
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was then carried out on each chick in order to compare the effect 
of each treatment on calcium transport. Residual lumenal and 
residual gut wall isotope levels were measured.
Using the following expression it was possible to calculate the 
mean %^^calcium transferred to body:-
l ^ i  - (dpm in lumenal fluid + dpm in gut tissue) « 
yicCi transported to body.
RESULTS
The results are shown in tables 22 and 23.
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STATISTICAL ANALYSIS.
Students t-tests.
a) For plasma analyses:
(i) "Peak 3” v "peak A"
calcium (p<0.037) 
phosphate (p<0.015) 
strontium (p<0.029)
(ii) Control v "peak A"
phosphate (p<0.009) 
strontium (p<0.003)
Otherwise differences not significant.
b) For radio-calcium analyses:
(i) Control V "peak 3"
A5calcium transported to body (p<0.065)
^^calcium remaining in lumen (p<0.081).
The results for b) (i) are not significantly different at the 0.05 
level however.
Plasma total calcium was higher in "peak 3" treated birds than in 
any other group, although not significantly so when compared with 
the untreated controls. A comparison between the plasma calcium 
levels of group 2 and 3 reveals that "peak 3" produces a 
significantly higher level (p<0.037) of plasma calcium.
Plasma strontium levels in group 3 are significantly higher than 
control levels (p<0.003). The plasma strontium levels of group 2
are similar to control levels. The mean plasma phosphate level for 
group 3 is significantly higher than that of the control group
(pA0.CX)9) whereas for group 2 it is very similar to that of the 
control group. "Peak 3" had no significant effect upon plasma
lAl
phosphate levels.
The results of the radio-calcium measurements show that "peak 3" 
treated birds have a lower level of lumenal isotope than the 
controls although this is not statistically significant (p<0.081). 
"Peak A"-treated chicks show lumenal levels of isotope very 
similar to control levels. Levels of isotope within the gut tissue 
are very similar for all three groups and none differ significantly. 
For levels of isotope transported to body, "peak 3"- treated chicks 
showed higher levels of uptake when compared with controls, 
although the difference was not statistically significant (p<0.065). 
"Peak 4" -treated chicks showed no evidence of isotope transport 
above control levels.
DISCUSSION.
The two plant extracts have contrasting effects upon the strontium 
treated chicks. "Peak 3" induced total plasma calcium levels 
slightly higher than control levels ,but not significantly so,as 
well as increasing radio—calcium transport, a result which is very 
close to being statistically significant. Plasma phosphate levels 
for group 2 are similar to control levels. "Peak 4", however, shows 
no ability to increase radio-calcium transport but produces a 
significant increase in plasma phosphate levels.
In conclusion, "peak 3" appears to cause responses akin to calcitriol 
in that total plasma calcium levels are significantly raised 
(p<0.037) and ^^calcium uptake from the gut is also raised, despite 
the strontium-induced rachitic condition of the chicks. It appears 
likely that the calcitriol-like effects seen in the crude aqueous 
extract can be ascribed to a substance contained within the 
partially purified extract "peak 3".
The effects upon plasma phosphate levels brought about by "peak 4
1 4 2
would contribute to the higher plasma phosphate levels seen after 
treatment with the crude aqueous extract. Thus, two calcinogenic 
factors, with contrasting modes of action seem to be present in 
Trisetum flavescens in water-soluble form.
1A3
experiment 6 (i) .
The Effects of "Peak A" on Plasma Calcium and Phosphate in 
Vitamin D^-Deficient Chicks.
Introduction.
This experiment was designed to compare the time-course of response 
to "peak 4", seen in vitamin D^-deficient chicks. Changes in plasma 
calcium and phosphate levels were monitored over a thirty six hour
period.
Methodology.
Twenty-four chicks were reared from one day of age to four weeks 
on a vitamin D^-deficient diet. They were then divided randomly into 
groups, as shown below, and dosed at time zero with "peak A".
TABLE 2A
Treatment of Experimental Groups.
QSOÜP NO. OF CHICKS
TEST
SUBSTANCE
RESPONSE TIME 
ALLOWED (HRS)
1 6 CONTROL 0
2 6 PEAK A 12
3 6 PEAK A 2A
A 6 PEAK A 36
Key: "Peak A" was given as an oral dose in all cases,each dose 
being equivalent to Ig of original dried leaf material.
The control group was sacrificed at zero hours, following the 
removal of blood from a wing vein for measurement of plasma calcium 
and inorganic phosphate. Test groups were sampled at 12, 2A, and 
36 hours post-dosing.
lAA
RESULTS. 
TABLE 25 Plasma Calcium and Phosphate Changes 
in Chicks Dosed with "Peak 4” .
TIME POST 
DOSINQ (HHS)
PLASMA CALCIUM 
mg/100ml8 
mean - S.E.
PLASMA PHOSPHATE 
mg/IOOmls 
mean — S.E.
[Ca X P^J 
mean ^ S.E.
0 9.06 i 0.A2 3.38 i O.Mf 30.62 i 3-6
12 8.30 i 0.A7 3. ^  - 0.65 28.80 - A.6
2A 7.31 - 0.39 A.17 - 0.A1 30.A8 - 3.A
36 5.75 - 0.32 5.32 - 0.69 30.59 - 2.5
Four groups of vitamin D^~deficient chicks were dosed with plant 
extract at time zero and plasma minerals were tested at intervals. 
STATISTICAL ANALYSIS.
The results were analysed for differences between the groups 
using the students t-test.
The students t-test showed significant differences between the 
following:
(1 ) Calcium
0 and 2A hours (p<0.012)
0 and 36 hours (p<0.001)
12 and 36 hours (p<0.001)
2A and 36 hours (p<0.012)
(ii) Phosphate
0 and 36 hours (p<O.OA)
(iii) [Ca X P^] - NS (all groups).
The results show that, when vitamin D.,-deficient chicks were dosed
1A5
with the partially purified extract (peak 4*) of Trisetum flavescens. 
there followed a dramatic decline in plasma calcium; which is 
significantly lower at twenty four hours post-dosing (p<0 .0 1 2 ) 
when compared with zero time (see figure 11). Between twenty four 
and thirty six hours post-dosing a further significant drop in 
plasma calcium occurred (p<0.012). These changes were accompanied 
(figure 10) by a steady increase in plasma phosphate, which was 
significantly higher at thirty six hours post-dosing than at zero 
time (p<0.04)
The calcium x phosphate product levels vary very little throughout 
the experiment. It appears that the rise in phosphate levels is 
bringing about the precipitation of calcium phosphate and if this 
is indeed the case, then plasma phosphate levels are actually lower 
than they might be . The dangerous decline in plasma calcium cannot 
be arrested due to the vitamin D^-deficient status of the chicks.
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FIGURE 10
Graph to Show the Changes in Plasma Phosphate in Chicks Dosed with 
g Partia l Aqueous Extract of Trisetum flavescens.
TIME (HOURS)
Groups of chicks dosed with partially purified Trisetum flavescens 
extract at twelve hour intervals, were monitored for changes in 
their plasma phosphate levels. The results are shown in figure 10.
The chicks were vitamin D^-deficient.
1A7
FIGURE 11
Graph to show the Changes in Plasma Calcium in Chicks Dosed with 
3 P a r t i P u r i f i e d  Aqueous Extract of Trisetum flavescens.
Groups of chicks were dosed with partially purified Trisetum 
flavescens extract and monitored for changes in their plasma 
calcium levels at twelve hour intervals. Figure 11 shows 
the mean group plasma calcium levels as well as the standard 
error for each group. The chicks were vitamin D^-deficient.
1A8
FIGURE 12
Graph to Show the Effects of "Peak 4” on the Calcium x Phosphate 
Product in Vitamin Di-Deficient Chicks.
CO
TIME (HOURS)
Four groups of chicks, consisting of six chicks per group, 
were dosed with the partially purified aqueous extract of 
Trisetum flavescens at zero hours and then at twelve hour 
intervals. Figure 12 shows the changes in the plasma calcium 
and phosphate product values for each group. The standard error 
values for each group are also Indicated.
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DISCUSSION.
These results suggest strongly that the phosphataeraic factor in 
this extract of Trisetum flavescens, exerts its effect only upon 
the levels of plasma phosphate, no rise in plasma calcium level 
is seen. The administration of "peak A” to vitamin D^-deficient 
chicks results in stability of the low [Ca x P^] . This was not 
the case with vitamin D^-deficient chicks dosed with vitamin 
(unpublished observations) where plasma calcium rises. "Peak A" 
therefore, changes the proportions of calcium and phosphate in 
the blood - calcium levels decrease in direct proportion to the 
increasing plasma phosphate. This decrease in plasma calcium occurs 
because there is no way for these vitamin D^-deficient animals to 
restore their plasma calcium level , therefore it may well be 
precipitating out as calcium phosphate as phosphate levels rise.
If the latter is true, then plasma phosphate levels are actually 
lower than they might otherwise be.
In conclusion,"peak A" does not reverse the rachitic state, as it 
shows no ability to promote uptake of calcium into the bloodstream 
during a thirty six hour period. Instead, "peak A", when administered 
to vitamin D^-deficlent chicks appears to alter the calcium:phosphate 
ratio by greatly increasing the plasma phosphate level. The [Ca x P^] 
remains stable at the low level brought about by the vitamin D^- 
deficient status of the animals.
Therefore the biological activity of "peak A" is not at all 
reminiscent of vitamin or its major hydroxylated derivatives. 
Following these results, a similar experimental approach was used 
with vitamin D^-replete chicks.
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E x p e r i m e n t  6 ( i i )
Examination of the Effect of "Peak 4" on Plasma Calcium and 
Phosphate in Vitamin D^-Replete Chicks.
Introduction
Since  experim ent 6 (1 )  showed a  prounced d e crease  i n  th e  p la sm a
calcium of chicks dosed with "peak 4" when vitamin D-deficient.
3 *
it was decided to test the same extract on chicks reared on a
vitam in  D -re p le te  d ie t .  I n  t h i s  way, th e  e f f e c t s  o f  th e  e x t r a c t  c o u ld
3
be seen in animals whose calcium homeostatic mechanisms were 
fxmctioning normally. This would mimic the situation found in 
affected cattle, which can be presumed to be vitamin D-replete 
when they develop calcinosis.
Methodology
Twenty day-old male chicks ('Soss Brown*) were raised on.^a 
complete diet to four weeks of age. The chicks were then divided 
into four groups housed separately and dosed orally, at time zero, 
with "peak 4" (equivalent to 1g of original dried Trisetum 
_flavescens). Blood samples were taken from one group successively 
at time zero, twelve, twenty four and thirty six hours. Each group 
was sacrificed immediately after the removal of blood. The 
treatment of the blood and analyses of plasma calcium and phosphate 
were carried out in the usual way.
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FIGURE 13
Graph to Show the Effects of a Partially Purified Aqueous Soluble
Extract of Trisetum flavescens on Plasma Calcium and Phosphate.
® = Plasma Phosphate
Four groups of chicks were dosed with plant extract at time zero 
and blood was taken from each group at twelve hourly intervals. 
The above graph shows the mean plasma levels of calcium and 
inorganic phosphorus for each group. The chicks were vitamin D^- 
deficient.
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FIGURE U
To Show the Changes in the Calcium and Phosphate Product
Values of Vitamin D^-Replete Chicks Dosed with Partially 
Purified Trisetum flavescens Extract.
Four groups of chicks, reared on a complete diet, were dosed 
with an aqueous-soluble extract of Trisetum flavescens at time 
zero. The three remaining groups were dosed at twelve,twenty- 
four and thirty-six hours respectively. The mean calcium and 
phosphate product values are shown in figure lA above.
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STATISTICAL AN ALYSIS
The in d iv id u a l  g ro u p  r e s u l t s  were su b je c te d  to  the  s tu d e n t s  t - t e s t
( i )  C a lc iu m  -  a l l  g ro u p s  were com pared, and th e  f o l lo w in g  
com parisons re v e a le d  s i g n i f i c a n t  d i f f e r e n c e s :
0 and 12 hours (p< 0 .006)
0 and 2 k  hours (p< 0.0 3 2)
0 and 36 hours (p < 0.0 1 2 )
Phosphate:
0 and 12 hours (p < 0 .002)
0 and 2 k  hours (p< 0.0 0 1)
0 and 36 hours ( p < 0 .0l)
Plasma phosi^ate levels were greatly elevated within twelve hours 
of administration of the extract, increasing on average by to 
above 7mg/l00mls, this being maintained throughout the experiment. 
Plasma calcium levels show a small decline during the course of 
the experiment, the greatedb change being within the first twelve 
hours. Plasma [Ca x P^] shows a sharp increase within twelve 
hours of administration of the extract, followed by a gradual 
decline.
DISCUSSION
When the [ Ca x R  ] is greater than 58* precipitation will occur 
and the results showed that the [ Ca x I^] was greatly in excess of 
this value within twelve hours of administration of the plant 
extract. It can be seen that the increase in plasma phosphate in 
these chicks shows a very similar trend to the [Ca x ^
This is in contrast with the effect seen in experiment 6(i) where 
no increase in plasma [Ca x P^] occurs. It appears that vitamin
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must be present. Without vitamin being present an 
increase in plasma phosphate has no effect at all upon the [Ca x P . ] 
because calcium is precipitated. From the results of experiment 6(ii) 
it can be seen that a water-soluble component (or components) of 
this partially purified extract of Trisetum flavescens is very likely 
to be causing the abnormally high [Ca x P^] of normal animals grazing 
on the live plant. The effect of the partially purified extract used 
here appeared to be solely upon the plasma phosphate levels; calcium 
levels being maintained within the normal range.
These animals, of course, have a normally functioning calcium- 
homeostatic system. The small decline in j£Lasma calcium during the 
experimental period (presumably due to precipitation of calcium 
phosphate in soft tissue) suggests that the homeostatic mechanisms 
are being hard-pressed to maintain normo-calcaemia.
Ihilike the chicks in the previous experiment, where a continuing 
decline in plasma calcium woxald have occurred, these chicks could be 
expected to develop calcinosis but survive for a considerable time.
The results of both experiment 6(i) and 6(ii) suggest that the partially 
purified aqueous extract ("peak ^") acts as a calcinogen. by 
increasing blood phosphate levels. The source of the high levels of 
blood phosphate is not likely to be the bone because calcium w ^ l d  
necessarily be released with the phosphate. Therefore either the 
intestine (increased phosphate absorption), or the kidney (increased 
renal retention) are likely to be the source of the phosphate.
Increased renal retention is probably not the cause, since Dirksen 
et al (197^) reported elevations in the urinary phosphate of affected 
cattle. The ability of "peak 4" to increase intestinal phosphate 
absorption was investigated in experiment 7 •
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Experiment 7
An Tnvestip;«tiQn i n t o  the  H e la t iv e  E f f e c t s  o f  **Peak k** 
and V itam in  on I l e a l  B a d io -P h o sp h a te  U p take .
Introduction
The a b i l i t y  o f  ’’peak 4 ” t o  s t im u la t e  i n t e s t i n a l  ph o sph ate  t r a n s p o r t  
was in v e s t ig a te d .  T h i s  w as n e c e s s a ry  i n  o rd e r  to  de te rm in e  w hether  
the e le v a t io n s  in  p la sm a  ph osph ate  seen  i n  e a r l i e r  s t u d ie s  were the  
r e s u lt  o f  in c re a se d  u p ta k e  a t  th e  i n t e s t i n a l  s i t e .
Experim ental
T h ir ty  'R o s s  Brow n' c h ic k s  were re a re d  t o  fo u r  w eeks o f  a ge  on a
v itam in  D -d e f ic ie n t  d i e t .  They were th en  random ly  a s s ig n e d  t o  f i v e
3
groups o f  s i x  b i r d s  and  d o se d  w ith  e it h e r  v it a m in  o r  "p e a k  V ' ,
H a lf  the  dose was a d m in is te re d  f o r t y - e i g h t  h o u rs  and  h a l f  tw e n ty - fo u r
*52
hours p r io r  t o  e s t im a t io n  o f  ph o sph ate  t r a n s p o r t .
157



S i^ i f i c a n e e  o f  D i f f e r e n c e s  -  S tu d e n t s  t - t e s t
b)
c)
d)
e)
f )
For calcium
group 1 V group 2 ( p < 0.0 6)
group 1 V group 3 (p<0.02?)
group 2 ▼ group 5 (p< 0.002)
group 3 V group 5 (p< 0.001)
group 2 T group k  (p< 0.015) 
gropp 3 V group k  (p < 0.0 1 3)
For phosphate
group 3 ▼ group k  ( p < 0 .03l) 
group 1 ▼ group k  (p<0.0l4) 
group 2 ▼ group k  (p<0.00?)
For alkaline phosphatase 
No significant differences
32Levels of phosphate in gut tissue 
group 1 V group 2 (p< 0.023)
group 1 V group 3 (p <0.037) 
group 1 Y group k  (not significant) 
group 1 Y group 5 (not significant)
Levels of residual ^ phosphate in lumen 
no significant differences.
Levels of ^^phosphate transferred to body 
no significant differences.
significant differences are reported.
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The results for plasma calcium levels show that vitamin 
administered bjt either route, causes a significant rise in plasma 
calcium ( p ^0.06.for sub-cutaneous administration and p<0.027 for 
orally administered vitamin D^). Vitamin caused no significant 
change in plasma phosphate when administered by either route when 
compared with control animals.
Both groups treated with plant extract show plasma calcium levels 
significantly lower than the vitamin D^-treated groups. The plasma 
calcium levels of extract treated groups are also lower than the 
control group althou^ not significantly so.
The plant extract treated groups show plasma phosphate levels that are 
higher than the other groups; group k is significantly higher than
vitamin D-treated groups or the controls (p< 0.014, p <»0.007 and
3
p <^ 0.031 respectively). Plasma alkaline phosphatase, as expected, 
has dropped below control levels in vitamin ^treated birds (althoiigh 
not significantly); in both plant extract treated groups there is a 
slight (not significant) increase in plasma alkaline phosphatase 
levels.
Levels of radio-phosphate in the gut tissue are higher in vitamin D^- 
treated chicks than in the control and plant extract treated groups. 
The latter are very similar to control levels; the vitamin D^- 
treated groups are significantly hi^er than other groups at the O.O3 
level. Residual lumenal isotope levels show that all treated groups 
have lower levels of radiophosphate in the lumen than the control 
group; "peak k** dosed sub-cutaneously shows comparable residual 
isotope levels to vitamin dosed orally. These differences are not 
statistically significant however. The estimated levels of isotope 
transported to the bloodstream for each group reveal that, with the
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surprising exception of group 3, there is stimulation of isotope 
transport taking place. Variations in transport varied considerab­
ly within each group, as indicated by the standard errors, but 
overall, both plant extract treated groups and the vitamin 
subcutaneously treated group show a .generalised uptake of isotope 
when compared to control levels. Again,the levels of variation 
precluded a statistically significant result.
DISCUSSION
The plasma analyses confirm the results of previous experiments in
that administration of an aqueous soluble extract of Trisetum
flavescens to vitamin D^deficient chicks brings about an elevation
in plasma i^osphate with an accompanying decrease in plasma
calcium. Vitamin D^, of course, raises calcium levels and has
little effect on plasma phosphate levels. The isotope transport
results show surprisingly high levels of phosphate within the gut
tissue of vitamin treated groups and relatively low transport to
body. Groups k and 5 however, show definite evidence of transfer
32of the isotope into the bloodstream %dth no build up of ^phosphate 
within the gut tissue itself. This was the picture presented by the 
organic soluble extracts (Chapter 3t experiment 1) of Trisetum 
flavescens in a similar experimental situation.
In conclusion it appears that the activity of "peak 4" is influencing 
the mechanism which transfers phosphate from the gut tissue to the 
bloodstream, this was also concluded for the organic-soluble 
phosphataemic factor (chapter 3, experiment 1). The vitamin Un­
treated birds experience a build up of phosphate within the gut tissue 
Cells and a lower rate of transfer to the bloodstream.
In conclusion, it appears that the "peak 4 " phosphataemic factor
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does not effect phosphate uptake by the gut in the same way as 
vitamin and must be influencing a different phosphate transport 
mechanism. This mechanism may possibly be the para-cellular route 
by which phosphate can cross the gut wall, and is thought to be 
"the only route for phosphate entry in vitamin D^-deficient animals" 
(Fuchs and Peterlik,1979 ; Birge and Avioli 1981). If this is indeed 
the case, then the active factor in "peak 4" is the first yet found 
that influences para-cellular phosphate transport.
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Experiment 8
The Effect of Partially Purified Aqueous Extracts of 
Trisetum flavescens on Bone Cultured In Vitro
Introduction
Having established the action of crude and partially purified aqueous 
extracts of Trisetum flavescens upon intestinal calcium and phosphate 
transport, the effects of the two active partially purified extracts 
were examined using the bone culture model previously described.
Experimental
Twenty four mouse calvariae from six-day old mice were utilised, 
fourteen of them were from mice pre-labelled at one day of age with
if55yCi *^calcium. The remaining bones were unlabelled. Following 
pre-incubation of all bones, the bones were transferred to fresh 
medium and treated with either "peak 3" oz* "peak according to the 
following regimen
TABLE 29 DOSING REGIMEN
GROUP CULTURENUMBERS TREATMENT
WEIGHT OF 
DRY PLANT 
MATERIA!/ 
CULTURE (mg)
WHETHER 
WITH ^5c ALCIUM
1 1 - 7 "PEAK k» k.k 5yCi/M0UBE
2 8 .  Ilf NONE - 5yCi/M0USE
3 15 - 17 "PEAK 3” 5.7 NO
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The fourteen pre-labclled bones were sampled at various times 
throughout their experimental incubation period by removing 20vl 
aliquots of culture medium. This was then added to 200yl of 1009^  
formic acid for solubilisation. 130yl of this solution was then 
added to 10mls of Amersham triton scintillant prior to counting 
in the Beckman 1^7500 scintillation counter. Aliquots of culture 
medium were taken at the following times for analysis.
TABLE 30 Sampling Times of Tissue Culture Medium.
CULTURE NUMBERS SAMPLING TIMES (HOURS)
1 -14 2 h 6 8 2 4 .3 48
Analyses of stable calcium, phosphate, radio-active calcium and 
glucose utilisation were carried out at forty-eight hours post 
addition of test substances.
RESULTS 
TABIÆ 31 Table to Show the Effects oH Medium Calcium and 
Phosphate Levels of ”Peak 3” and *'Peak 4” and 
Glucose Utilisation
ANALYSES OF TISSUE CULTURE MEDIUM AT 48 HOURS.
GROUP CULTURENUMBERS
CALCIUM
(mg/100mls)
PHOSPHORUS
mg/l00mls)
% AVAILABLE 
GLUCOSE UTILISED
1(T) 1-7 8.02 ± 0.57 3.97 ± 0.37 303Î
2(C) 8-l<t 7.25 ± 04.25 3.79 ± 0.53 305Î
3(T) 15-17 8.02 i 0.24 2.88 ± 0.06 2 %
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FIGURE 15
45The Effect of "Peak 4” on Calcium Release from Pre-Labelled
Bone in vitro.
TIME (HOURS)
The experimental group of ^^calcium labelled bones cultured 
in vitro were treated with the partially purified aqueous extract 
of Trisetum flavescens. The control group was untreated. During 
a forty-eight hour culture period samples of culture medium 
were removed at various times for measurements of isotope levels 
to be taken.
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The results show that pre-labelled bones treated with "peak 4" 
material (group 1), show a very similar trend of radio-calcium 
release into the mediiun when compared to control bones. This 
is despite a significantly higher level of total calcium in the 
medium of treated bones after forty-eight hours. Hedium phosphate 
levels of groups 1 and 2 are very similar (no significant 
difference). Group 3 (unlabelled bones treated with "peak 3") 
show a significant increase in medium calcium when compared %fith 
controls (p^O.01) and have a significantly lower level of medium 
phosi^te (p^0.0l4)
DISCDSSION
^5,The virtually identical pattern of ''^calcium release into the medium, 
seen in both control and "peak treated bones suggests that no 
bone resolving comix>und such as calcitriol is present in the plant 
extract. The significant increase in medium calcium levels 
produced by treatment of the bones with "peak 3" suggests that a
vitamin D-like metabolite may be present in this extract. "Peak 4"
3
however has no detectable effect on bone resorption.
1 6 9

CHAPTER 5
PURIFICATION AND CHARACTERISATION OF THE AQUEOUS 
SOLUBLE PHOSPHATAEMIC PRINCIPLE
Introduction
Investigations into the purity and composition of the phosphataemic 
fraction obtained by Sephadex chromatography were carried out using 
a number of techniques.
Initially, the non*~purity of the biologically active fractions was 
determined, followed by attenq>ts at isolation of the components 
and general characterisation using, mostly, physical analytical 
techniques.
Experiment 1
Evidence That The Biologically Active Eluate 
From The Liquid Chromatography Co 1 m m  Was Not Pure
Introduction
Because of the relatively wide band of fractions pooled under the 
phosphataemic peak of the eluate, it was reasonable to expect that 
the phosphataemic fractions were not of uniform composition. This 
IS particularly so because the starting material was the crude 
aqueous extract. Nevertheless, examination of the eluate in the 
region in question using ultra-*violet spectroscopy (as was routinely 
carried out on the fresh eluate) always yielded a predictable pair
of peaks in the ultra-violet range and none at all in the visible 
range.
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Methodology
Evidence that more than one substance was present in the phosphataemic 
fractions was obtained from four main sources which were as follows:
1 Measurements of the relative intensities of the pe a k  heights 
in the ultra-violet absorption spectrum.
2 Fluorescence Spectroscopy.
3 Thin-Layer Chrcnnatography.
4 Polarimetry.
1;1 Examination of the Ultra-Violet Absorption Spectrum
Following Sephadex chrooiatography, examination of the ultra-violet 
absorption spectrum of the pooled fractions obtained by Sephadex 
chromatography, revealed that consecutive fractions varied in the 
relative height of the two absorption maxima. The wavelengths of 
the absorption maxima did not vary however.
If only one substance were present in the solution, then the 
relative heights of individual peaks would not be expected to vary, 
if conditions were uniform. Typical differences were detected 
among phosphataemic fractions obtained from a Sephadex column 
containing Sephadex grade G15 (column dimensions 48 cm x 1.5 cm) 
and used for attenq>ting to separate the constituents of pooled 
phosphataemic fractions obtained from Sephadex (grade G25) chromato­
graphy of the crude aqueous extract.
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When individual fractions of the eluate from this column were 
examined at constant wavelength (269 nm) only one absorption
was obtained (i.e. no separation of individual substances 
had occurred) but measurements of the relative intensity of the peak 
heights of these fractions (following scanning of each fraction 
in the ultra-violet range 400 nm to 190 nm) showed that variations 
existed in the relative heights of the two peaks.
The differences between the relative peak heights of consecutive 
fractions are shown in Table 33.
Further confirmation of these observations was obtained when the 
relative intensities of the peak heights of consecutive fractions 
obtained from under "peak 4" of the elution profile, were scanned 
between 190 nm and 400 nm.
1 7 3
Results
TABLE 33
Table to show the Ratios of Absorption Maxima IntenBitift« of 
fractions obtained from a Sephadex G15 column and a sample of
Partially Purified Trlsetum flavescens Extract containing the 
Phosphataemlc Principle.
Fraction No. Ratio of Peaks 
At 270nm : 345nm
Absorbance At 
270nm
72 1.47 0.10
74 1.41 0.14
76 1.37 0.18
78 1.33 0.21
80 1.31 0.24
82 1.27 0.28
84 1.30 0.30
86 1.27 0.31
88 1.26 0.30
90 1.26 0.29
92 1.31 0.26
94 1.31 0.22
96 1.27 0.19
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TABLE 34
Table to Show Relative Peak Heights of Fractions Obtained 
from a Preparative Sephadex G25 Column, in the Region of
Fraction No.
Ratio of Peak 
270nm : 345nm
Absorbance Of 
Peak Maxima
270nm 345nm
27 5.73 0.315 0.055
29 4.62 0.37 0.08
30 2.32 0.545 0.235
32 1.82 0.565 0.31
33 1.52 0.63 0.415
35 1.37 1.22 0.89
37 1.23 1.08 0.88
40 1.15 0.46 0.4
Conclusions
These observations suggested that gel filtration was not a suitable 
method for separating the constituents.
The finest grades of Sephadex (Sephadex GIO and 615) failed to yield 
more than one absorption maximum, on examination of the eluate but 
the observations made on the differences in the ratio of peak heights 
led to the use of other techniques to detect and characterise the
constituents.
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Experiment 1:2
Fluorescence Spectroscopy 
Introduction
This technique was chosen to examine the biologically active 
phosphataemic fractions of the plant, because fluorimetry allows 
a fluorescent material in the presence of a non-fluorescent material 
to be scanned independently of a contaminant present in the solution.
If one of the constituents of the extract were fluorescent, the 
excitation spectrum would be similar to its ultra-violet absorption 
spectrum in that one is usually a mirror image of the other (Pesce,
Rosen and Pasby, 1971).
Method
A dry saoq>le of the aqueous soluble phosphataemic extract ("peak A") was 
placed in a cuvette, dissolved in water and scazined in a Pye-Unicam 
Luminescence spectrophotometer for the presence of absorption and 
emission spectra. The results are shown in Figures 16 and 17.
Results
The results of the scan (see Figure 16) revealed that there was a 
fluorescent compound present in the extract, with an absorption 
maximum of 3A6 nm - identical to one of the two peaks seen in ultra­
violet absorption spectroscopy. The ultra-violet spectrum of the 
fluorescent confound shows no absorbance at 270 nm Hence it seems 
likely that the peak corresponding to the phosphataemic factor 
contains two substances, one with an ultra-violet maximum of 3A6 nm 
(pH dependent) and the other with a maximum of 270 nm.
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The emission maximum of the fluorescent compound peaks at 458 nm 
(the emission maximum of a fluorescent compound is always higher 
than that of the ultra-violet absorption spectrum; this is known 
as the ’Stokes shift*). This is strong evidence that two compounds 
were present in the solution.
Experiment 1:3
Thin Layer Chromatography 
Introduction
Because of the suspected presence of more than one compound in the 
Sephadex fractions with phosphataemic activity ("peak 4") and the 
failure of liquid chromatography to achieve a separation, thin layer 
chromatography was used in an attenq>t to separate the compounds.
This technique is very adaptable to quick trials with different 
stationary and mobile phases allowing many conibinations of the 
system to be tried with minimum loss of plant extract and time.
A similar procedure was used for Solanum malacoxylon (Peterlik 
and Wasserman, 1975).
Methodology
Selection of a Suitable System for Separation of the 
Aqueous Soluble Constituents
The solid *peak 4* material was moderately soluble in alcohol as 
well as water and so various alcohol/water mobile phases were tested 
with either cellulose or silica gel G stationary phases. Visual­
isation of the components of the extract was possible using Ehrlich s 
reagent (see below) or Potassium ferricyanide/ferric chloride.
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reagent. The following table shows the results of using various 
combinations of stationary and mobile phases:-
Results
table 35
Choice of a Suitable Mobile and Stationary Phase
Mobile
Phase
Stationary
Phase
Comments
1. Water Cellulose Very slow rate of travel.
2. Butanol/Ace tic 
Acid/Water
4 :1 :11
Cellulose Slow travel - no evidence of 
separation of the compounds.
» 3. n-pentanol/ 
Water
1:1
Silica Gel 
G
1
1
Travels well - but no evidence 
of separation.
; 4. lOOZ Methanol
1
i
Silica Gel 
G
Good rate of travel and spray 
reagents revealed two separate 
spots.
lOOZ methanol with Silica gel G was chosen as the most suitable 
and was used for all subsequent studies on "peak 4", It was 
necessary for the solvent front to travel 25 — 30 cms to achieve 
separation of the compounds and so 20 cm x 40 cm plates (Camlab Ltd.)were 
used with analytical grade methanol (BDH chemicals). The extract 
was dried on to the base of the plate in a current of air and allowed 
to run in an ascending for 3—4 hours. Subsequentlyy after
brief drying, suitable chromogenic reagents could be used. The
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reagent. The following table shows the results of using various 
combinations of stationary and mobile phases:-
Results
TABLE 35
Choice of a Suitable Mobile and Stationary Phase
Mobile
Phase
Stationary
Phase
Comments
1. Water Cellulose Very slow rate of travel.
2. Butend/Acetic 
Acid Abater
Cellulose Slow travel - no evidence of 
separation of the conq>ounds.
4:1:1
3. n-pentanol/ 
Water
Silica Gel 
G
Travels well - but no evidence 
of separation.
1:1
4. lOOZ Methanol Silica Gel 
G
Good rate of travel and spray 
reagents revealed two separate 
spots.
i
lOOZ methanol with Silica gel G was chosen as the most suitable 
and was used for all subsequent studies on "peak 4". It was 
necessary for the solvent front to travel 25 ~ 30 cms to achieve 
separation of the compounds and so 20 cm x 40 cm plates (Camlab Ltd. )were 
used with analytical grade methanol (BDH chemicals) • The extract 
was dried on to the base of the plate in a current of air and allowed 
to run in an ascending tank for 3-4 hours. Subsequently, after 
brief drying, suitable chromogenic reagents could be used. The
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ineffectiveness of aqueous solvents with Silica gel G is because of 
its structure. It is a dehydrated product of polysilicic acid 
with surface pores and hydroxyl groups which hydrogen bond with polar 
molecules. Hence an aqueoiis solvent prevents the polar constituents 
of the extract from reaching the gel surface, thus affecting the 
residing time and convective velocity of the sample. Pure alcohol 
was therefore chosen as an effective compromise.
Testing of Various Spray Reagents as an aid to Characterisation 
of the Components .
The various spray reagents used are shown in the following table 
together with their colour reactions with the fraction components. 
(Reagent coo^ositions are according to Stahl (1969) and are detailed 
in Appendix 3).
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TABLE 36
Reagents Used In The Characterisation Of ”Peak A” Fractions
REAGENT |
1
TARCTT COMPOUNDS COMMENTS
1. Ferric Chloride/
Potassium Ferricyanide
Amines and reducing 
compounds.
POSITIVE - Two dark 
blue spots indicate 
Aromatic Amines.
2. A-Dimethylaminobens 
aldehyde (Ehrlich’s 
Reagent)
Amines, Hydroxy- 
skatoles, Sulphon*- 
amides.
One purple and one 
yellow spot. 
Positive
3. Silver Nitrate Phenols and Aroma­
tic Amines
Positive - Brown/ 
Black, similar to 
Amidol standard.
4, Formaldehyde /HCL
(Prochazka Reagent)
Indoles and their 
derivatives.
Substance at Ef 
0.68 fluoresces - 
implies indole 
structure.
Dimethylaminocinnam - 
aldehyde
Indoles Two yellow patches 
on orange background.
6. 1, 2 Naphthoquinone - 
4 - sulphouic acid
Aromatic Amines.
1
Test gives limited 
reaction colour but 
pale yellow at 
Rf. 0.76.
Contd/.
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table 36 Contd/...
EEAGENT TAKGET COMPOUNDS COMMENTS
7. Fluorescein/ 
Amnonia
Purine, Pyrimidines 
Barbiturates.
1
Substance at Rf 
0.76 absorbs 
strongly as do 
nucleotide bases.
8. Perchloric Acid/ 
Ferric Chloride
Indole
Derivatives
Indeterminate
result.
9. Iodine/Potassium 
Iodide
Alkaloids Negative
10. Bismuth Trichloride Sterols Negative.
11. 2, 6 dichlorophenol - 
indophenol.
Organic Acids Negative
12. Antimony Trichloride
i1
Vitamin Negative
See Appendix 3 for reagent composition.
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This reagent is a test for indoles. Pure indole (position 1) 
shows up as blue. Positions 2 and 3 are from later fractions 
of "peak 4" and positions 4 and 5 are from earlier "peak 4" 
fractions.
J i
lODINE/POTASSIUM IODIDE REAGENT.
V ^ >
rAOr Tr.- ir -
1 2 3 4
This reagent detects alkaloids. Position 1 shows a positive reaction 
with the alkaloid atropine. Positions 2, 4 and 5 were treated 
with ’’peak A" material. Positions 3 and 6 were treated with ’’peak 
3" material. Plate ’b ’ shows no positive reaction for any of the 
samples tested.
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This reagent detects alkaloids. Position 1 shows a positive reaction 
with the alkaloid atropine. Positions 2, 4 and 5 were treated 
with "peak 4" material. Positions 3 and 6 were treated with peak 
3" material. Plate 'b' shows no positive reaction for any of the
samples tested.
4-DIMETHYLAMINOBENZALDEHYDE (EHRLICHS*) REAGENT.
1 3 4 5 6
This reagent reacts with amines, hydroxyskatoles and sulphonamides 
Samples at positions 1-6 are consecutive fractions from beneath 
"peak 4” as detailed in table 37. Two distinct compounds have 
been separated with Rf values of 0.76 (yellow spots) or 0.68 
(blue spots).
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This reagent reacts with amines, hydroxyskatoles and sulphonamides 
Samples at positions 1-6 are consecutive fractions from beneath 
’’peak 4” as detailed in table 37. Two distinct compounds have 
been separated with Rf values of 0.76 (yellow spots) or 0.68 
(blue spots).

This plate shows the clear separation of the two compounds found 
under ' 'p e a k 4". The sample at position 2 was taken from the final
fractions of "peak 4".
FLUORESCEIN/AMMONIA REAGENT.
1 2 3 4 5
This reagent detects purines and pyrimidines. The samples at 
positions 4 and 6 absorb most strongly (a positive reaction) and 
they are derived from ”peak 4 '* material, having an Rf of 0.76, 
The samples at positions 1 and 2 are standards, a purine and 
pyrimidine.
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ALKALINE SILVER NITRATE REAGENT.
1 4 5
This reagent reacts with phenols and aromatic amines. There is a 
positive reaction to "peak 4” material (positions 3 and 5). 
Position 4 is material from "peak 3" and responds negatively to 
this reagent. Position 1 is the standard , amidol.
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ALKALINE SILVER NITRATE REAGENT.
i/' ff :<■ . '■ -:,.vSr*
>.---;•• PiiVg'-.----
i,'
1 3 4
_f
This reagent reacts with phenols and aromatic amines. There is a 
positive reaction to **peak 4” material (positions 3 and 5). 
Position 4 is material from "peak 3" and responds negatively to 
this reagent. Position 1 is the standard , amidol.
189
FERRIC CHLORIDE/POTASSIUM FERRICYANIDE REAGENT.
This reagent detects aromatic amines. This plate shows the reaction 
produced with various fractions from beneath ’’peak 4 . Both the 
compounds, at Rf 0.76 and Rf 0.68 produce a dark blue colouration 
indicating that they are possibly aromatic amines.
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Photographs taken of the most informative TLC plates, soon after the 
spray reagents were used,are shown. Each plate was run with a suit­
able standard that could be expected to react with the spray reagent
chosen.
Kpy to Plates.
a = Dimethylaminocinnamaldehyde reagent. Sample at position 5 shows 
two compounds coloured yellow. This sample is from the central 
fractions of "peak 4" indicating separation from the substance with 
a lower Rf value. As this reagent is a test for indoles, both substances 
may be indolic. Position 1 shows the colour reaction of pure 
indole with this reagent.
b « lodine/potassium iodide reagent for alkaloids. The sample at 
position 1 is a standard alkaloid (atropine). No evidence is shown 
for the presence of an alkaloid in the test substances, 
c « ’Ehrlichs" reagent. This plate shows the effect of Ehrlichs' 
reagent on consecutive fractions of "peak 4". From left to right 
fractions applied to the plate are shown in table 37.
Table 37
Sample Positions.
Sample Position Fraction Numbers
1 25-26
2 27-28
3 29-30
4 41-42
5 43-44
6 45+
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It can be seen that the purple coloured component of lower Rf. value 
is only present in fractions 29 ~ AA.
d The sample at position 2 again shows reaction of Ehrlich's reagent with 
"peak A" material. Position 1 is a fraction obtained from the final 
column fractions.
e Fluorescein/Ammonia spray for the detection of purines and 
pyrimidines. Sample at position 6 shows that only the "peak A" 
coupound with the highest R£ value absorbs ultra»violet li^t 
(photograph taken tinder ultra violet light). The sample at position 
A is pure material from the far right of "peak A". Samples at 
positions 1 and 2 are pure nucleotide bases, run as standards.
£  Alkaline silver nitrate solution. The sample in position 3 is 
material from the centre of "peak A". Position 1 is a standard, amidol.
Ferric chloride/Potassium ferricyanide for aromatic amines.
The sample at position 3 shows material from the centre of "peak A". 
Position A (far right) shows material from the final fractions and 
position 2 shows material from the earliest fractions of "peak A".
Discussion
The use of the ferric chloride/potassium ferricyaaide reagent resulted 
from infra~*red spectrophotometric evidence that a secondary amine was 
present; the ferric chloride reagent is able to react with aromatic 
amines. The reagent gave an immediate dark blue colouration with both 
the substances within "peak A", thus indicating that both substances 
®ay be aromatic amines.
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Ehrlich's reagent indicated that the two substances were structurally 
dissimilar, giving a yellow spot at Rf 0.76 which is indicative of 
an amine or a sulphonamide structure (Clark and Humphreys, 1970;
Kirchner 1978). The substance at Rf 0.68 reacted with Ehrlich's reagent 
to give a deep purple colouration which is indicative of an indolic 
structure, eg 5 hydroxyskatole. The substance with Rf 0.68 also 
showed fluorescence, when treated with Prochazka reagent, which is 
characteristic of indoles.
With alkaline silver nitrate solution the substance with Rf value
0.76 yielded brown spots which are characteristic of arylamines 
or phenols, (Snq^th and McKeown, 1964). The plate is shown in photo­
graph £.
Sprays used to test for sterols, organic acids and alkaloids all 
yielded negative results.
Conclusions
Thin layer chromatography indicated that the substance at Kf 0.76 
had the characteristics of an aromatic amine, and possibly also a 
phenol. The lemon yellow colour obtained with Ehrlich's reagent allows 
the possibility of a sulphonamide structure.
The substance at Rf 0.68 gave strong indications of being an indole 
derivative, in that it reacts as an aromatic amine with ferric 
chloride/potassium ferricyanide, and shows purple colouration with 
Ehrlich's reagent and fluorescence under long wavelength ultra-violet 
light. The latter two reactions are typical of indole derivatives.
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EXPERIMENT 1:4
Polarimetry
Use of a polarising microscope on a dried sample of the "peak 4" 
extract revealed that 90Z - 95Z of the crystals were yellow and did 
not rotate the plane of polarised light. The remaining crystals 
were tiny and did show optical rotation, indicating a dissymétrie 
molecule. Unfortunately the polarimeter used was not sensitive enough 
for an accurate measurement of the angular rotation.
Discussion
The observations and results detailed above revealed the presence of 
two substances within the partially purified phosphataemic extract.
Fluorescence spectroscopy showed that the substance with absorption 
maximum 270nmdoes not fluoresce, whereas the peak at 345nm does 
fluoresce. When this is considered with the results of the thin ~ 
layer chromatography and polarimetry it is certain that two substances 
are present in the extract.
The results for thin layer chromatography indicate that either of the 
two compounds could be aromatic amines. The compound with Rf 0.68
may be an indole.
194
EXPERIMENT 2
Evidence  T h a t The P h osph ataem ic  F r a c t io n  C o n ta in s  No S u b sta n c e s  
S t r u c t u r a l ly  S im i l a r  to  V ita m in  D
2:1 Water Solubility
Vitamin itself is organic soluble, hence the phosphataemic fraction 
cannot contain pure vitamin The dried phosphataemic fraction was 
completely insoluble in organic solvents such as chloroform and 
hexane.
2:2 Mass Spectrometry
If the phosphataemic fraction contained any vitamin ^  metabolites that 
were rendered aqueous soluble by substituents or side chains, (as in 
Solanum malacoxylon) then analysis by Mass Spectroscopy would reveal 
breakdown products with identical molecular weights to fragments of
vitamin D breakdown products. Typical peaks occur at m/e 416 (Holick,
3
Schnoes, DeLuca, Suda and Corradino, 1971) m/e 134 and m/e 380 for 
calcitriol and these are not seen in the mass spectrum of the two 
conq>ounds.
This suggests that neither compound is structurally related to vitamin
2:3 Coniparison Between Vitamin D^And The Phosphataemic Fraction 
Using X~Ray Diffraction
The p la t e s  show the r e s u l t s  o f  X - r a y  Powder D i f f r a c t i o n  A n a ly s i s  
of b o th  v it a m in  D^ and the d r ie d  phosphataem ic  f r a c t io n  (h  - k ) .
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x-ray diffraction is conmonly used as a confirmatory technique 
in the analysis of the composition and stereochemistry of con^lex 
molecules. Powdered or crystalline material is capable of scattering 
incident X-radiation in a way dictated by the relative angles of 
the planes of the crystal lattice. The radiation is reflected as 
light on a mirror, and the resultant photograph of the diffracted 
X-rays gives a reliable fingerprint of the substance. If a mixture 
of substances is present then the two will produce superinçosed 
photographic images. (Lipson and Steeple, 1970).
Therefore, the X-ray diffraction pattern for the phosphataemic 
fraction cannot be used to identify the structure of either compound 
but can be used to determine whether or not rings are comparable
with those of vitamin D. It is clear that the two diffraction
3
patterns are very different and thus vitamin is not present in 
the phosphataemic fraction. The above plates show the powder 
X-ray diffraction photographs of vitamin D^» vitamin D2 and peak 4 
material (plates j.h and k respectively).
2:4 Thin Layer Chromatography
The Carr—Price reagent is used to identify v itamin in thin— layer 
chromatography. When the extract was tested the reaction was 
negative - no orange reaction product was revealed. (See Appendix 
3 for reagent cosmosition).
2:5 Ultra-violet Spectroscopy
The ultra-violet absorption spectrum of l,25(Cfl)2 cholecalciferol 
has an absorption maximum of 265 nm in absolute ethanol. When
197
dissolved in pure ethanol "peak 4" has two absorption maxima .
These are at 345 nm and 270 nm, which is similar to those obtained 
in aqueous solution. Vitamin has absorption maxima at 265 nm 
when dissolved in absolute ethanol.
Hence, it appears that the plant extract components have different 
structures and compositions from either of these vitamin compounds 
It is likely that the two peaks of the plant fraction correspond 
to each of the compounds separated by thin layer chromatography in 
Experiment 1:3.
3. CHARACTERISATION OF THE "PEAK 4" MATERIAL
3:1 Confirmation of the Presence of a Secondary amine 
within '*Peak 4"
The presence of an amine may be confirmed by using the nitrous 
acid test. Nitrous acid is liberated from the test substance by 
hydrochloric acid and sodium nitrate. The nitrous acid is then 
detected by starch-iodide paper. (Vogel,1978 ).
Method
A small amount of freeze dried "peak 4" material was dissolved 
in 0.5 ml 2M HCl, cooled in ice and then 0.2 ml ice-cold lOZ 
aqueous sodium nitrite was slowly added.
Result
The solution gave an inmediate positive result with starch-iodide 
paper in that the colour of the solution changed to orange/brown.
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Ccnclusioc
Xhe ”?eak 4*^ naterial coatains an aaine.
Deteiminatioc of the Type of Amine Present in '*Peak 4”
(i) T'ae "peak 4” material was subjected to more specific tests 
for aliphatic and arooiatic primary amines which proved negative.
(ii) Similarly a test for tertiary aliphatic amines proved
negative.
(iii) The presence of the orange-brown colour following the 
nitrous acid test was indicative of a secondary amine. This was 
confirmed by the Liebemann nitroso reaction. The nitrosamine 
(formed by the nitrous acid test) is warned with phenol and conc­
entrated sulphuric acid. The latter liberates nitrous acid from 
the nitrosamine and this reacts with the phenol to form p—nitro- 
sophenol The latter can then be combined with another molecule of 
phenol to give red indophenol.
Method
The oil from the nitrous acid test was extracted with ether and 
washed with water, dilute sodium hydroxide and again water. The 
ether was then evaporated. The nitroso compound was added to 
phenol, warmed, then cooled and concentrated sulphuric acid was 
added. The solution then turned purple and became red on addition 
of the solution to an excess of cold water.
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Conclusion
The "peak A" material contains a secondary amine.
3:2 The Effect of Solvent pH on the Partially Purified 
Material from "Peak A"
Introduction
The effects of solvent pH on the ultra-violet absorption spectrum 
of the extract, in aqueous solution, was examined.
Methodology
An aqueous solution of the material from "peak A" was placed in a 
cuvette and the absorption spectrum scanned between 200 nm and 500 nm. 
The resultant absorption profile was drawn out on a chart recorder.
The pH of the solution was then carefully varied and 
the absorption profile at each pH drawn superimposed on previous 
Spectra. Sodium hydroxide or hydrochloric acid was used to raise or 
lover the pH respectively.
Results
It was found that the solution became a deep yellow colour at 
high pH values . Below pH 6.0 the solution became colourless.
The different spectra are shown in the following Figure 18.
Discussion
The results of previous experiments have shown that two substances 
are present in the partially purified phosphataemic extract, in 
particular fluorescence spectroscopy indicated that the peaks
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(at neutral pH) at 270 nm and 345 nm belonged to separate confounds. 
This experiment also suggested that two individual absorption 
spectra are present because the peak at pH 6.35 is at 350 nm and 
this shifts to 400 nm at pH 9.8. The 270 nm peak only shifts to 
283 nm. Similarly, the 350 nm peak at pH 6.35 shifts to 340 nm at 
pH 3.2, while the 270 nm peak is unchanged. The increase in 
absorption maxima under hi ^ e r  pH conditions is termed a'batho- 
chromic shift*and is often accompanied by an increase in the 
intensity of absorption as the result of a substituent attaching 
to the molecule. (Dawber and Moore, 1973). There is evidence 
of an increase in the intensity of the peak at 400 nm with increasing 
pH, which is indicative of a *bathochromic shift'; the 270 nm peak, 
however, shows little variation in intensity with changing pH.
These observations indicate that the substance with absorption 
mayiwuTi) 350 nm (pH 6.35) becomes hydroxylated at higher pH values 
and that the hydroxyl group(s) is lost at lower pH.
The deepening in colour of an alkaline solution (to yellow) is 
typical of primary and secondary aliphatic nitro compounds and also
where there is a nitro group substituted in the 'o' and 'p 
positions of an aromatic phenol. The latter observation
would best fit the compound under study. It may be
that the hydroxy group is incorporated as the result of raising the
pH and the nitro~groups were part of the original molecule. The
hydroxyl group would then be lost on acidification (generating a
clear solution).
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CHAPTER 6
GENERAL DISCUSSION
The speed with which Trisetum flavescens could induce the clinical 
signs of calcinosis in domestic ruminants (Simon, Daniel, Hänichen 
and Spiess, 1978) was an indication that a potent calcinogen was 
present. Researchers had found calcinogenic activity in organic 
extracts of the plant which produced significant elevations in the 
plasma phosphate levels of rats (Zucker, Kreutzberg and Rambeck , 1977) 
and thus it was clear that the calcinogenic activity of Trisetum 
flavescens was not immediately comparable with that of Solanum 
malacoxyIon which possesses a water soluble calcinogen. Further— 
more, Rambcck, Oesterhelt, Vecchi and Zucker (1979) were unable to 
detect significant amounts of vitamin D-related substances in organic 
extracts of Trisetum flavescens.
The presence of a phosphataemic principle in organic extracts is 
confirmed in Chapter 3 (Experiment 1) where the organic extract is 
reported to promote intestinal phosphate transport in vitamin 
deficient chicks. That this is not likely to be caused by vitamin 
or 1,25(0H)2D2 is suggested by a) the findings of Rambeck et al (1981) 
that only 0 . 1  ppm vitamin and no 1,25(OH)2^2 is present in the 
organic fractions. These workers used lyophilised Trisettm flavescens 
for their bioassays for vitamin “ potency of the plant and it 
was recognised that the organic fractions might not possess all of 
the calcinogenic activity; and b) the findings of Zucker, Kreutzberg^ 
Nitsche and Bittner (1979) who showed that organic extracts of the 
plant were unable to overcome strontium inhibition of the renal
20A
25(OH) cholccalciferol - la - hydroxylase.
The results of the present study (chapter 3, experiment 2) which 
indicate that organic extracts are not able to promote intestinal 
calcium transport in vitamin D^- deficient birds are in accordance with 
Zucker's results. The results reported in chapter 3 (experiment 1) 
indicate that the increase in intestinal phosphate transporting 
ability of vitamin D^- deficient birds given a single dose of an 
organic extract (equivalent to 1.5 g dried plant) is in excess of 
that in birds fed a vitamin D^- replete diet. On the other hand,
vitamin D - deficient birds given 500 iu vitamin D- and subsequently
3
tested for radiophosphate transport (chapter 4, experiment 7) 
shoved a low net transfer of phosphate combined with much higher 
levels of phosphate 'trapped* in the gut tissue when compared with 
either controls or "peak 4" treated birds. Vitamin D^- deficient 
controls have both a low level of radiophosphate 'trapped* in the gut 
tissue and a low net transfer to the body.
Thus, there appears to be a difference in the 'pattern* of phosphate 
transport induced by vitamin and organic extracts of the plant.
The rate limiting step in the transfer of phosphate from the gut 
lumen to the bloodstream is the transfer out of the gut tissue and 
into the blood (Wasserman and Taylor, 1972). These workers thought
that this process was vitamin D - dependent although later workers
3
have thought that only diffusion is involved. Peterlik and Wasser­
man (1980) and Fuchs and Peterlik (1979) state that vitamin D^only 
affects phosphate uptake from the mucosal side, by increasing the
Vmax of the reaction.
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There appear to be two Independent trans-cellular mechanisms for
phosphate transfer across the mucosal surface - one Na^-dependent
and the other Ca** -dependent - and a non-vitamin ¡ndependent
paracellular route. Very little is known about the transfer of
phosphate to the bloodstream, except that a Na K ATPase is involved
♦ ♦
(Taylor, 1974) with the sodium dependent process. The Na K 
ATPase is the means by which the sodiijm ion gradient is formed and 
maintained (Matsumoto, Fontaine and Rasmussen, 1980) . Later 
research has shown that the Ca** -dependent phosphate transport 
process is probably associated %rith an intestinal calcium-dependent 
alkaline phosphatase, which in turn is stimulated by calcium and 
magnesium ions. The calcium-dependent alkaline phosphatase could 
be acting as an ATFase (Birge and Avioli, 1981). It is not possible 
to tell which of the transport mechanisms is being influenced by 
the organic extracts of Trisetum flavescens but it is most likely 
to be the paracellular pathway.
Experiment 2 (chapter 3) reveals the non-identity of the final 
purified extract used in Experiment 1 with vitamin D^; a higher 
dose level was used (■ 2.7g) and yet vitamin D2(200Iu/chick) 
stimulated the transport of significantly higher levels of radio- 
calcium into the bloodstream. This again suggests that the plant 
extracts influence phosphate transport and do not affect vitamin D- 
dependent calcium transport.
In addition, biologically active fractions of the organic extract 
of Trisetum flavescens show little variation from control values 
in their effects upon the time course of radiocalcium release from
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bone tissue cultured in vitro. The lack of evidence for calcium 
release from bones treated with organic extracts, together with 
the fact that there is no significant release of phosphate from 
bones cultured in vitro suggests that the high plasma phosphate 
levels of animals treated with these extracts result from increased 
intestinal transport and not bone resorption. An increase in the 
renal retention of phosphate is also a possibility but it was not 
possible for this to be investigated in this project. Dirksen 
has reported elevations in urinary phosphate (Dirksen, Plank,
Dammrich and Hänichen, 1970) in cattle with Trisetum flavescens- 
induced calcinosis and thus increased renal jrcab sorption of phosphate 
is not likely to be the cause of the phosphataemia.
Thus the organic soluble phosphataemic factor is not directly 
coiq>arable with either vitamin or calcitriol and yet has a potent 
effect upon the transfer of phosphate to the bloodstream. It could 
therefore be influencing the, as yet unidentified, mechanism (s) 
for phosphate uptake by the bloodstream from the gut.
The technique of strontium inhibition of the kidney 25(OH) chole~ 
calciferol**lci”hydroxyla8® as a model for testing calcitriol—like 
effects of calcinogenic plants has been used in investigations into 
the activity of purified organic extracts of ^^ j*8etum flavescens.
The results showed that no reversal of the strontium—induced vitamin 
D*~deficiency occurred (Zucker at al 1979) and yet when whole 
lyophilised leaves of the plant were used (Peterlik, Regal, Kohler, 
1977) it was found that there was a reversal of the effects of 
strontium. Similarly, workers found a high level of vitamin
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ooterxy in lyophilised plant material used in the 'Japanese Quail Egg- 
Shell Test* Raobeck, Kreutzberg, Bnms-Droste and Zucker (1981), and 
vet it was only the organic extracts that were exaitined for vitamin 
content. These observations suggested that vitamin I^like activity 
night reside in aqueovis soluble extracts of the plant.
Investigations into the activity of aqueous soluble extracts of 
the plant, as described in Chapter 4, have shown this to be the case. 
Activity found in a crude aqueous extract of the plant was quickly 
shown to be unlike that of Sol^"«™ malacoxylon. Feeding an active 
aqueous extract of Solanum aalacoxylon to vitamin D-deficient rats 
caused an increase in plasma calcium after twenty—four hours, 
following an initial decline in the levels, which reached a maximum 
at forty-eight hours. Plasma phosphate, in the same animals, 
showed a decline at twenty-four hours after an initial transient 
increase (Campos, Ladizesky and Mautalcn, 1973). In contrast, a 
crude aqueous extract of Triscttg^^lavescans given to vitamin 
deficient chicks catxsed a significant increase in plasma phosphate 
at forty-eight hours, and little change in plasma calcium. This 
compares well with the situation seen in cattle suffering from 
Trisetum flavescens—induced calcinosis where plasma phosphate 
levels are persistently above normal.
There is evidence (chapter 4, experiment 2) that the phosphataemic 
effect of the crude aqueous extract of Trisetum flavescens is 
only active when dosed orally. This is surprising, since the purified 
organic extract (chapter 3, experiment l)and the partially purified 
aqueous soluble extract ("peak 4": chapter 4, experinent 7) are
208
both shown to increase plasma phosphate levels when dosed sub-cutane - 
OUsly. Also, the crude aqueous extract (chapter 4, experiment 1) 
and whole lyophilised plant will raise plasma phosphate when given 
orally and so the decline in both plasma phosphate and [Ca x P^] 
when the crude aqueous extract is dosed non-orally, is difficult to 
interpret. It is possible that the aqueous soluble calcémie and the 
phosphataemic factors complex when dosed in this fashion.
The evidence showing that the crude aqueous extract, when dosed sub­
cutaneously or intra-muscularly causes a rise in plasma calcitmi 
levels (significantly higher than in orally dosed birds) suggested 
that the crude aqueous extract possessed a vitamin IHlike substance 
capable of stimulating calcium transport. To determine the ability 
of the crude aqueous extract to promote intestinal calcium transport, 
use was made of the »strontium chick model* (experiment 4(i) chapter 4) 
As shown by Peterlik at al (1977), who used whole lyophilised plant 
leaf, the crude aqueous extract was found to be able to promote 
intestinal calcium transport. Therefore the contradictory results 
of Peterlik at al (1977) and Zucker at al (1979) can be explained in 
the light of these results, namely, that a phosphataemic factor, 
not similar to calcitriol, is present in organic soluble fractions 
of Trisetum flavescens, whilst an aqueous soluble constituent is 
present which resembles calcitriol, at least in its action. Thus 
only the use of whole lyophilised plant material or aqueous extracts 
pan result in the reversal of strontium inhibition of calcium trans­
port.
Evidence for a third aqueous soluble calcinogenic factor in the
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plant was found «ben partially purified material obtained from under 
the final major peak ("peak following Sephadex chromatography 
(See Figure 8) was tea ted in the strontiui chick model and coiqiarcd 
with the previous major peak ("peak 3"). This revealed that 
"peak 4" could significantly raise plassm phosphate levels but had no 
significant effect upon plassia calcium or calcium transport levels. 
"Peak 3", however» did significantly increase intestinal calcium 
transport and plasma total calcium levels were above those of 
control birds although not significantly so. It can therefore be 
presumed that the stimulation of calcium uptake seen in chicks
having strontium-induced vitamin D-deficiency» and dosed with the
3
crude aqueous extract» is brou^t about by the activity found in 
"peak 3" material. Further» this active fraction» in order to over­
come strontium inhibition» must be akin to a calcitriol analogue or 
a substance able to miaic the effects of calcitriol» or calcitriol 
itself linked to a water-soluble constitumat as seen in the sterol- 
glycoside of Solanum malacoiqrlon. This would explain the siseable 
increase in [Ca x P^] since plasma phosphate is also raised when
vitamin I^^eficient chides are given a crude aqueous extract of
3
Trisetum flavescens, as well as the stability of plasma calcium 
levels in affected cattle where plasma calcium is siaintained at 
a little above normal despite large increases in plasma inorganic 
phosphate.
Investigations into the mode of action of the aqueous soluble
phosphataemic factor ("peak 4") showed that it raised plassia
phosphate levels in chicks with strontiusrinduced vitasdn
deficiency» dietary vitamin D deficiency as well as in vitamin Do-
3
replete birds (experiments 5, 6(i) and 6(ii) respectively, chapter 4)
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The increase in plasma phosphate levels appears to reach a 'celling' 
only in the vitamin I^replete birds. This, I would suggest, was 
due to the msximal solubility product being exceeded after a twelve 
hour period leading to precipitation of calcium and phosphate and 
resulting in the slow decline in the [Ca x P^] . It therefore appears 
that this aqueous soluble phosphataemic factor is operative in both
vitsmin D-replete and vitamin D-deficient animals and appears to
3 3
affect only plasma phosphate directly.
Comparison of the effects of vitamin and "peak 4" upon ileal
radio-phosphate transport (experiment 7, chapter 4) reveals a great
dissimilarity between the effects of the two treatments. Vitamin
Dj and "peak 4" had opposite effects upon plasma calcium, phosphate
and alkaline phosphatase levels althou^ the latter were not
significantly different from vitamin D—deficient controls • "Peak 4
had a greater effect upon radio-phosphate transport and showed only
control levels of isotope within the gut tissue, but higher levels
of isotope transported into the bloodstream. "Peak 4" can be seen
to differ from calcitriol as it does not increase calcium transport
in with strontium-induced vitamin D-deficiency (experiment 5,
3
chapter 4). These observations suggest that the factor under 
"peak 4" is able to influence one of the mechanisms involved in 
intestinal phosphate uptake. Furthermore, the phosphataemic 
factor will only bring about an increase in the [Ca x P^] in vitamin
D-replete chicks; in vitamin D-deficient chicks it produces a steep
3 ^decline in calcium levels which is accompanied by a stable [ga x P^] 
In other words, calcium is being displaced by phosphate in the 
[Ca X P^] equilibrium presumably because of calcium phosphate
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The increase in plasma phosphate levels appears to reach a ’ceiling' 
only in the vitamin IKreplete birds. This, I would suggest, was 
due to the maximal solubility product being exceeded after a twelve 
hour period leading to precipitation of calcium and phosphate and 
resulting in the slow decline in the [Ca x P^] . It therefore appears 
that this aqueous soluble phosphataemic factor is operative in both
vitamin D-replete and vitamin D-deficient animals and appears to
3 3
affect only plasma phosphate directly.
Comparison of the effects of vitamin D3 and "peak 4" upon ileal
radio*i>ho8phate transport (experiment 7, chapter 4) reveals a great
dissimilarity between the effects of the two treatments. Vitamin
D3 and "peak 4" had opposite effects upon plasma calcium, phosphate
and alkaline phosphatase levels although the latter were not
significantly different from vitamin D“deficient controls• Peak 4
had a greater effect upon radio—phosphate transport and showed only
control levels of isotope within the gut tissue, but higher levels
of isotope transported into the .bloodstream. "Peak 4" can be seen
to differ from calcitriol as it does not increase calcium transport
in chicks with strontium-induced vitamin D—deficiency (experiment 5,
3
chapter 4). These observations suggest that the factor \mder 
"peak 4" is able to influence one of the mechanisms involved in 
intestinal phosphate uptake. Furthermore, the phosphataemic 
factor will only bring about an increase in the [Ca x P^] in vitamin
D-replete chicks; in vitamin D-deficient chicks it produces a steep
3 ^
decline in calcium levels which is acconqpanied by a stable [Ca x P^] , 
In other words, calcium is being displaced by phosphate in the 
[Ca X P ] equilibrium presumably because of calcium phosphate
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deposition in soft tissues, and of course the calcium homeostatic 
system is not able to maintain noxmo-calcaemia (experiment 6(i) chapter
4) because the animals are vitamin D-deficient.
3
This is very illustrative of the concept that phosphate transport is
here being stimulated independently of the vitamin D-endocrine
3
system. It is widely accepted that phosphate uptake is independent 
of calcium absorption by the gut, and in this instance it appears 
that the aqueous soluble phosphataemic factor stimulates a phosphate 
transport mechanism without having any effect upon calcium metabolism. 
The pathway of phosphate transport here is possibly the paracellular
route which is independent of vitamin D and is thought to be the...
3
"only possible route for phosphate transport in vitamin ¡^deficient 
animals" (Fuchs and Feterlik, 1979).
It is possible that the aqueous soluble phosphataemic factor increases 
the permeability of the intestinal epithelium in the regions of these 
paracellular pathways. Hence it may be concluded that Trisetum 
flavescens contains three distinct biologically active factors 
that are able to influence calciton and phosphate metabolism in 
animals,(four if the low level of vitamin is included, although 
the level of 4 lu/g dry Trisetum flavescens of vitamin per se 
would not produce a significant response in chicks at the dosages 
used).
One of these three major calcinogens is organic soluble and influences 
intestinal phosphate transport. It is able to raise the plasma
[Ca X P ] of vitamin D-deficient chicks and lower plasma alkaline
i 3
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phosphatase. The two latter effects are indicative of the presence 
of vitamin D^. However, the organic soluble factor does not 
stimulate intestinal calcium transport in vitamin Djdeficient chicks.
Aqueous soluble extracts contain two factors, one of which is similar 
to that found in Solanum malacoxylon in that it appears to act in the 
manner of a water*-soluble form of calcitriol. Finally there is a 
potent phosphataemic factor in the aqueous extract that has effects 
upon the levels of plasma phosphate similar to those of the organic 
soluble phosphataemic factor. The major difference between the 
modes of action of the two phosphataemic substances is that the 
aqueous soluble one causes a dramatic decline in plasma calcium 
levels in vitamin ¡^deficient animals whereas the organic soluble 
one does not, this is possibly due to contamination with vitamin ^ •
Rambeck has found sizeable amounts of vitamin in the milk of 
lactating ewes fed Trisetum flavescens (Rasdbeck, Elmer, Dirksen, 
Krausslich and Zucker, 1980) which suggests that more than the 
estimated 4 lu/g of vitamin may be present in the plant.
Investigations into the physico-chemical properties of the aqueous 
soluble phosphataemic factor (’’peak 4", chapter 5)revealed the 
pres^ce of two substances within the fraction, one with fluore­
scent properties and one without. Analysis of this mixture using 
X-ray diffraction and Mass Spectrometry techniques gave strong 
evidence that neither substance was structurally similar to Vitamin 
D^ . The two compounds could be separated by thin layer chromoto- 
graphy, but time did not permit the use of preparative TLC in order 
to further test these substances in vivo. Evidence was obtained
2 1 3
}that one substance was a secondary aromatic amine, and the other 
possibly had an indolic structure.
The mixture, when dissolved in water, showed pronounced changes in 
colour and ultra-violet absorption profile at different pH values. This is 
indicative of the presence of a nitro confound. Fluorescence 
spectroscopy revealed that the two peaks seen in the ultra-violet 
absorption belonged to each of these two constituents.
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FIGURE 19
Diagrammatic Representation of Proposed Mechanism of action of
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SUMMARY
1. Studies have been conducted on the calcinogenic plant Trisetum 
flavescens in order to determine the physiological actions and 
chemical nature of the toxic substance or substances.
2. An organic soluble substance was extracted and purified using 
HPLC and shown to promote intestinal transport of radio-phosphate, 
increase plasma levels of inorganic phosphate, reduce plasma 
alkaline phosphatase; but to have no effect on plasma total 
calcium, calcium transport across the gut or bone resorption 
when studied ^  vitro.
3. An aqueous soluble substance was extracted and partially purified 
on Sephadex columns, which when administered to both vitamin D- 
deficient and vitamin D^-replete animals raised plasma inorganic 
phosphate levels but unlike the organic soluble extract, caused a 
dramatic decline in plasma total calcium. Intestinal radio-phosphate 
transport was stimulated supposedly by the paraeellular pathway of 
phosphate transport.
4. A second aqueous extract was shown to have no effect on plasma 
phosphate, but significantly increased intestinal transport of 
calcixim and strontium in chicks with a metabolic deficiency of
vitamin D caused by the inclusion of strontium in the diet.
3
This substance appears to be able to mimic the actions of 1,25 
(OH)2cholecalciferol.
5. The potent aqueous soluble phosphataemic factor is not related
chemically to vitamin D but has the characteristics of an aromatic
3
indole or amine with nitro groups.
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6. The organic soluble phosphaCaemic factor is apparently not vitamin
D since it did not promote intestinal transport of calcium in
3
chicks with a privational deficiency of vitamin D^.
7. It is concluded that the actions of these three substances in 
raising plasma [Ca x chiefly by increasing intestinal absorp­
tion of phosphate, results in calcinosis.
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APPENDIX 1 
ANIMAL HUSBANDRY
Day-old cock chicks were obtained from hatcheries and housed in large 
steel cages (Im square) on sterile sawdust. They were kept warm using 
powerful white-light lamps (Philips ). The varieties used were either 
*Ross-Brown* or "RIR x LS*. They were fed and watered ad-lib and separa­
ted into smaller groups as they grew to avoid overcrowding.
DIETS
The basic diet used was always obtained from the University of Reading 
and had the following compositions:
INGREDIENTS OF BASIC DIET.
Ingredient 1  Composition
Ground Maize 48
Soyabean Meal 44
Soyabean Oil 4
Limestone Granules 0.8
Sodium Chloride 0.54
D-L Methionine 0.06
Dicalcium Phosphate 2.6
(N.B. Limestone granules were omitted from diets in which strontium was 
supplemented, giving a calcium content of 0.15Z).
A vitamin/trace element mix was obtained from Beecham Pharmaceuticals. 
This was in a finely powdered form suitable for addition to animal 
feeds, and was carefully added to the basic diet to give the following 
composition:
(b)
BEECHAM VITAMIN/TRACE ELEMENT MIX
COKPONENT CONCENTRATION/KG BASIC DIET
Vitamin A 8000 units
Vitamin B .12
5vg
Vitamin B 2
6.Amg
Vitamin E 10 lu
Vitamin K 1.6mg
Pantothenic Acid S.Omg
Nicotinic Acid lA.Amg
Folic Acid l.Omg
Choline 250mg
Copper A.Sag
Manganese 6A.0mg
Iodine 1.6mg
Selenium O.lmg
Vitamin was supplied separately for addition to the vitamin D y  
replete diets. The supplement was added to the diet at a level of 
2000 lu/Kg.
(c)

AMINO ACIDS Contd/.
L - Methionine 50.0
L - Phenylalanine 50.0
L - Proline 400.0
L - Serine 200.0
L - Threonine 75.0
L - tryptrophan 40.0
L - tyrosine 40.0
DL - Valine 65.0
VITAMINS
Alpha Tocopherol phosphate 1.0
(disodium salt)
Ascorbic acid 50.0
Biotin 0.2
D - Calcium Pantothenate 0.2
Choline chloride 50.0
Folic acid 0.2
i *■ inositol 0.2
Nicotinamide 20.0
Para-aminobenzoic acid 2.0
Pyridoxal phosphate 0.2
Riboflavin 0.2
Thiamine hydrochloride 4.0
Vitamin 0.04
(e)


VITAMINS Contd/,.. C0NCENTRA1
(ing/l)
Choline chloride 0.5
Folic acid 0.01
i - inositol 0.05
Menadione 0.01
Niacin 0.025
Niacinamide 0.025
Para ~ aminobenzoic acid 0.05
Pyridoxal HCl 0.025
Pyridoxine HCl 0.025
Riboflavin 0.01
Thiamine HCl 0.01
Vitamin A 0.1
The pH of the medium is 7.4.
( h )
APPENDIX 3
COMPOSITION OF TLC SPRAY REAGENTS
1. Ferric chloride/potassium ferricyanide reagent.
a) A IZ aqueous solution of potassium ferricyanide.
b) 2Z aqueous ferric chloride. These solutions are mixed together 
in equal volumes just prior to use.
2. k  -  dimethylaminobenzaldehyde (Ehrlich's reagent).
Ig A - dimethylaminobenzaldehyde in a mixture of 25ml 36Z HCl 
and 75ml ethanol.
3. Alkaline silver nitrate for phenols and aromatic amines.
Spray 1
1 ml of a saturated solution of aqueous AgNO^ was added, with 
stirring to 20ml acetone then this was treated dropwise with 
water until the precipitated AgNO^ had just dissolved.
Spray 2
The plate was treated finally with a solution of 0.5Z sodium 
hydroxide in 80Z ethanol.
Arylamines + phenols give brown/black spots.
A. Formaldehyde and HCl (Prochazka reagent).
The following solutions are mixed together:
i) lOmls 35Z formaldehyde solution
ii) lOmls 25Z HCl v/v
iii) 20mls ethanol.
The plate is sprayed with the above mixture, then heated in an 
oven at 100®C. The plate is then examined in long wave ultra-violet 
light.
5. Diraethylaminocinnamaldehyde Reagent.
2g of this is added to lOOmls 6N HCl and lOftal ethanol. This is then 
diluted with four times its volume to produce the spray reagent.
U )
10.
11 .
12 .
1,2 Naphthoquinone-4-sulphonic acid (sodiua salt) 5ml acetic acid 
added to 0.5g 1,2 aaphthoquiaotxe-4*-sulphonate in 95ml water.
Reaction occurs within 30 minutes.
Fluorescein and asmonia Reagent. A 0.0051 solution of fluorescein 
in 0.5M ammonium hydroxide. Inspect in long and short wave 
ultra-violet light.
Perchloric acid/ferric chloride Reagent. lOCmls of 5Z aqueous 
perchloric acid is mixed with 2ml of 0.05M ferric chloride 
solution prior to spraying.
Iodine and potassiim iodide Reagent. Ig of iodine and lOg of 
potassium iodide are dissolved in 50ml water by warming. 2mls 
of acetic acid was added and then the solution is made up to lOOmls 
with water.
Bismuth Trichloride Reagent. A 33Z ethanolic solution of BiCI^, is 
sprayed onto the plate, which is then heated at llO^C until 
there is optimum fluorescence of the spots in long wavelength ultra~ 
violet light.
2,6 dichlorophenol — indophenol (sodium salt) Reagent. A O.IZ 
ethanolic solution of the sodium salt of 2 ,6 dichlorophenol- 
indophenol. Red spots indicate a positive reaction with organic 
acids.
Carr Price Reagent for vitamin D. A saturated solution of
3
antimony III chloride in chloroform is sprayed onto the plate 
and the plate is then heated at 100®C for 10 minutes. Orange 
spots indicate a positive result.
(J)
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SUMMARY
A crude aqueous extract of the leaves of T, flavescens when 
administered orally to vitamin D-deflclent chicks produced signifi­
cant Increases in plasma phosphate but had little effect on plasma 
calcium. Vfhen chicks, fed a high strontium diet to inhibit 
endogenous l,25(OH)2 vitamin D3 production and Intestinal calcium 
transport, were dosed with the extract or synthetic 1,25(OH)2D3**^Ca 
absorption from the duodenum in vivo was stimulated, whereas 
vitamin D 3 was ineffective. Partial purification of the crude 
extract on a Sephadex GH25 column yielded two factors, one of 
which mimicked 1,25 (OH)2D3 activity in chicks fed the high 
strontium diet while the other produced a significant Increase in 
plasma phosphate. The presence of these substances, together 
with previously demonstrated organic solvent soluble vitamin 
D-type activity, may account for the calclnogenlc nature of the 
plant.
Cattle grazing on the alpine pastures of Austria and Germany develop calcinosis, 
a disease characterised by elevated levels of plasma calcium and phosphate, soft 
tissue calcification, lameness and emaciation (1,2). The disease, «»hlch is 
reminiscent of vitamin D intoxication, is caused by the ingestion of Trisetum 
flavescens L. (Golden oat grass) (3) which has been shown to possess antira­
chitic activity when fed to vitamin D-deflcient chicks (4). The leaves posses 
vitamin D3 (5) but at a concentration (0.1 ppm) which would not be calcinogenlc. 
The solanaceous plants Solanum malacoxylon Sendtner and Cestrum diumum L. are 
calcinogenic (6,7) and the causative agent has been identified as l,25(OH)2 
vitamin Da (l,25(OH)2D3) (8,9) which occurs as a glycoside. It has been 
suggested that the calcinogenic principle in T. flavescene is also l,25(OH)2D3 
(10). Since organic solvent extracts have been reported not to contain this 
metabolite (1 1 ) we have examined aqueous extracts of the leaves of the grass for 
vitamin D and l,25(OH)2Da-like activity.
MATERIALS AND METHODS
Anisals and diets
Day old Rhode Island red x White Leghorn cock chicks were used. They were 
reared on a diet based on maize and soya bean and supplemented with minerals and 
vitamins with the exception of vitamin D. The diet contained 0.95Z calcium and
0024-3205/82/151255-08$03.00/0 
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0.46Z available phosphorus. To produce a D-repleCe control diet 1200 lU 
vitamin D 3/kg were added. These diets were fed for three and a half weeks 
prior to the commencement of the experiments.
To produce a high strontium diet supplemental calcium as the carbonate was 
replaced on a molar basis by strontium as the carbonate. Thus, this diet 
contained 1.74Z Sr., and 0.151 Ca. The incorporation of stable stronium into 
the diet produces rickets (12). Strontium inhibits vitamin D3-lnduced calcium 
binding protein (CaBP) production and the intestinal calcium absorptive mechan­
ism (13) by blocking the conversion of 25(OH) vitamin D3 to 1,25(OH) 3 by the 
kidney (14).
Preparation of T. flavescens extracts
Finely ground dried leaves of the grass, harvested from a monoculture in early 
July, were extracted with chloroform (10 g leaf in 150 ml chloroform) for two 
hours. Chloroform soluble material was discarded and 10 g of the drlef leaf 
residue stirred for 20 hours in 100 ml distilled water. The extract was 
separated from Insoluble material by filtration and freeze-dried. Freeze-dried 
material was taken up in distilled water, so that 1 . 0 ml contained the equiva­
lent of 2 .0 g of original leaf powder, to provide a crude aqueous extract.
Chromatography
1.5 ml aliquots of the crude aqueous extract were applied to 40 x 2.8 cm columns 
packed with Sephadex G25 (fine) which had been equilibrated with distilled 
water. The coltimns were eluted with distilled water (2.0 ml/min.) and 7.5 ml 
fractions collected. The chromatographic profile of the eluent was followed by 
determining the UV absorbance at 267 nm (Flg.l). Fractions under the peaks 
were bulked and freeze-dried to provide six partially purified extracts (I-VI) 
for biological testing. Prior to testing the extracts were taken up in 
distilled water so that 1 .0 ml contained the equivalent of 2.0 g of starting 
material.
Chemical determinations
Plasma calcium and strontium were measured by atomic absorptiometry and plasma 
inorganic phosphorus (Pi) by a commercial method (Boehringer Kt No. 124974). 
Radioactivity was measured in a Beckman LS7500 liquid scintillation counter, 
corrected for quench and efficiency and is expressed as disintegrations per 
minute (dpm).
Experiment 1
The crude aqueous extract was screened for vitamin D and l,25(OH)2 vitamin 
D—type activity. To test for vitamin D—type activity four groups of five
chicks were used; group 1 was vitamin D-replete, groups 2,3 and 4 vitamin 
D-deficlent. After 28 days group 3 received one oral dose of crude extract 
(“ 0.5 g dried leaf) at time 0 and plasma Ca and Pi were estimated 24 hours 
later. Group 4 was similarly dosed at 0 and 24 hours and plasma Ca and Pi 
measured at 48 hours: at this time plasma Ca and Pi were also assayed in groups 
1 and 2.
In order to test the crude extract for 1,25(08)2^3-type activity four groups, 
each of five chicks, were transferred from the D-replete/Ca-replete diet to the 
high Sr. diet at 23 days of age. On day 28 and again on day 29 the 
groups were dosed with either 0.2 ml propylene glycol (control) vitamin D3 (100 
lU/dose), 1,25(OH)203(0.25 pg/dose) or 0.25 ml crude aqueous extract of 
^l*vcao» (= 0.5 g dried leaf powder/dose). On day 30 the chicks were
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anaesthetized with sodium pentabarbltone (3.5 mg/100 g body weight). The
duodenum was exteriorized and an 8 cm segment ligated to form a sac. 1 .0 ml of
a solution, at 40*C, containing 1 mg of calcium as calcium acetate and lOpCl'^^Ca 
was injected into the sac (15). The duodenum was returned to the body cavity, 
the wound closed by clips and a fifteen minute absorption period allowed. At 
the end of this time, radio-calcium, total calcium and strontium were measured 
in blood samples taken from the wing vein.
Experiment 2
Following Sephadex G25 chromatography material under peaks I-VI (Flg.l) was 
screened for vitamin D and 1,25(OH)2D-type activity in a pilot experiment. 
Biological activity appeared to be associated with peaks III and IV and these 
were subjected to further examination. The experimental protocols were those 
adopted in experiment 1 , except that at the end of the fifteen minute absorption 
period the duodenum was removed and residual radioactivity determined In the 
ligated segment. The absorption data are expressed as percentage of administ­
ered dose.
FIG. 1
Partial purification of an aqueous extract of T-flavescens on a 
Sephadex G25 column. Chromatographic conditions are described In the 
text. Biological activity resides In fractions under peaks III and 
IV. Conductivity measurements Indicated that fractions under these 
peaks were essentially salt-free.
RESULTS
Experiment I
Plasma phosphate levels in vitamin D-deflcient chicks given oral doses of a 
crude aqueous extract of the grass were significantly greater than in untreated 
vitamin D-deficient chicks. Following a single dose of extract phosphate 
levels were significantly elevated twenty-four hours later. The mean plasma 
phosphate level in the group given two doses of extract was greater than for 
vitamin D-replete chicks, but not significantly so. The extract was without 
significant effect on plasma calcium levels (Table 1).
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TABLE I
Plasma Phosphate and Calcium in Vitamin D-deflclent chicks following the oral 
administration of a crude aqueous extract of T. flavescens (TFE).
Treatment
Group (oral doses)
1 D-replete
2 D-deflcient
3 D-deflcient
TFE (24h)
4 D-deflcient 
+ TFE (48h)
Significance of differences (t-test)
For Pi: Group 1 v 2, P < 0.001
2 V 3, P < 0.025
2 V 4, P < 0.001
1 V 4. NS
Plasma levels (mean t SEM) 
Pi
4.60 ± 0.33 
2.06 ± 0.25 
3.08 ± 0.28
5.74 ± 0.82
Ça
10.10 ± 0.24 
8.00 1 0.69 
8.36 ± 0.12
8.12 ± 0.85
For Ca; Group 1 v 2, P < 0.025 
2 V 3, NS
2 V 4, NS
Chicks were dosed orally with a crude aqueous extract of T. Flavescens (TFE) 
equivalent to 0.5 g dried leaf per dose. Group 3 chicks were given one dose 
and plasma Ca and Pi estimated 24 hours later. Group 4 chicks were dosed at 0
hours and 24 hours and plasma Ca and Pi measured at 48 hours. Values are 
mg/100 ml plasma ± S.E.M.
In chicks fed the high strontium diet the crude extract was without significant 
effect on plasma calcium or strontium although the mean value of the latter was 
considerably greater than that for the control group. Absorption of radio- 
calcium from the duodenum was significantly increased by this treatment. When 
compared with the control group 1,25((N1)2D3 prompted uptake into the plasma of 
duodenally adminiatered **^ Ca, significantly increased plasma strontium, but was 
without significant effect on plasma calcium levels. Vitamin D3 was without 
effect on any of these variables (Table II).
Experiment 2
The partially purified extracts, peaks III and IV, were without significant 
effect on plasma calcium and this was also true for l,25(OH)2D3 and vitamin D3. 
When compared with the control group plasma phosphate was significantly reduced 
by 1,25(0R)2D3 but significantly increased by peak IV. Vitamin D3 and peak III 
were without effect on this variable. Duodenal transport of •»Sca* was not 
influenced by vitamin D3 or peak IV but was significantly increased by 
1,25(0H)2D3 and peak III (Table III).
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DISCUSSION
These experimenta have revealed the presence of water-soluble vitamin D-like 
substances in the leaves of the calcinogenlc plant T. flavescens. The obser­
vation that the extract was greatly effective in increasing plasma phosphate 
levels but had little effect on plasma calcium is in accord with the reported 
levels of these ions in the blood of animals affected by calcinosis. Such 
animals have plasma calcium levels in the upper part of the physiological range 
whereas plasma phosphate levels may be twice normal (16). Since the crude 
aqueous extract was able to overcome the inhibitory effect of the high stable 
strontium diet on calcium absorption from the duodenum, this provides evidence 
for the presence of l,25(OH)2D3 or a substance able to mimlck its actions. In 
the vitamin D-deficient chick the crude extract produced very small increases in 
plasma calcium suggesting that the grass contains a low 1,25(OH)2D3-llke 
activity.
Following Sephadex G25 chromatography a partially purified factor was Isolated 
which overcame the strontium inhibition of duodenal calcium absorption, thus 
confirming the l,2S(OH)2D3-like action of the crude extract. The presence of 
this 1,25(0H)2D3-like substance in a water-soluble form would explain the 
induction of calcium binding protein (CaBP) in chicks fed a high strontium diet 
to which lyophllized leaves of T. flavescens had been added (10). It also 
affords an explanation for the failure of Zucker and colleages (11) to overcome 
strontium inhibition of CaBP synthesis with the plant and for the failure of 
Rambeck and colleages (5) to identify the presence of l,25(OH)2D3 by gas 
chromatographlc/mass spectrometric analysis, since in both cases diethyl ether 
extracts were used.
The administration of material from a second peak (peak IV) was ineffective in 
overcoming strontium inhibition of calcium absorption but did increase plasma 
phosphate. Hence, it appears that the vitamin D-llke activity of the crude 
aqueous extract is due to the presence of at least two substances, one having a 
l,25(OH)2D3-llke effect, the other having a potent phosphataemlc action. It 
may be that this latter substance is the major causative principle in 
T. flavescens-induced calcinosis.
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